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SUMMARY
The present research was carried out to investigate the chemoattraction activity of 
rheumatoid and non rheumatoid synovial fluids for human lymphocytes separated 
from peripheral blood, synovial tissue and synovial fluid. The phenotyping of 
locomotor cells in response to these fluids was also studied. Established 
procedures were used to separate lymphocytes from blood, synovial tissue and 
synovial fluid. The level of the chemotactic factors in the synovial fluid was 
measured by commercial and in-house developed methods. The inhibitory effect 
of anti-inflammatoiy dmgs on the lymphocyte locomotion was also studied.
Tlie chemoattractant activity of synovial fluid for human lymphocytes was 
investigated using the following methods: i. A Polarization assay which measures 
the shape change from spherical or round to a polarized shape (i.e from immotile 
to a motile shape) following stimulation with chemoattiactants. ii. Collagen gel 
invasion, which measures the migration of lymphocytes into collagen gels- 
containing chemoattractants. Two methods were used for phenotyping the cells 
responding to the synovial fluids (1) APAAP which allowed the detection of 
lymphocyte surface markers in stained cytospin preparations, (ii) FACS which 
allowed the detection of cell surface markers of lymphocytes recovered from 
collagen gels after collagenase digestion. In addition methods used to measur e the 
levels of chemotactic factors in the synovial fluid, were (D Commercial single
25
antibody sandwich ELISA kits (R&D) which measured IL-2, IL-8, M IP-la and 
MCP-L ff l  In-house developed multiple antibody sandwich ELISA which 
measured IL-15 in the fluids.
The ability of synovial fluids from patients with rheumatoid (n=35) and other 
arthiitides (n=18) to attract lymphocytes from peripheral blood of normal subjects, 
from rheumatoid synovia, and from joint fluids, was studied. The majority of 
synovial fluids from 29 rheumatoid arthritis patients were strongly attractive for 
blood lymphocytes which had been cultured overnight. Three out of five fluids 
from OA also attracted lymphocytes but to a lesser extent than RA fluids. In 
addition four of seven fluids from other inflammatory arthritides also gave high 
responses
Rheumatoid synovial tissue lymphocytes responded to synovial fluids without a 
requirement for a period of culture. In contrast lymphocytes derived from 
rheumatoid and other synovial fluids were completely unresponsive to locomotor 
stimulants. Most of the responding cells from blood mononuclear cell fractions 
were T lymphocytes and the CD45RO isotype was attracted preferentially. 
Rheumatoid synovial fluids contained IL-8 , IL-15, MIP-la and MCP-1 at levels 
in the nanogram range, sufficient to attmct lymphocytes, but levels of IL-2 were 
too low to exert a chemoattractant effect. In contrast the levels of chemotactic 
factors in OA fluids were low and these fluids also showed less activity in 
attracting lymphocytes. The activity of the fluids could not be abolished by
27
à
treatment with antibodies to IL-8, IL-2, MIP-la, MCP-1 or IL-15 tested 
individually, but combinations of these antibodies inhibited most of the activity, 
suggesting that attraction of lymphocytes by the fluids is due to a combination of 
attiactants. The accumulation of lymphocytes within the synovial fluids was 
not correlated with any single chemotactic factor mentioned above, suggesting 
that such accumulation is due to combined chemoattractants.
In the present study it was also observed that neutrophils separated from 
normal blood gave a strong chemotactic response to the synovial fluids. In 
contrast neutrophils separated from the synovial fluid were immotile, 
suggesting that these cells had an intrinsic defect or that their locomotion was 
selectively blocked by synovial fluid chemotactic inhibitors. Moreover there 
was no correlation between IL-8 or levels of any other single cytokine and the 
accumulation of these cells in the fluids, indicating the possibility of multiple 
chemotactic factor involvement.
The manipulation of the locomotion activity of lymphocytes in vitro in 
response to synovial fluid was studied using anti -inflammatory drugs. It was 
demonstrated that NSAIDs (including Aspirin, Ibuprofen and indomethacin), 
DMARDs (including gold, D-penicillamme and primaquine) and cytotoxic 
drugs including rapamycin and cyclophosphamide had no inhibitory effect on 
lymphocyte locomotion. On the other hand cyclosporin A and 
Glucocorticosteroids (including dexamethasone, prednisone and prenisolone) 
showed a significant inhibitory effect.
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CHAPTER: ! INTRODUCTION 
Section I: Lymphocyte Locomotion in Inflammation
1.1 General Introduction
The inflammatory response protects the body from physical and chemical 
agents and infectious pathogens. Inflammation is defined as the response of 
living tissue to injury and it my be divided into acute and chronic responses 
(Cotian et al., 1988). The acute response is dominated by infiltration of 
tissues with neutrophils associated with the exudation of fluid and plasma 
protein. The chronic response is usually of longer duration and characterised 
by the presence of macrophages and lymphocytes and by the activation and 
proliferation of connective tissue (Cotian et ai, 1988). This chapter will 
discuss firs t, the current knowledge about joint diseases (rheumatoid arthritis 
and other inflammatory arthritides) which represent the best example of 
undesirable reaction of a complex inflammation (acute and chronic) in the 
synovium. Second the properties, adhesion, locomotion and chemotaxis of 
the above mentioned inflamraatoiy cells will be examined. Particular attention 
will be paid to the pathophysiology of T lymphocytes which are reported to be 
the most predominant cells in the rheumatoid synovium. Finally the dr ugs that 
have been reported to control the acute and inflammatory immune response in 
the joints will be discussed in detail.
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1.2 Disease associated with acute and chronic inflammation
1.2.1 Rheumatoid arthritis
1.2.1 A. Définitions of disease and criteria
Rheumatoid arthritis (RA) is an inflammatory disease which primarily affects the 
joints, with formation of chronic synovitis leading to bone and cartilage damage. It 
also involves the skhi, lymph node, heart, lungs, blood and nerve system. Three 
times as many women as men are affected. As the clinical diagnosis is difficult 
(due to overlapping of signs and symptoms with other rheumatoid diseases ) most 
rheumatologists use the clinical criteria of the American College of Rheumatology 
(Ropes et al., 1956) to differentiate RA from other arthritides. These criteria 
include clinical, serological, radiological and histological features (Arnett et 
<ar/.,1988) and have been widely used in clinical diagnosis of RA and in 
epidemiological studies.
1.2.1 B. Aetiology
Despite many years of investigation of metabohc, nutritional and environmental 
factors the aetiology of RA is still mrknown. As will be discussed below most 
curr ent studies have focused on various immune factors, including autoimmune 
reactions, immimogenetics, and the initiation of acute and chronic inflammatory 
immune responses in rheumatoid arthritis and other inflammatory arthritides.
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1.2.1.Bl. Autoimiiniimitv and autoimmune disease
i. Background
To discriminate between self and non self is an essential feature of the normal 
immune system . When something occurs to destroy the ability of discrimination 
(such as endogenous or exogenous factors) an immune response to self may 
develop. This immrme response is called autoimmunity or an autoimmune 
response. Autoimmunity may be organ specific, localized or systemic. The conse­
quence of this reaction may be minimal or catastrophic damage depending on the 
extent to which the integrity of self tolerance has been affected. The distinction 
should be made between an autoimmune reaction and autoimmune disease in 
which autoimmunity evokes pathologic consequences with the possible 
involvement of antibody, complement, immune complexes and cell mediated 
immunity . hr 1963 Burnet, defined autoimmune disease to include multiple 
conditions in which structuial or functional damage is produced by the 
immunologically competent cells or antibodies against normal body components. 
The presence of autoimmune reactions was confirmed by die presence of 
autoantibodies and of lesions in the tissue against which the antibodies were 
directed (Burnet, 1972).
According to the site of autoimmune reaction, type of antibody production, and 
clinical manifestations, the autoimmune diseases can be classified into three 
gi'oups. The first group is characterised by specific organ damage and the
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presence of specific antibody against antigens in that organ, for example Graves 
disease where thyioid gland hyperfunction is driven by an autoantibody which 
reacts with and stimulates the thyioid stimulating hormone (TSH) receptor (Strak- 
osch et ai, 1982). The second group is characterized by specific organ damage but 
the antibody is non specific for that organ such as primary bihary ciiThosis in 
which the bile ducts within the liver are destioyed causing cirrhosis and portal 
hypertension. In this group the autoimmune antibody reacts with the mitochondria 
in all cells (Taal et al .,1983, Frazer et al, 1985). The third group is characterized 
by damage in differ ent organs of the body (joints, nervous system, heart, kidney, 
lungs, and skin) including rheumatoid arthritis and other inflammatory diseases.
ÎÎ. Arthritis and Automimunitv
The concept of autoimmunity in rheumatoid arthritis was introduced in the 1940 s 
by Waaler when he described the abnormality of connective tissue metabohsm in 
this disease. He formd Irigh levels of an autoantibody called rheumatoid factor 
(RF). This observation gave an evidence that the immune system might be 
involved in the disease. As mentioned above autoimmune diseases may be a 
consequence of the generation of self reactive antibodies and the significant 
relationship between rheumatoid factor and rheumatoid aithritis provided evidence
which he suggested that RA may be a collagen autoimmune disease, and animals 
models of collagen type ll-induced arthritis have confirmed his theory (Stuart, et
that autoimmunity is involved in RA. In 1970 Steffen, proposed a hypothesis in
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ai, 1982; Klareskog, et al., 1983, Cremer, 1988; Terato., 1985, 1990; Holmdahl. 
et al, 1986; Myres, et ai, 1989; Watson and Townes 1985., Watson, et ai, 1986). 
Several autoantibodies including RJF and anti-collagen antibodies are produced by 
synovial plasma cells suggesting that local antigen may be involved in both 
immune complex formation and lymphocyte activation in this tissue (Munthe and 
Natvig 1972., Hoffinan. et ai, 1982, 1990; Weinick. et ai, 1985). However 
despite many reports of a variety of autoantibodies in RA, rheumatoid factor s are 
still considered as the unique serological indicator in RA diagnosis.
iii. Rheumatoid Factors
The rheumatoid factors ar e a group of antibodies directed against the Fc portion 
of the immimoglobulin G (IgG) molecule. Waaler in 1939 and in 1940 and 
Rose and Co-workers in 1948 reported that the sera from patients with rheuma­
toid arthritis agglutinated sheep erythrocytes coated with rabbit anti-sheep 
erythrocyte antibody. The serum factor responsible for the agglutination was a 
high molecular* weight immunoglobuhn of the IgM Class, hr the fir st years of RF 
research the factors were detected in serum but later several experimental studies 
reported RF production in the synovial tissue and synovial fluids of RA patients 
(Mellors et ai, 1959., Munthe and Natvig 1971, 1972a, 1972b). Although they are 
present in 70-80% in patients with RA during the cour se of the diseases (Carson 
et ai, 1981) , their occmTence in many connective tissue diseases , chronic 
infections and healthy individuals without clinical manifestation of arthritis raised
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doubts about how specific a role they played in the pathogenesis of rheumatoid 
aithiitis (Johnson and Faulk., 1976; Mannik., 1979). A possible harmful effect 
of RF is suggested by clinical data showing a conelation between RF and disease 
activity, particularly extia-ailicular manifestations (Allen, et ai, 1981; Masi et 
a/., 1976; Feigenbaum et al., 1978 ). Further interesting obseivations of IgG 
oligosaccharides have shown that IgG in active RA disease lacks Hie terminal 
galactose in the Fc region of IgG at position 297 (Mullinax et a/., 1976; Young, el 
ah, 1991). This structural abnormahty alter the IgG antigenicity and may facilitate 
immune complex formation and effective binding of IgG to RFs (Soltys et al, 
1994). Plasma cells in the synovial membrane produce RF of five 
immunoglobulin classes (Muthel and Natvig 1972; Soltys., et ah, 1994; Randen 
et ah, 1993).
1.2.1.B2. Immunogcnetic and susceptibility to rheumatoid arthritis
During the past four decades it has been described that there is an association 
between RA and certain alleles of hmnan leukocyte antigens (HLA), particularly 
HLA class II. The human class II locus has at least 14 different genes on the sixth 
chromosome, most of which ar e found in three major subregions, designated as 
DP, DQ and DR (Oilier and Symmons 1992). The first evidence of a genetic 
linkage was reported by Astorga and WilHams (1969) who noticed that the 
peripheral blood lymphocytes fiom unrelated patients with RA were non 
stimulatory in mixed leukocyte cultures. Subsequently it has been reported that
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Caucasians with seropositive RA have an increased frequency of expression of the 
cell surface human leukocyte antigen DR4 (Stastny 1976; Grennan et ai, 1983; 
Del Jungo et al, 1984; Walker et ai, 1987). In addition it has been reported that 
the RA association with HLA is localized to the thud hypervariable region 
(HVRIII) of the HLA-DR4 (3 chain. This region is a critical component in the 
formation of the groove which binds antigenic peptide for their presentation to the 
T cell receptor of responding cells (Panayi, 1995). DR4 are expressed by 70% of 
white seropositive RA compared to 28 % of normal controls (Stastny, 1978). It 
has been observed also that an individual heterozygotic for DR4 has an eight fold 
higher risk than normal for developing RA, while DR4 homozygotes have a 36 
fold risk factor (Legrand et ai, 1984; Nepom et ai, 1984). Further evidence of an 
influence of HLA on the severity of disease has come from studies of the Felly's 
syndrome (another variant of RA characterized by splenomegaly and leg ulcers 
associated with polyarticular RA) ( Lanchbury, et al, 1991; Wordsworth, et al., 1- 
992; Van Zebend et al., 1991) in which 95% of patients with this disease were 
found to be HLA-DR+ (Bowman 1995 et al, 1995). Many patients with most 
severe RA are DR4 homozygotes (Brackeretz and Wemet 1980). Other studies 
reported that RA was linked to co-expression of certain DQ alleles in association 
with DR4 ( Wallin et al, 1988; McCusker et al, 1991).
Recent developments in understanding antigen presentation or the interaction 
between MHC and T cells (Babbit et al, 1985; Guillt et al, 1987) have led to the 
suggestion of several molecular mechanisms concerned the role of MHC in RA,
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These are (i) The expression of specific D molecules may allow the presentation 
of foreign antigen that results in a cross-reactivity of certain T-cells with self 
antigen causing an autoimmune reaction, (ii) Class II MHC molecules may 
themselves resemble an exogenous epitope. Exposuie of an individual with a 
haplotype to the exogenous epitope may trigger T-cells that cross react with cells 
bearing MHC class II molecules. Despite the importance of immunological 
mechanisms mentioned above, the critical question now relates to the type of 
antigen which initiates the inflammatory immune response in human rheumatoid 
arthritis and to the molecular events involved in the formation of peptide-MHC 
complex and towards imderstanding how, when and where MHC-I or MHC-II 
molecules are associated with this unknown antigen. Several studies have 
suggested that heat shock proteins (hsps) may play a significant role in arthritis 
aetiology (see below).
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1,2.1. B3. Heat shock proteins and rheumatoid arthritis
i. Background
Heat is a major clinical sign of inflammation. It may be either systemic (fever) or 
localized to the sites of inflammation including rheumatoid synovium. It can 
modulate the inflammatory immune response and induces the synthesis of 
specific proteins. This phenomenon was firstly described by Ritossa in 1962, 
where he observed that exposure to heat induced a physiological response in host 
cells called heat shock response (Polla B.S 1988) which causes chromosomal 
puffing associated with synthesis of proteins termed heat shock proteins (hsps). 
These were classified according to then moleculai’ weights, e.g liigh molecular 
weight hsps (65 68, 72, 83, 92, and 110 Kda) and low moleculai* w e i^ t hsps (20 
Kda) (Polla, 1988).
ii. Pathophysiology of hsps in rheumatoid arthritis
Heat shock proteins are induced not only by high fever but by many other factors 
including, heavy metals, ethanol,vhal and bacterial infections. It has been reported 
that hsps play a complex role in the interaction between host and pathogens. In 
human rheumatoid arthritis it has been obseived that the 65 Kd heat shock 
proteins found in the joints is similar to that found in Mycobaterium leprae and 
Mycobacterium tuberculosis. This moleculai* niimiciy could initiate an 
autoimmune reaction in die rheumatoid joints, because the immune system
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recognizes the mimicking microbe as a self antigen. Such reactions have been 
produced in animal models when certain strains of rats have been injected 
intradennally with an emulsion of killed Mycobacterium tuberculosis in mineral 
oil (complete Freund’s adjuvant) which caused a rheumatoid-like disease (Pearson 
and Wood 1959). Also this disease can been transfeiTed from affected to healthy 
rats thi'ough T cell lines or clones that recognize a mycobacterial antigen and that 
cross react with a self antigen in joint caitilage (Van Eden et al., 1985). It has 
been cleaiiy established that the 65 KD hsp found in the synovial fluid (Fisher et 
al., 1991) induces proliferative responses in synovial fluid T cells from 
rheumatoid arthritis patients (Res et al., 1988) and also 65 KD hsp induced 
adjuvant arthritis (AA) in rats by a T cell clone specific for amino acids 180-188 
of the 65 KD HSP (Gaston et al., 1990). However one senior rheumatologist 
criticises the role of hsps m RA (Panayi 1995) because of their lack of tissue 
specificity and the low frequency of T cells responding to the 65KD protein which 
is the most predominant hsp in the synovial fluid.
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1.2.1 C  Histology of Synovial compartments in rheumatoid arthritis
1.2.1.C1. Syiiovimn
Several reports have been described the histological features of the synovium 
during early and late stages of the rheumatoid disease (Schumacher and Kitridou 
1972; Schumacher 1975) . Dming early stage of the disease there is congestion, 
eiythi'ocyte extravasation and luminal obliteration. Fibrin deposition occurs 
throughout the synovium. Endothehal cell are swollen and exhibit vascular 
activity. Neutrophils appeal in the superficial synovium and lymphocytes are rare. 
Plasma cells and germinal follicles are uncommon or absent (Schumacher and 
Kitridou 1972; Schumacher 1975; Konttinen et al., 986). In contrast the 
histopathologic obseivations of the synovium during chronic inflammation have 
shown that the synovium contains swollen synovial cells (Lewis and Ziff 1966 ) 
and massive hypeiplasia with 100 to 1000 fold weight increase (Smiley ei ai, 
1985). It has been obseived also that the hyperplastic synovial tissue responsible 
for the joint destruction has an extensive vascular network, (Koch et a/., 1986). In 
addition it has been demonstrated that a subpopulation of macrophages is 
responsible for neovascularization probably by elaboration of IL-1, IL-6 and TNF- 
a  cytokines that have the abihty to promote the growth of blood-vessels. As will 
be discussed below numerous investigations have shown that the most 
predominant cells in the chronic stage of synovitis are lymphocytes. Most of 
these cells aie T cells bearing surface markers that reflect in vivo activation
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(Pearson and Wood 1964; Cush and Lipslcy 1988; John et al., 1975; Kurosaka 
and Ziff, 1983; Panayi 1992).
1.2.1.C2. Synovial fluid
Synovial fluid contains a large vaiiety of inflammatory cells including 
neutrophils, lymphocytes ( prominently T and B cells, and NK cells) and 
monocytes. Eosinophils and basophils are uncommon. Many cytokines (e.g IL-1, 
IL-6, IL-8, IL-15, MCP-1, MIP-la, TNF-a) are present. Also synovial fluid 
contains enzymes (e.g collagenase), proteins (e.g C-RP; Albumin; lubricin), 
carbohydrates, hyaluronic acid (which gives the fluid the consistency of egg 
white or glare and viscosity) and a variety of fibrillar materials (fibiin, collagen) 
and crystals (Urate, Calcium pyrophosphate dehydrate; Cholesterol ciystals) 
(Kitridou et al, 1969; Kitridou et al., 1969; Zuckner et al., 1964), Synovial fluid is 
important for the diagnosis and evaluation of many patients with rheumatic 
diseases particularly rheumatoid arthritis. In monoarticular aithritis, septic aithritis 
must be distinguished from other possible causes. Also synovial fluid cell count 
and volume aie useful approximate measures of the intensity of the inflammation. 
For instance it has been observed (Al-Mughales unpublished obseivations) that 
total white cell count (WBCs) in most active RA synovial fluids were very high 
(range from 6.4-65.5 x 10^/ml) compared with other diseases such as 
osteoarthritis (range from 0.1-3.3 x loVml). Also the synovial fluid volume *
collected from most active RA was high (20-40ml/patient) compared with 
osteoarthritis (5-7ml/patient).
1.2.1. D. Lymphocyte and macrophage infiltrate in the svnovliiiii.
1.2.1.D1. Background
Over the past two decades a considerable amount of evidence has accumulated 
to implicate the role of lymphocytes and macrophages in the pathogenesis of this 
disease. As mentioned above, the first evidence is the hyperplasia and 
hypeitiophy of the synovium with infiltration of mononuclear cells mainly 
lymphocytes, macrophages and plasma cells in the sublining layer of the 
synovium. The importance of lymphocytes was shown by improvement of patients 
with severe RA after depletion of lymphocytes thiough thoracic duct fistula 
diainage (Wegehus et al, 1970; Paulus et al, 1977) and total lymphoid irradiation 
(Panayi et al, 1982). Further evidence for the role of lymphocytes is the 
discovery of rheumatoid factor (RF), immune complexes in joint fluid with 
depressed complement and deposition of hnmune complexes in the synovial 
membrane, which attr act the attention to the inflamed synovial tissue (Kunkel and 
Tan 1964; Hannested, 1967). However recent opinion suggests that synovitis is no 
longer seen as an antibody-mediated process involving RF and hnmune 
complexes, but rather as mediated by T cells (Panayi et al, 1992) and
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macrophages (Firestein et al, 1990) which are reported to play an important role 
in the pathophysiology of RA.
1.2.1.D2. Cells: phenotype and distribution.
i. T lymphocytes
As mentioned above, the majority of lymphocytes in synovial tissue and synovial 
fluid of RA patients are activated T lymphocytes as phenotyped using 
monoclonal antibodies (MoAb) directed against T cell activation molecules such 
as human leukocytes antigens (HLA-DR) or the interleukin-2 receptor a  chain (IL- 
2R; CD25) (Panayi 1994). The majority of these cells are primed and express 
surface antigens characteristic of mature memory cells, such as CD4+ CD45RO+ 
(Pitzalis et al., 1987; Cush et al, 1988; Burmester et a/., 1987). In addition to 
CD45RO+ and HLA-DR antigens, they express very late antigens (VLA-1-VLA» 
4) and the mtegrin LFA-1 with low expression of IL-2 (lannon F, et al, 1994) and 
y-IFN . It was recently observed that synovial fluid T cells express CD69 an early 
activation marker (lonnone et al, 1994). CD69 is a member of the c-type animal 
lectin superfamdy and is the earliest inducible antigen expressed on the surface of 
T cells after activation with various stimuH (Fernandez-Gutienez et al, 1995).
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ii. B lymphocytes
B cells constitute about 1-5% of synovial cells fraction. As mentioned above 
these cells contribute to the inflammation of the joint through a number of 
physiological processes. First production of antibodies such as IgM, IgG, and 
IgA. These antibodies especially IgM form immune complexes (ICs) in situ 
leading to a subsequent antigen processing and presentation to immune reactive T 
cells (Munthe and Natvig 1977; ; Van Snick et ai, 1978; Aho et ai, 1987). 
However other studies have concluded that during RA there is a preferential clonal 
expansion of RF B cells which lead to the production of high circulating RFs. As 
mentioned above the RFs are not purely pathogenic, but then concentration is 
significantly corxelated with the disease activity (Smiley e t a l 1968; Mimthe and 
Natvige 1972; Tuomi 1988).
iii. Natural Killer cells (NK cells)
The NK cells constitute approximately 1% of mononuclear cells in the synovial 
membrane (Fox et al, 1984; Dobloug et al, 1982). NK cells play several 
ftmctions in the hnmime response including, target cell destruction, autologous 
mixed leukocyte reactions and suppression of other immune fimctions (Shah et 
al, 1985). Then absence in RA may contribute to the chr onicity of the disease.
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%iv. Macrophages
Although the RA synovial tissue is characterized by the predominant infiltr ation of
T lymphocytes, macrophages also participate in the inflammatory hnmune
response hi the joints. Most of these cells express CD 14 and CDU and high
levels of activation markers including, HLA-DR which are involved in antigen
presentation. It has been observed that synovial macrophages produce a variety of
inflammatory mediators , including prostaglandins, collagenase , elastase and
cytokines such as IL-1, TNF-a, IL-6, granulocyte-macrophage colony stimulating
factor (GM-CSF), macrophage colony stimulating factor (M-CSF) (Dayer et al,
1986; Amed and Dayer 1990). It has been also reported that most of the IL-8 
.found hr the synovial fluid is produced by macrophages in the synovial tissue 
(Koch el a/., 1991).
In conclusion, the critical question now relates to which cells mediate the complex 
inflammation in the synovium. Fhestein and Zvaifler (1990) assign prhnacy to the 
macrophage hr the immimopathogenesis of RA. Then argument is supported by 
strong evidence (mentioned above) including cytokine and enzyme production, 
and expression of activation markers. Panayi and his colleagues (1992) proposed 
that both cells are important in RA pathogenesis, but suggested that the T cell is 
the conductor of the orchestra. Then argument was supported by several 
rmmimological studies including involvement of T cells in most immimological
aspects of RA aetiology including, predominant infiltration of T cells in the
................................................................
synovium with then cytokine production and numerous activation markers (more
i ,
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than six hunched studies reported the immunological activity of T cell in the 
rheumatoid synovium) then important role in antigen presentation, then 
association with MHC in RA, evidence of animal models such as adjuvant aifhiitis
Î
in which this disease can be tiansfened from ill mice to healthy mice by T cell 
clones, beneficial effect of immunotherapy directed against T cells such as 
thoracic duct drainage, total lymphoid madiation, beneficial effect of cyclosporin 
A and monoclonal antibodies.
However I do suggest that both macrophages and lymphocytes mediate the 
complex inflammation in RA (direct or indirect, either through antigen 
presentation or production of enzymes), hr addition, the locomotion studies m the 
present research produced further important evidence that the T cells play a role 
m RA pathogenesis.
1.2.1 E. Pathophysiology of cvtokmes m the synovium
Several studies reported that the cytokines produced in the synovial tissue and 
synovial fluid serve as important mediators of inflammation and joint destruction 
in RA. This was shown by numerous investigators who found that macrophages, 
fibroblasts or T cells in RA synovial tissue release a variety of cytokines which 
can be detected in the synovial fluid. These are first, IL-1 (Miyasaka, et al, 1988; 
Wood et al., 198; Nouri et al., 1984; Hopkins , et al, 1988., Dalton et al, 1989) 
TNF-a (Chu ., et al, 1991; Yocum etal.,19^ 9; Brenaim, et al, 1992). Both ÏL-1 
and TNF-alpha stimulate chondrocytes and synovial fibroblasts in the synovial 
tissue to release collagenase and elastase, and neutral protease which have been 
reported to degrade proteoglycans and collagen resulting in cartilage destruction. 
TNF also has been documented in vivo to stimulate the neovascularization and 
leukocyte infiltration (Frater-Schroder et al, 1987). However animal studies have 
shown that the inflammatory activity of TNF-a might be secondary to IL-1. 
Injection of TNF-alpha into the rabbit knee induced a weak inflammatory 
response but injection of both IL-1 and TNF produced strong inflammatory 
activity (Arned et al, 1990). IL-6 is also detected in the synovial tissue and 
synovial fluid and is produced by macrophages, fibroblasts (Field, et al, 1991; 
Bhardawi, et al, 1989; Guerne, et al, 1989; ), T lymphocytes and chondrocytes 
(Guerne, et al., 1989; Wong et al, 1988). IL-6 is reported to be an RF B cell 
stimulating factor (Yasukawa, et al, 1987) and also stimulates lymphocyte 
prohferation of the CD8+ subset.
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Third GM-CSF has reported to be detected in the rheumatoid synovium (Leizer et 
al,, 1990; Alvaio-Gracia et al, 1991; Haworth et ai, 1991) and plays an impoitant 
role in the HLA-DR and HLA-DQ expression by synovial tissue macrophages and 
fibroblasts (Dayer et al, 1990). Finally various chemotactic factors have reported 
in the synovial tissue and synovial fluid including IL-8 (Brennan et al ., 1990; 
Sietz, et al, 1991; Sietz et al, 1992; Koch, et al, 1991; Hhota et al, 1992;) , 
IL-15 (Macinness et al 1995), and MIF-1 alpha. As will be discussed below these 
chemoattractant factors induce polarization and locomotion of lymphocytes in 
vitro (Wilkinson and Newman 1992; Wilkinson and Newman 1994; Wilkinson 
and Liew 1995;) and recently MCP-1 was reported to cause polaiization of T 
cells (Wilkinson 1995 unpublished observations). IL-2 is a potent chemotactic 
factor for lymphocytes but is undetectable in synovial fluids in a dose that 
causes locomotion of lymphocytes in vitro (Combe et al., 1985; Firestein et al, 
1987). The chemotactic factors produced in the synovial tissue or the synovial 
fluid may activate the adhesion molecules that are expressed on the synovial 
tissue blood vessel endothelial cells which in turn stimulates the adhesion of 
lymphocytes to the blood vessels (Harris, 1990). Thus lymphocyte chemotactic 
factors govern the mediation of locomotion of lymphocytes from synovial 
venules, through synovial tissue into the synovial fluid.
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1.2.2. Other variants of rheumatic diseases
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1.2.2. A. Osteoarthritis (OA)
Osteoaithiitis is the most common joint disorder reported in most populations. It 
affects hand joints, the distal inteiphalangeal joints, proximal inteiphalangeal 
joints, the carpometacarpal joint of the thumb (frequently involved) and other 
joints (Cotran et al, 1988) . OA is very common in old age , it affects women 
more often than men, under the age of 45, and occurs with equal frequency above 
the age of 50. The onset and the aetiology of OA is still unclear. Several 
investigators have reported many risk factors which are associated with OA
including obesity (reported to be associated with bone mineral density) (Anderson
:and Felson 1988), acute major injuries during sports activities and any heavy 
repetitive labour (Felson et al, 1988). Another possible cause of OA is crystal 
depositions in the joints such as calcium pyrophosphate dehydrate which was 
found in about 60% OA synovial fluid (Schumacher et al, 1981). A Further cause 
of OA is impairment of the integrity of cartilage by collagenase and other protease 
enzymes which cause synovitis with release of inflammatory mediators, white
cell degenerative enzymes and free radicals which in turn lead to cartilage 
degradation ( et al, 1988).
1.2.2 B. Ankvlosmg spondylitis (AS)
Ankylosing spondylitis (AS) is prototypical of a group of rheumatic disorders 
.collectively called the seronegative spondylaithritides (Moll et al., 1974). These 
.disorders are characterized by chronic inflammation of the spine. The sacroiliac
joints aie always affected but the hip, shoulder joints and other joints are rmely 
involved. The histopathology of the synovial lesions closely resembles that 
typical of RA (Moll et al, 1974). Classically AS is seronegative for IgM RT 
(Holborow and Swannell 1983). It affects mostly young men. The aetiology is 
unknown but over 90% of patients across the world have stiong association with 
the HLA-B27 antigen (Khan et a l, 1990). HLA-B27 is an MHC class I antigen 
(Kellner and D.Yu 1992). Hereditaiy influence appears to play an important role 
in AS because about one quar ter of close relatives also have asymptomatic or 
symptomatic spondyUtis (Cotran et al, 1988).
1.2.2. C. Psoriatic arthritis (PsA)
This is an erosive chronic , recurrent inflammatory polyarthritis affecting about 5- 
7% of patients with psoriasis (Stites and Terr 1991). The onset of arthritis may be 
acute and preceded by skin disease. It differs from rheumatoid arthritis in being 
consistently seronegative for RFs and anti-nuclear antibodies (ANAs), but in half 
of the patients there is immune complex circulation and high levels in serum of 
IgA and IgG. Synovial fluid examination has shown high white cell counts. The 
inteiphalangeal joints of the fingers are affected including a considerable 
periostitis which produces a sausage-like appearance of the fingers (Holborow and 
Swannell 1983). The disease might progress to ankylosing spondylitis (Khan and 
Linden 1990). The cause of PsA is unknown. Genetic factors appear to play a role 
in disease causation. PsA are found in family members of 15% of patients. 
Patients with PsA have an increased prevalence of HLA-DR4 and HLA-B 27
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(Leonard et al, 1978; Stern, 1985). These genetic markers might be associated 
with an increased susceptibihty to unknown infectious or environmental agents or 
to autoimmune phenomena (Kenneth and Kenneth 1991).
1.2.2. D. Polymyalgia Rlieiiinatîca
Polymyalgia rheumatica (PMR) is a subgroup of giant cell arteritis (GCA) .The 
name was introduced in the 1950’s to define a syndrome with pain and stiffiiess 
of proximal muscle of elderly people (Bengtsoon 1991) with fever, weight loss, 
and synovitis that may be persist out or recurrent (Chuang et al., 1982). The 
synovitis is relatively mild confined to several joints, likely to appear at the onset 
of disease and does not cause deformity or erosive radiographic changes (Healey 
1984). The synovial fluid is inflammatory with white cell count ranging from 
5,900 to 21,000 celVmm .^ In contrast with rheumatoid arthritis, it has been 
reported that PMR patients are seronegative RF (Healey 1984). PMR is 
characteiized by general arthitis which involves the large arteries. However the 
aetiology of this disease is not well defined but several studies reported that the 
lymphocytes from patients with PMR showed higher transformation responses to 
arterial antigens than lymphocytes from controls (Ziko et al, 1977; ) It has been 
also observed that patients with PMR have increased prevalence of HLA-DR4 
expression in the arterial wall (Richardson et al, 1987; Sakkas et al, 1990). Thus 
genetic factors may be associated with the autoimmune reaction.
I
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1.2.3. How lymphocytes enter the rheumatoid synovium and sustain their
1.2.3. A. Introduction
The synovium is more vascular than the structures supporting the joints such as 
capsule, ligaments and tendons. This vasculature m chronically inflamed joints 
has unique venules with speciahsed endothehum called high endothelium venules 
(HEV). There is preferential binding of lymphocytes at these sites wliich is 
enhanced by IL-1, TNF and interferon gamma. The high endothelial venules play 
an important role in blood lymphocyte adhesion and entrance into the synovium 
(Cavender et al., 1987). This section will examine the cuiTent knowledge about 
the development, adhésion, locomotion and chemotaxis of the major 
lymphoid cells (T cells) which are postulated to play a centr al role in chronic 
inflammatory lesions, including joint diseases.
1.2.3.B. Lymphocyte, adhesion, locomotion and chemotaxis
1.2.3. B l. Historical background
Lymphocytes are first formed in the bone marrow (B cells) and thymus (T cells) 
in adults; in the foetus, the yolk sac, and liver are additional sources. T 
lymphocytes arise from stem cells (in the bone marrow) migrate to the thymus 
where they undergo differentiation into mature T cells and then leave the thymus. 
Although the lymphocytes were first described before the 1900’s (McGregor and
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MacKaness 1974; Powers, 1989), it was not until the second half of this centuiy 
that the properties and the function of lymphocytes began to be understood. The 
classical experiments of Gowans in the rat provided a large step forward in the 
understanding of lymphocyte circulation in the secondary lymphoid organs 
through which they recirculated into the efferent lymph and thence back to the 
blood (Gowans and Knight 1964; Pabst 1988). Lymphocytes are the most 
predominant cells in the lymphoid organs. Mature T cell recir culate in the blood 
and migrate to the main secondary lymphoid organs, the periarticular* sheath of 
the spleen (PALS), lymph node and gut associated lymphoid tissue (tonsils and 
peyer’s patches), and to other lymphoid accumulations in respiratory and 
urogenital tracts. The majority of the lymphocytes in blood s (90%) are 
homogenous lymphocytes of small size (6-10 pm in diameter), with a minority of 
10% of large cells (12-16 pm in diameter). The mean size of the recirculatmg 
lymphocyte pool m man has been estimated as 23 x 10  ^ with approximately 50 
percent of recirculating cells being present in the blood (Scott et al, 1972). The 
mean blood transit of recirculating lymphocytes is approximately 30 min, (Fig). 
However despite this information the exact function of lymphocytes was still 
imclear, until 1961 when Miller reported the crucial role of the thymus in ceU 
mediated immunity. Miller working on a murine leukaemia that originated in the 
thymus showed that thymectomy of new-born mice resulted in animals that were 
hnmunodefrcient. They could not reject skin allogiafts and could not produce 
effective antibodies to either sheep erythrocytes (SRBC) or to salmonella H
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antigens (Miller 1961). Similar studies confirmed these findings and showed that 
the delayed type hypersensitivity response to tuberculin was also impaired 
(Cooper et al, 1966). It was also shown that in birds not only did thymectomy had 
a similar effect, but that extirpation or removal of a secondary lymphoid organ-the 
bur sa of Fabricius also led to immune deficits (Warner 1962) It has been has also 
noticed that the Bursa of Fabricius contained cells that can produce antibodies 
(Klaus, 1990) which increased the knowledge about the real fimction of B 
lymphocytes. However, in contrast to thymectomy, bursectomy ablated all 
antibody responses but did not affect graft rejection ( Warner and Szenberg 1964).
It was then appreciated that there were two major lymphoid organs responsible 
for the production of lymphocytes and the terms ‘T’ and 'B ' were coined for the 
ceils produced in the thymus and bursa respectively.
Subsequently further investigations have been accumulated which described the 
role of lymphocytes in delayed-type hypersensitivity, antibody dependent cell 
mediated cytotoxicity (ADCC), graft versus host disease, antibody production, and 
cytokine production (Thomson and Prcotor 1984, Stites and Terr 1991; Abbass et 
al, 1991; Alberts? a/., 1989; Reinherz e/a/., 1979, Hirohata er a/., 1988). Recent 
development of monoclonal antibody techitiques has led to further designation or 
phenotyping of lymphocyte surface molecules which defined the immunological 
activities of lymphocytes in primary and secondary lymphoid organs and allowed 
examination of their inflammatory role in numerous diseases, including 
rheumatoid arthritis and other inflamnratory arthritides.
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1.2.3.B2. Lymphocyte Surface Molecules
Several molecules located on the surface of the T-cells play an impoitant role in 
the differentiation and function of the cell type. Although these molecules were 
initially designated by the monoclonal antibodies with which they react, recent 
internationally accepted terminology has designated tliem as clusters of dif­
ferentiation antigens (CD). The CD designation refers to the whole molecule and 
not simply to an epitope detected by a specific antibody.
With the use of the monoclonal antibodies it has been possible to define several 
cell markers on immature and mature lymphocytes. In the case of T-lymphocytes 
many CD molecules such as CD3 and CD2 have been recognized on all peripheral 
T-cells whereas others define functionally distinct subsets. For example the CD4 
marker has been found on approximately 60% to 70% of mature T-cells in the 
human blood whereas CDS is expressed on about 30% to 40% of T-lymphocytes. 
Thus m normal healthy individuals the CD4 to CDS ratio is approximately 1.5- 
2%. This may vary according to sex, age and various diseases. Although initially 
discovered as markers for T cells, subsequent studies documented that these mol­
ecules were associated with particular* cell functions. For* example the CD4+ and 
CD8+ phenotype of the T-cell is related to its capacity to recognize antigen in the 
context of either Class II or Class I MHC antigens on the surface of other* cells 
respectively (Biddison et al, 1982, Engehnan et a/., 1981,). A direct physical con­
tact between antigen and MHC has been demonstr ated (Babitt et a/., 1986, Town­
send. et al., 1986), . Class I MHC molecules play an important role as restricting
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elements for peptide derived endogenously within antigen presenting cells where­
as class II MHC molecules restrict T cells responses to exogenous proteins that are 
taken up and degraded in the lysosomes of antigen presenting cells to reveal 
antigenic peptide (Morrison et al, 1986).
The strong association between Class I and Class II MHC restriction and the 
CD8+ and CD4+ subsets of T-cells respectively is likely to reflect a fundamental 
role of the CD4 and CDS molecules during T cell activation and also dur ing the 
selection of the T cell repertoire in the thymus, hr addition recent studies in the 
mouse have suggested that CD4 T cell clones can be generated that express speci­
fic fimctional activities (Mosman et al., 1986, Street, et al., 1991). For example 
Thl cells are effective mediators of delayed hypersensitivity reactions and the 
primary producers of IL-2 and interferon-gamma whereas Th2 cells produce IL-4, 
IL-5, IL-6 and are effective helper cells for B cell differentiation. Fur ther evidence 
for the existence of Thl and Th2 subsets came fiom rheumatoid arthritis studies 
(Miltenburg et al., 1992) which suggest a relation between Thl-type functions 
(through the production of large amount of IFN-y and absence of IL-4 and variable 
production of IL-2 and IL-6) and chronic inflammation in RA.
In both the human and the mouse CD4+ cells are subdivided into memory and 
naive subsets based on the expression of a variety of markers (Akbar et ai, 1991, 
Sanders et al.,19%%, Cerotini et ah, 1989). Although these subsets differ in the 
expression of a number of markers the most useful ones to separate them have
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proven to be CD45 RA and CD45RO the isomers of the leukocyte common 
antigen.
Properties and function of the leukocyte common antigens (CD45)
The transmembrane protein tyrosine phosphatase CD45 comprises a family of 
180-220 KD glycoproteins present in high abundance on the surface of all 
leukocytes (Thomas, 1989). They share a common intracellular domain that 
exhibits protein tyrosine phosphatase activity (Tonks et al, 1990). Then different 
extracellular domains are produced through alternate mRNA splicing of three 
exons (A  B, C) present on the common parent gene (Streuli et al, 1987; 
Morrmoto et al, 1986b). While the exact function and role of the different CD45 
proteins chains remains to be determined the CD45RA (RA identified by 2H4; 
Morimot et al, 1985; see chapter) and CD45RO (Identified by mAb UCHLl; 
Smith et al., 1986; see chapter 2) forms have proven to be reliable markers for 
identifying functionally distinct naive and memory T cells subsets. T cells that 
express the RA+ phenotype ar e resting lymphocytes. These cells when stimulated 
with anti-CD3 or phorbol 12, 13 myristate and ionomycin secrete a limited 
number of cytokines (Akbar et al., 1991; Salmon et al., 1989) including MIP- 
la , BL-8 and IL-2 (Conlon et al., 1995). It has reported that the CD45RA subsets 
express specific adhesion molecules at low levels (Wallace et al, 1990; Sanders 
et al, 1988) and respond slowly to primary antigenic stimuli. This phenotype 
predominates in peripheral blood, especially in the blood of neonates (Demeur e et
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al, 1994). In contiast , CD45RO+ aie larger, more activated lymphocytes that 
express activation markers such as CD25. These cells secrete a large repertoire of 
cytokines including IL-2, IL-4, IL-5, IL-6, GM-CSF, TNF, INF-gamma, M IP-la 
and IL-8 (Conlon et al., 1995) and express high levels of adhesion molecules 
including CD2, LFA-1, and CDw29 (Sanders et al., 1988).They also respond 
briskly to recall antigens (Akbar et al., 1988). T lymphocytes in RA peripheral 
blood primarily express the CD45RA isoforms (Summers et al., 1994) whereas 
CD45RO+ lymphocytes predominates in the rheumatoid tissue (Hanly et ai., 
1990; Nakao et al., 1990; PitzaUs et al., 1987; Sew et al., 1992; Lasky et al., 1988) 
and synovial fluid (Ichikawa et ah, 1992). Antigen presentation is believed to be 
the primary in situ signal that induces CD45RA^ lymphocytes to transform to 
memory cells and concordanfly express the RO isoforms. Several in vitro models 
have been developed to study this transition process including activation of 
CD45RA+ T cells with alloantigen (Akbar et al, 1988) or with mitogens such as 
Con A, PHA, or anti-CD3 mAb 2 (de Jong et al, 1991; Akbar; et al., 1988).
1.2.3. B3. Lvmnhocvtc adhesion
The extravasation of lymphocytes from blood into tissue is mediated by specific 
interactions between lymphocytes and the endothelial cells lining post-capillary 
venules. These interactions are a crucial step for migration of lymphocytes into 
chronic inflammatory sites including synovial compartments in rheumatoid 
arthritis (RA) where HEV-like morphology resembles that of lymphoid tissues
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(Freemont 1983; Janossy et ai, 1981) and where HEV can bind to normal 
peripheral blood lymphocytes (Fan and Dale 1994).
The molecular mechanisms which direct lymphocyte migration through 
endothehum into inflamed tissue have been the subject of intensive investigation. 
Over the past decades it has been found that several molecules (called adhesion 
molecules or homing receptors) influence the first step of lymphocyte- 
endothelium interactions and entry into tissue. Many of these molecules have 
been identified and characterised using monoclonal antibodies (Osborn et ai, 
1989; Staunton et al, 1989; Picker et al, 1992) and also several adhesion 
regulatory factors have been identified such TNF-a IL-1, INF-y , IL-4, and 
bacterial hpopolysacharide (LPS) (Wilkinson 1994; Hamblin 1994; Panayi 1994). 
When endothehal cells are exposed to any of these factors in vitro marked 
lymphocytes emigration across the endothehum is seen (Pettiffer et ai, 1986; 
Munro et al, 1989), Combinations of these factors enhance adhesiveness for T 
cells further. The combination of TNF and IL-4 was found to be more potent than 
the combination of TNF and IFN-y (Thornhill et al., 1991).
The fir st adhesion molecule char acterized as a homing receptor was the L-selectin 
which was previously named lymphocyte-endothehal cell adhesion molecule-1 
(LECAM) or murine MEL-14 , LAM-1 or Leu 8 (Gallatin et al, 1983; Picker et 
al., 1991). It belongs to a family of ceh surface receptors characterized by a lectin 
binding site recognizing carbohydrate ligands (Lasky et al., 1989; Siegalman et 
al., 1989; Tedder et al, 1989; Speitini et al., 1991; Camerini et ai, 1989) on the
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following HEV glycoproteins: glycosylation-dependent cell adhesion molecule 
(GlyCAM-1,) CD34 and mucosal addressin cell adhesion molecule (MAdCAM-1)
(Girai'd, J.P and Spiinger 1995). It is not clear whether these molecules are 
involved in lymphocyte traffic into inflamed tissue.
Another adhesion molecule expressed on the surface of human lymphocytes
which plays a role in lymphocyte migration is CD44 (Pgp-1, Hermes antigen).
Antibodies against CD44 have been found to inhibit lymphocyte adhesion to
peripheral blood lymph node, and synovium high-endothelial venules (Jalkanen et 
. .al., 1987). In addition numerous studies have reported another family of adhesion
molecules which mediate lymphocyte adhesion to endothelium in vivo. This
family consists of three surface membrane heterodimeric glycoproteins named the
Psintegrins (GDI la, 11b and 11c /CD 18). CD 11 a/CD 18 is commonly called
leukocyte fimction antigen-1 (LFA-1, on lymphocytes) (Dana and Amaout 1988;
Dahams and Hart 1986; Dahmas and Hart 1985; Haskard et al., 1986; Hamann et
.al., 1988;) and a^/Pi or pyJntegrins also known as very late activation antigen-4 
(VLA-4)( Holzmann et al., 1989; Elices et al, 1990) that appear 2 to 4 weeks after
:T cell proliferation in vitro at a time that is late relative to the expression of other 
.activation antigens. There are about six VLA antigens which are variably 
expressed depending upon cell lineage and activation (Hemler 1990). It has been 
reported that lymphocyte adhesion via integrin (LFA-1 (CD 11a), VLA-4 (CD49d)
■ : fand some non integrin (e,g., CD2 CD43) receptors provides costimulatoiy signals
.to T lymphocytes engaging antigen via the T cell receptor/CD3 complex as well as I
iI
to B lymphocytes that recognize antigen on follicular dendritic cells. When these 
accessory and costimulatoiy adhesion are blocked with antibodies in vitio, gr eater 
than 100-fold higher concentiations of antigen are required to initiate lymphocytes 
responses (Wegner et al, 1993) whereas a 4integrins seem to be involved in 
homing into mucosal tissues and into inflamed sites . It has been shown that VLA- 
4 (on lymphocytes) mediates the adhesion of lymphocytes to fibronectin ( that 
have separate tissue cell-binding sites) which is abundant in synovium and 
throughout the lining, blood vessels and interstitium (Issekutz and Issekutz 1991; 
Van Dmther-Janssen et al., 1991). VLA-4 binds to the cell smface molecule 
VCAM-1 (Vascular-cell adhesion molecule-1). Endothelial ligands for these pi 
integrins such as intracellular adhesion molecule-1 (ICAM-1 or CD54) (Diamond 
et al, 1991) and Vascular cell adhesion molecule-1 (VCAM-1) (Osborn et al, 
1989; Thornhill and Haskard 1990) have reported to be stimulated by cytokines 
produced in the inflamed synovial tissue suggesting a role in lymphocyte 
infiltration into inflamed synovial tissues (Pober and Cotran 1990). ICAM-1 is 
widely distributed among synovial tissue cells including fibroblasts, macrophage- 
Hke synovial lining cells and the endothelium of blood vessels in the lining as well 
as deep hr the subsynovium. It has been found hr vitro that treatment of 
synoviocytes (B cell type) with TNF-a, IL-1 or INF-y upregulated ICAM-1 
expression (Chin et al, 1990). Also it has been found that aivpy (LFA-1) is present 
on synovial T cells and could play a role in the hrgress and retention of T 
lymphocytes. Also it has been formd that ICAM-1 expression is upregulated by
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TNF-a and IL-1 with an expression peak of 24-48 hours after cytokine treatment 
and remains elevated as long as cytokine is present (Pober et af, 1986; Pober and 
Cotran 1990; Osborne et af, 1989; Mariln and Springer 1987). On the other hand 
it has been observed that TNF-a and IL-1 has the same effect on VCAM-1 with 
similar time courses of expression as ICAM-L It has been reported tliat the 
rheumatoid synovial T cells exhibit a higher avidity than peripheral blood T 
lymphocytes for VCAM-1, the endothelial cell ligand for a4p and a4p7 integrins 
as well as for several extracellular matrix proteins (Arroyo et aL, 1995).
The lymphocytes-endothelial interaction involves the following multistep cascade 
(Fig ) (Ager 1994; Girarad and Springer 1995). i) attachment and rolling 
mediated by L-selectin, which recognizes CD34 and GlyCAM-1. ii) Triggering 
and stable adhesion mediated by LFA-1 (atp2; CDlla/CD18) integrins on 
leukocytes (following their activation by chemoattractants) and endothehal 
counter receptors ICAM-1 and ICAM-2. iii) Transendothelial migration mediated 
by unknown factors.
However adhesion of lymphocytes to the luminal surface of endothehum is not 
sufficient to promote migration and accumulation of cehs into tissues. As will be 
discussed below locomotion and chemotaxis are excellent mechanisms, for ceh 
accumulation, in acute or chronic inflammatory lesions.
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1.2.3.B4. Lymphocyte Locomotion and Chemotaxis
1.2.3.B4.1 Histoncal background
Although several studies by many researchers in the middle of this centuiy gave 
surprising amount of insight into the ways in which cells moved, chemotaxis 
studies were hampered by the lack of suitable techniques for testing soluble 
substances for chemotactic activity and for collecting quantitative data on the 
movement of die cells. In 1962 , Boyden developed a method (Filter assay) which 
provided a simple way of quantifymg the locomotion stimulus given to a cell by 
a chemical. Subsequently a number of articles were published using this assay to 
deteimine the chemotactic potential of complement component C5a (Sliin et al, 
1968; Syndeiman et al, 1970).
However despite the progress of chemotaxis methods the definitions of 
different forms of locomotor behaviour were unclear until 1977 when Keller and 
Wilkinson revised the teims describing leukocyte locomotion and presented a 
proposal for a standardisation of locomotor terminology. These was serious 
contusion in misuse of terms (relating to the locomotion of leukocytes). First the 
term, chemotaxis was used in many different ways such as interchangeably using 
the term chemotaxis (directional locomotion) to describe any form of leukocyte 
movement. Second confusion is use of the terms random migration or random 
locomotion to describe the intrinsic locomotor capacity and change in the speed 
of locomotion.
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CuiTent definitions of leukocyte locomotor behaviour are as follow; a) 
Chemotaxis ( Pfeffer, 1884) is a reaction by which chemical substances determine 
the directional of locomotion of cells. It is usually accompanied by morphological 
orientation of the cells towards the souice of concentiation gradients of a 
chemical substance ( positive chemotaxis) or away fiom the source (negative 
chemotaxis) (Wilkinson 1994); b) Chemokinesis (Rothert 1901; Wilkinson,
1985) is used in many different contexts but in the case of leukocytes it 
refers to the reaction by which chemical substances determine the speed or 
frequency of locomotion of cells in their envhonment (orthokinesis); c) 
Haptotaxis (Carter 1967 R27) is defined as chemotaxis along a gradient in 
which the attractant molecules are surface boimd rather than in the fluid 
(Wilkinson 1995 in press); d) Random locomotion is a term which 
describes the random dhection of cell movement along a path which is not 
oriented in relation to the stimulus. (Wilkinson 1995; Abercrombie 1965; Gail 
and Boone 1970) el Directional locomotion Locomotion with a preferences 
for (or avoidance of ) a particular direction. The axis of the migrating cell is 
oriented hr relation to the stimulus (Wilkinson 1977; and Wilkinson 1995).
1.2.3.B4.2 Methodology
As mentioned above chemotaxis studies have been faced witii a lot of difficulties 
in finding reliable methods to quantify cell locomotion. For this reason numerous
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reports have been published in scientific journals using assays to deteimine the 
chemotactic migration of cells in vitro. These are as follows:
1. Microfilter assays (Boyden chamber)
This assay was first introduced by Boyden in 1962 and proved to be a reliable 
method for quantifying die chemotactic migration of neutrophils, and was also 
used to measure the chemotactic activity of various factors which might cause the 
locomotion of lymphocytes. The piinciple of this assay is as follows: A porous 
filter paper (of size large enough to allow cells to move into the filter by active 
migration) is separated into two compartments, one contaming the 
chemoattractants (lower chamber) and one containing the cells (upper chamber). 
The attractant diffuses up through the filter to form a gradient to which the cells 
respond by migrating through the pores of filter towards its lower surface and 
then after incubation the filters are fixed. The evaluation of locomotion by 
counting cells on the bottom of the filter is inaccurate (Keller et al, 1972) . 
However a leading fiont count method developed by Zigmond and Hirsch (1973) 
is a more accurate method for evaluation of locomotion using the filter assay.
ii. Polarization assay
As mentioned above the accumulation of lymphocytes at the site of inflammatory 
tissues requires adhesion and locomotion. Differentiation between these pr ocesses, 
needs assays independent of adhesion to evaluate the locomotor activity of
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leukocytes in response to chemoattiactants (Wilkinson 1995 in press). An assay 
which acliieves this is the polarization assay (Hasten and Shields 1985). It is 
earned out on cells in suspension (for more details see chapter 2) and it enables 
leukocytes polarized in response to a chemotactic factor to be scored visually . 
Compared with the filter assay the advantages of this assay are, short time 
incubation, low cost, accuracy, and excellent dose response data (Wilkinson 1995 
in press; for details, see chapter 3). This assay has been used to study the activity 
of various chemotactic factors which cause locomotion of either neutrophils (such 
as FMLP, Casein, LPS-activated serum; Haston and Shields 1985) or lymphocytes 
such as IL-2 and MIP-1 alpha (Wilkinson and Newman 1994) IL-8 (Wilkinson 
and Newman 1992), IL-15 (Wilkinson and Liew 1995), synovial fluid (Al- 
Mughales et al., 1995 submitted for publication), IL-4 and IFN-y (Wilkinson and 
Islam 1989) Phorbol ester (Wilkinson et al., 1988) MCP-1 (Wilkinson 
unpublished observation)
However this assay is not a direct measure of locomotion, but simply of the 
morphological change that accompanies locomotion but data collected from this 
assay do conelate very well with locomotion assays, such as collagen gel invasion 
(Wilkinson 1986 ; Al-Mughales et al., 1995 submitted for publication)
iii. Collagen gel invasion assay
As mentioned above polarization of lymphocytes in response to various stimuli 
does not allow full evaluation of locomotion. Polarization studies (using
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polarization assay) needs to be supplemented with migration studies. In 1982 
and 1985 Haston et al and Wilkinson respectively, reported the locomotion or 
migration of normal lymphocytes into a 3- dimensional collagen gel, using the 
collagen gel invasion assay. This assay analyses very well the invasion of cells 
into three dimensional collagen gels (Haston, Shields and Wilkinson 1982; Schor 
et ah, 1983) or fibrin gels (Wilkinson and Lackie 1983; Lanier et al., 1988). The 
collagen gel invasion assay has been used to evaluate the locomotion activity of
lymphocytes in response to many chemoattrctants.
"I
fI
I
1.2.3.B4.3. Activation of lymphocyte locomotion in vitro
Studies of the behaviour of lymphocyte locomotion showed that most 
lymphocytes separated fiom peripheral blood are immotile. These cells are 
not in cell cycle (Go) (see Fig 1.1). Several studies have shown that the 
locomotor capacity of resting T cells is enhanced if they are cultured (24-48h) 
in the presence of activators of growth, such as phytohemoagglutinin (PHA), 
Con A ,mixed lymphocyte culture, OKT3 (anti-CD3), PPD and FCS 
(Wilkinson 1986; Wilkinson and Higgins 1987; Wilkinson 1987; Wilkinson 
and Islam 1989; Wilkinson 1992). The idea that lymphocyte locomotor 
capacity is increased in culture is supported by the finding that these 
locomotor cells increase in size (Wilkinson 1986) and in uptake of tiitiated 
uridine or leucine. Polarization occurs when lymphocytes move from Go to the 
Gi pjiase of growth and polarized G1 cells show increased synthesis of RNA
J
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and proteins. In addition it has been found that the acquisition of locomotor 
capacity (Gq.Gi phase) can be inhibited by cyclosporin A (Wilkinson and 
Higgins 1987a) and FK506 (Wilkinson and Watson 1990). Recently it has 
been found that corticosteroids such as dexamethasone and prednisolone 
inhibit the acquisition of lymphocyte locomotion. The activation of 
lymphocyte locomotion occurs during the first 24h of growth and is 
accompanied by protein and RNA synthesis but precedes DNA synthesis (48 
hours). As will be discussed below, once the lymphocytes acquire locomotor 
capacity they can respond to a variety of chemoattractants which mediate the 
lymphocyte locomotion either in vivo or in vitro. This locomotion activity can 
be blocked either by Cytokine-specific antibodies (Al-Mughales et al., 1996 
submitted for publication) or by a variety of anti-rheumatic drugs.
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Fig 1.1. Lymphocyte Growth Cycle.
This figwe shows 4 phases in mitosis : G% (the pre- DNA synthetic phase which is 
the stage at locomotor capacity develops), S ( tlie DNA synthetic phase), G2 (the 
premitotic phase) and M (the actual mitosis). (Adapted from Basic and clinical 
Immunology. Stites & Terr, 7tli ed 1991).
p re - D N A  
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1.2.3.B4.4. Factors Mediating Lymphocyte Locomotion
As mentioned above adhesion is not sufficient to organize and ensure the 
accumulation of leukocytes at the site of inflammation, because, during the 
process of adhesion (to endothelial cells at site of inflammation) lymphocytes 
may be exposed to chemoattiactants derived from extravascular sources. These 
stimuh aie thought to regulate extravasation of leukocytes by stimulating 
movement and dhectional locomotion (chemotaxis) (Panott and Wilkinson 
1981). The description of these chemoattractants will be discussed below in more 
detail with special reference to lymphocytes attractants, such as IL-2 (Wilkinson 
and Newman 1994), IL-8 (Wilkinson and Newman 1992), IL-15 (Wilkinson and 
Liew 1995), M IP-la (Taub et al., 1993; Schall et al., 1993; Wilkinson and 
Newman 1993), MCP-1 (Carr et al, 1994; Taub et al, 1995).
i. Iiiterleukin-2 (IL-2)
IL-2, was fii st discovered dming stimulation of normal human blood lymphocytes 
with PHA (Morgan et al, 1976), Subsequently it was reported to have several 
activities (Ruscetti et al, 1971; Robb, 1984) as a T cell growth factor (TCGF), 
thymocyte stimulation factor (TSF), T cell replacing factor (TRF), thymocyte 
mitogeneis factor (TMF), and Killer helper factor and (KHF). Its molecular 
weight is of 19 Kd by gel filtration chromatogmphy and 14-16 by SD-PAGE 
(Robb et al, 1981; Kuziel and Greene, 1991; Waldmann 1993; Minami et al,
1993).
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IL-2 plays a central role in the regulation of cellular immune responses by 
expansion of the function of T-lymphocytes (Fanar et ah, 1982) proliferation of 
mmine NK cells (Biron et a/., 1990) and production of IFN-y by T cells (Kashara 
et ai, 1983; Yamamoto et al., 1982; Kelin et a/., 1983), Several researchers also 
confirmed the important role of IL-2 in many aspects of the immune response. 
Blocking IL-2 production in the thymus interrupts T-cell development (Tentori et 
al., 1988), blocking IL-2 with anti-IL-2R in vivo inliibits the development of virus 
specific cytotoxic T cells (Leist et a/., 1989), blocking the activity of IL-2 may 
have potential in prevention of allograft rejection (Kirkman et al., 1985; Kelley et 
al, 1988).
The biological activities of IL-2 aie mediated by the binding to a receptor 
comprising a, [3, and y chains (Tsudo et ai, 1986; Sharon et al, 1986; Smith et 
al., 1989; Takeshita et al, 1990). The a-glycoprotein chain has a molecular 
weight of 55 KD (IL-2Ra; also known as Tac antigen and CD25) (Nikaido et al, 
1984; Cosman et al, 1984). The p-chain has a molecular weight of 75 KD (IL- 
2Rp Hatakeyma; et al, 1989; Minami et al, 1993). The y chain is 65 KD a 
tiansmembrane protein, necessaiy for high affinity binding and signalling 
(Takeshita et al, 1992; Cosman et al, 1993) .
.Although it has been reported that IL-2 is a T cell stimulating factor in rheumatoid
synovial tissue, the biological activity of IL-2 in the rheumatoid aifhritis is 
reported to be deficient. Several studies suggested that IL-2 production in vitio 
by lymphocytes from RA synovial fluid or RA peripheral blood lymphocytes is
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Ujvery low (Miasaka et al, 1984; Combe et al, 1989; Kitas et al, 1988) and also 
the IL-2 level in the rheumatoid synovial fluid was found to be low. The lack of 
this factor may be due to the activity of immune response duiing the disease 
activity or due to treatment effects such as steroids which inhibit the IL-2 
production (Aiya et al, 1984).
It has been reported that IL-2 has chemoattractant activity for human T 
lymphocytes (Komfeld et a/., 1985). Wilkinson and Newman (1994) reported 
that IL-2 is a stronger chemoattractant for T lymphocytes, than other 
chemokines. (see below). Although the IL-2 receptor has several chains 
(Uchiyama et al, 1981; Miyjima et ai., 1992; Sharon et al, 1986) it has been 
reported that the p chain of the IL-2 receptor is sufficient for activation of 
locomotion of IL-2 as judged by complete blocking of the locomotion activity of 
lymphocytes in response to IL-2 by aIL-2RP-chain, and not by aIL-2Ra 
(Wilkinson and Newman 1994).
ii. Interleukin-8 (IL-8I
IL-8 was originally described as a neutrophil activating peptide that was puiifled 
in several laboratories (Schroder et a/., 1987; Yoshimura et al, 1987; Walz et al, 
1987; ). These various studies led to the identiflcation of several peptides with 79, 
77, 72 or 69 amino acids (Schroder et al, 1990; Gimbrone et al, 1989). The 72- 
(secreted predominantly by T cells and monocytes) and 77- amino acid peptide 
fortns (secreted predominately by endothelial cells) are reported to be the most
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amino acid peptide was suggested to be the most potent form of NAP-l/IL-8 
(Noui'shargh e/fl/., 1992; Claik-Lewis a/., 1991).
NAP-l/IL-8 has been known under variety of names. It was initially called 
monocyte-derived neutrophil chemotactic factor (MDNCF; Yosimuia el al., 
1987); lymphocyte-derived neuti'ophil- activating peptide (LYNAP; Gregoiy, H el 
al., 1988), neutrophil activating factor (NAF, Walz el a/., 1987); and the term 
neuti'ophil-activating peptide (NAP)-l/IL-8 became widely accepted (Baggiolini 
el al., 1989) . Presently due to studies showing that that NAP-1 IL-8 has 
chemoattracive/ activating properties for different inflammatoiy cells, the term 
IL-8 is most widely used.
Several atticles reported that IL-8 is a member of the a  chemokine supeifamily of 
8-10 KD molecular weight (Schall el at., 1994; Murphy el al., 1994; Oppenheim 
et al, 1991; Baggiolini, et al, 1994; Taub, et al, 1993) characterized by foui' 
cysteine residues at identical relative positions. This family is called the a  
subfamily or -Cys-X-Cys-tC-X-C) (i.e the first two cysteine amino acids are 
separated by variable amino acids). Other members of this femily are , melanoma 
growth-stimulating activity (MGSA/gio; Schroder et al, 1990; Moser et al, 1990) 
and neutrophil activating protein (NAP-2; Walz et a/., 1989). The gene for these 
chemotactic factor is found on chromosome 4q.
The receptors for IL-8 have isolated and characterized (Samanta, el al, .1990). It 
has been shown that human IL-8 has two receptors tenned IL-8 RA and IL-8 RB 
(Holmes el al, 1991). The LL-8 RA is a 350 amino acid length with five potential
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N"linked glycosylation sites and seven hydiophobic membrane spanning sketches 
characteristics of the G-protein linked family of molecules (Sti osberg 1991). The 
IL-8 RB is 355 amino acids in length with one potential N-linked glycosylation 
site . It was also observed that in the rabbit, F3R, which was reported to be an N- 
foimyl-Met-Leu-Phe (fMLP) receptor has tmned out to be the rabbit IL-8 
receptor (Lee. J. et ai, 1992).
Different ceUulai* somces have been reported to produce IL-8. Although human 
fibroblasts are important for IL-8 production in response to IL-1 or TNF (Stiieter 
et al, 1989; Schioder J et al., 1990; Van Damme et ai, 1989; Larsen, C et al, 
1989), human macrophages appear to be the principal source of IL-8 (Koch et al., 
1991). Human synovial cells also release neutrophil stimulating activity when 
challenged with IL-1 (Watson et al, 1988), and also other cells produce IL-8 such 
as synovial chondrocytes (Bretman et a/., 1990), and articular chondrocytes (Lotz 
et al, 1992). IL-8 is reported to play a major role in neutrophil diapedesis 
through vascular endothehum and focal recruitment at inflamed sites. This study 
is supported by the obser^vations that upon exposme to IL-1 or TNF, endothehal 
cells not only express adhesion proteins (Bevilacquea et al, 1985; Pohlman et al,
1986) that promote their interaction wMi cir culating neutrophils but also produce
I
I
IL-8 (Srieter et al, 1988; Schroeder et al, 1989).
"7:IL-8 is also effective in vivo, hitradermal injection in rabbits results in plasma
;-}J
exudation and massive neutrophil infiltration (Colditz et al, 1989; Endo, H. et al,
1991).
I
I:
Several studies have also reported that IL-8 has chemoattractive/ activating 
properties for neutrophil in the joint cavities of RA and other arthiitides. Although 
a large propoition of the chemotactic activity for PMN in the synovial fluid was 
due to IL-8 (Elford and Cooper 1991; Koch A. et al 1991) no correlation 
existed between the concentration of IL-8 ( Koch et al, 1992) and accumulation of 
neutrophils or lymphocyte count in the RA and non RA.
The effect of IL-8 on the in vitro locomotion of human activated lymphocytes was 
studied. It was observed that IL-8 induced chemokinesis and chemotaxis in these 
cells as determined by several locomotion assays (Wilkinson and Newman 1992). 
IL-8 was released into the medium when mononuclear cells were cultured with a 
CD3 or PPD and induced locomotion and chemotaxis of the activated population 
of cultured lymphocytes. This might suggest that in vivo such activated 
lymphocytes would respond to specific signals fiom IL-8 in inflammatoiy sites by 
leaving the circulation and migrating into the lesion.
iii. Interleukin-15 (TL-15)
Recombinant IL-15 (14-15 Kd on SDS-PAGE) was originally pmified fi'om a 
simian kidney epithehal ceU line and shown to have lymphocyte activating 
properties like IL-2 (Grabstein, K et al., 1994). Activation of T cells by IL-15 is 
inhibited by preincubating the cells with antibody to the p chain of the IL-2 
receptor. Modelling studies have suggested that IL-15 shares a similar three 
dimensional strucmre with IL-2 but has a different sequence fiom IL-2. IL-15
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exerts its biological activity through the p and y chain of the IL-2 receptor
(Giabstein, et al, 1994; Girt, et ai, 1994). Subsequent investigations reported
that IL-15 mediates T cell (Burton et al., 1994; ), B cell (Armitage et al., 1995)
and NK cell proliferation (Bomford et al, 1994; Carson et al, 1994).
The chemoattractant activity of IL-15 for human lymphocytes was studied.
Wilkinson and Liew reported that IL-15 stimulates locomotion of T lymphocytes
as judged by several locomotion assays. IL-15 is widespread in the RA synovium
and IL-15 levels in the synovial fluid are high (Machines et al, 1996). Moreover
it has been found that the immunological activities of T helper cells , B cells and
NK cells in the in vivo immune response of IL-2 knockout mice were normal 
.(Kundig et al, 1993) which might suggest an important alternative role for IL- 
15.
iv. Macrophage Inflammatorv-Protein-l (MIP-la)
MIP-1 a  (7.8-KD on SD-PAGE) is a heparin binding protein, which was 
originally identified during stimulation of murine macrophages with 
Lipopolysaccharide (EPS) (Oppenheim, J . et al, 1991; Davatelis, G. et al, 1988; 
Wolpe et al, 1988; Wolpe and Cerami 1989). MlP-1 a, belongs to the family of 
chemokmes that have been called the intercrine B subfamily, defined by the Cys-
-V-
Cys- (C-C) motif. This family includes MIP-1 p, monocyte chemotactic and 
activating factor (MCAF, MCP-1), hRANTES, Hact-2h, and MJE,. The cellular 
sour ces of this molecule ar e various such as T cells, B cells, monocytic cells, mast
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were shown to express significant levels of M IP-la via hnmunochemistiy, both 
spontaneously and in response to lipopolysaccharide (LPS) (Denis and Ghadirian 
1994).
Several investigators have shown that MIP-1 a  exerts a variety of biological 
activities such as chemoattraction of monocytes and eosinophils (Taub et al,
1993) as well as induction of chemotaxis for neutrophils (Wolpe et a/., 1988; 
Alam et al, 1992), basophils and mouse mast cells (Alam et al, 1992). In 
addition it has been reported that M IP-la increases the adherence of T cells into 
inflammatory sites (Taub et al, 1993). The chemoattractant activity of MIP-1 a  
for human lymphocytes was first reported by Taub et al, 1993 and Schall et al, 
1993. Subsequently Wdkinson and Newman reported that M IP-la is 
chemoattractant for normal human lymphocytes as judged by several locomotion 
assays (Wilkinson and Newman 1994). In addition it has been shown that M IP-la 
in supernatants of alveolar macrophages has strong chemotactic activity for 
highly purified CD8+ T cells as judged by neutralizing the activity of M IP-la 
(Denis and Ghadrian 1994).
V. Macrophage, chemotactic protein-l (MCP-1)
MCP-1 (alternative designations: JE, monocyte chemotactic and activating factor, 
tumour-derived chemotactic factor) is a 76 amino acid protein structural^ 
belongs to the C-C supergene family of chemokines (see above) and has specific
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chemoattiactaiit and activating properties for monocytes (Leonard, et al, 1990; 
Schall et al, 1991; Van. Damm et al, 1989 MCP-,1 9) . The human MCP-1 gene 
maps to chromosome 17 (q 11.2 -12; Miller and Krangel 1992). However MCP-1 
is produced by various cell types, including PHA-stimulated blood mononuclear 
cells (Yoshimura, T. et al, 1989), fibroblasts (Lukacs et al, 1994), tumour cells, 
LPS treated macrophages, human fiver fat storing cells, endothelial cells and 
smooth muscle (Christensen et al, 1993; Marra et al, 1993; ).
The biological fimction of MCP-1 has been reported by many investigators., 
MCP-1 is a potent stimulus of histamine release fiom human blood basophils 
(Bischoff, et al, 1992; Kun et al., 1992), stimulates macrophage infiltration of 
tumours, which suggests its ability to stimulate the killing of tumour cells in 
animal models (Charo et al, 1994; Matsushima, K et al, 1989) . It is also 
suggested that monocyte recruitment into the artery wall is a critical step in the 
initiation of atherosclerosis , MCP-1 was reported to be abundant in the active 
macrophage-rich areas of human ar therosclerosis plaques (Charo, et al, 1994). In 
addition MCP-1 is reported to mediate monocyte recruitment of tissues in various 
inflammatory diseases such as alveolitis (Jones et al, 1992) and rheumatoid 
arthritis (Koch, et al, 1992).
Recently it has been found that MCP-1 has chemoattractant activity for human 
lymphocytes in vitro. Can' et al (1994) reported that MCP-1 is the major 
lymphocyte chemoattractant secreted by mitogen-stimulated peripheral blood 
mononuclear cells and is capable of acting as a potent T- lymphocyte as well as
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monocyte, chemoattractant. This may explain why monocyte and T lymphocytes 
of the memory subset are always found at sites of antigen-induced inflammation 
(Can et al 1994). MCP-1 has a chemoattractant activity for human blood 
lymphocytes in vitro at optimal concentrations of about Ing/ml (Wilkinson 1995; 
impubhshed observation).
vi. Foetal Calf Serum
The chemoattractant activity of FCS serum was investigated by several 
researchers. It has been reported that cultur e of lymphocytes in FCS cause a large 
proportion of lymphocytes to change from a roimd to a polarized shape (O' Neill 
and Parrott, 1977). A Similar study reported that neat or 20%, FCS can stimulate 
the locomotion activity of lymphocytes (45% or 20% respectively) as judged by 
short term polarization assays (Wdkinson 1986).
1.2.4. Laboratory evaluation of systemic and chronic rheumatic inflammatory 
diseases.
1.2.4.A. Introduction
The inflammatoiy immune response in rheumatic diseases mentioned above play 
an important role in the immunopathogenesis of these diseases.
Seveml laboratory methods have been used to evaluate the metabolic changes in 
the joint and peripheral blood including histopathology, iramunochemisüy, blood 
analysis. The major important changes noted aie in the increase of concentration 
of acute phase proteins such as complement components, ai antitiypsin, 
fibrinogen, haptoglobuhn and major important changes have been observed in the 
concentration of C-reactive protein and erythrocyte sedimentation rate (Several 
hundred fold the normal value) which have become widely employed indicators 
of the acute phase response in the rheumatic diseases and other systemic diseases.
1.2.4B. Erythrocyte sedinaciitadon rate
The ESR is a single most important laboratory test of inflammatory activity. The 
increased rate of setthng of erythrocytes in the blood of patients with 
inflammatory diseases has been known for many years. Measurement of the ESR 
was first applied to the study of the acute and chronic rheumatism by Herman in 
1924. The principle of this test relies on the concentration of fibrinogen and other 
acute phase proteins which cause increase aggregation of erythrocytes suspended
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in plasma (rouleaux formation) causing them to fall more rapidly (Ballou and 
Kushner 1993). The international committee for standardisation in haematology 
has recommended a method for ESR determination called Westergien’s method 
(ICSH. 1977).
1.2.4C. C-reactive protein.
CRP is present in all RA patients with clinical evidence of disease activity. C- 
reactive proteins were originally detected in human serum because of their ability 
to interact with somatic C-polysaccharide of the pneumococcus (Ballou and 
Kushner 1993). Its serum level rises and falls faster than ESR which gives an 
indication of the crurent inflammatory activity of patients more accurately 
(Morley et al., 1982). Following acute inflammation the serum concentration 
increases within a few hours and there is an increase in nmnbers of hepatocytes 
producing C-RP (Powell. 1983). The most widely used method for C-RP 
determination is immimotrubidometry assay.
$1.2.5 Control of systemic and chronic mflaminatioii in rheumatic diseases 
using anti-inflammatory drugs. 
1.2.5A. Non Steroidal Anti-inflammatory Drugs fNSAIDs)
In 1977 Brook and Corbett reported that the serious comphcations in RA occur 
within 2 years of disease onset. Hence rheumatologists have suggested that 
treatment with arthritis should be started with simple antirheumatic drags (first 
line drags) such as analgesic and non-steroidal antiinflammatory drags (NSAIDS) 
(Brooks 1985). These are relatively tipid soluble, weak acids (they have a 
carboxyhc acid, keto-enoHc moiety giving them a pKa of 3-6 which enables them 
to accumulate in inflammatory sites where the pH is about 6-9.5) (Rainsford
1994), and almost all aie absorbed fiom the gastrointestinal tract (Langman 1989; 
Fries et al., 1989). The presence of these drags at the inflammatory site including 
synovial tissue is critical for their manipulation of inflammation and other 
imdesirable inflammatory processes such pain (pain controlled by NSAIDs may be 
at the level of the central nervous system by regulation of nemokines). The 
mechanism of action of NSAIDs is as follows: They inhibit the biosynthesis of 
prostaglandin, thromboxane and prostacyclin by irreversibly blocking the enzyme 
cyclo—oxygenase (prostaglandin synthetase) which catalyzes the conversion of 
arachidonic acid to endoperoxide compounds (Rinsfoord 1994; Forest and Brook 
1988; Brook and Day 1991; Allen K 1995). They can also exert other functions 
mcludmg (e.g Aspirin indomethacin, Ibuprofen) suppression of lymphocyte
tiansformation (Opeiz et al., 1973;), inhibition of cartilage degeneration (Palmoski 
and Brandt 1983). In addition it has been reported that NSAIDs inhibit the 
migration, adhesion, and locomotion of leukocytes as well as the release of 
lysosomal enzymes (Brown and Collins 1977; Spisani et al., 1979; Higg et al., 
1980). A Fmther action of NSAIDs is the inteifering with the kallikiein system 
(KaUikieins are proteinases which generate small peptide molecules, kittins, from 
a protein substrate, kininogen) (Cuthbert 1994) and cell membrane activities 
(such as enzyme, NADPH oxidase and phospholipase). New generation of 
NSAIDs can inhibit the production or activity of cytokines such IL-1 (Rainsford
1994). For more detail about the sites of action of NSAIDs see Fig 1.2.
1.2.5B. Disease-modifymg antirhemnatic drugs
The second goal of rheumatic disease tr eatment is to alter the disease progression 
and outcome using second line or disease-modifying antirheumatic dings 
(DMARDS). Examples are Gold, D-penicillamine and anti-malarial drags.
There have been several trials using combined DMARDs to rheumatoid arthritis, 
such as hydi’oxychloroquine, penicillamine and hydroxychloroquine,penicillamine 
and chloroquine, penicillamine and salphazalazine (Dawes et al, 1987; Bitter 
1984; Gibson et al, 1987). The mechanism of action of these drags as follows:
(i) Gold compoimds were introduced for treatment of RA in 1929 (Forestier, J., 
1935; Kean et al., 1985) and most commonly administrated gold preparations are 
auiothiomalate and aurothiloglucose (Harfall et al, 1937). Gold compounds
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Figure 1.2. Scheme for mediators derived horn archidoîiic acid and site of action 
of NSAIDs (adapted firom Basic and clinical pharmacology, Katziuig, D.G, 4tli ed 
1989).
Stimulus
Disturbance of cell membranes
Phospholipase inhibitors 
Corticosteroids Phospholipids
Phospholipase
Fatty acid substitution 
{diet) Arachidonic acid
Lipqxygena^ mhiNtors NSAID, ASACyclo-oxygenase
Lipoxygenase
Receptor level 
antagonists Leukotrianes
Prostaglandins Thromboxane J Prostacyclin
[u u kocy te  modulation
Colchicine
Inflammation 1Inflammation
Phagocyte
attraction/
activation
Bronchospasm, 
congestion, 
mucus plugging
Alteration of vascular 
permeability, bronchial 
constriction, increased 
secretion
XÎ
,1;
::iV
"S
■f
A
:
83
I
A
available for therapeutic use contains elemental aur ons gold (Au+) combined with 
a sulfur-containing ligand. The mode of action of gold in RA still unclear. Several 
investigators reported that gold suppresses activity of lymphocytes , prostaglandin 
and leukotiienes (Lies, et al, 1977; Lipsky and Ziff 197).
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(ii) D-penicillamme (D_(A-2-amino-3mercanto-3methvlbutvric acid) is a
metabolite of penicillin and can be prepared from it by acid hydrolysis (Lock et
'al., 1986; Joyce and Day 1990). The mechanism of action in RA still unclear, but 
.heatment with this drug interferes with the lymphocyte membrane receptors and 
inhibits the production of RF by binding to the disulphide bonds (S-S). It has been 
reported that D-penicillamine in the presence of copper ion markedly inhibited 
mitogen—induced human T lymphocyte DNA synthesis. The mechanism by which 
D-penicillamine in the presence of copper inhibits T lymphocytes responsiveness 
was reported to be due to the production of the generation of hydrogen peroxide 
(Lipsky, 1984).
(iiik Antimalarial drugs
Choloroquine or hydr oxychloroquine have been used extensively in the tr eatment 
of RA, Anti-malarial drugs include 4-aruinoquinoline-choloroqiiine, 8- 
arninoqiiinoline-primaquine, and others (Golsmith 1989). Treatment with these 
drugs interferes with plasma proteins, RNA/DNA polymerase (Salako, 1985;
'
McChesney et al., 1966). Then interaction with phospholipids decreases the
lymphocytes fluidity (Beccricerica, 1989). In addition it has been shown that the
-:,X
:
anti-malaiial drugs (e.g Chloroquine) interfere with antigen processing and antigen 
presentation (Davis P, 1994).
1.2.5C. Cytotoxic drugs
Cytotoxic drugs are used for the tr eatment of rheumatoid ar thritis patients if their 
illness has failed to respond to less aggressive drugs or has been comphcated by 
systemic vascuhtis (Hofinan, 1993). Concern about toxicity, including the 
induction of mahgnancies has until recently limited more routine use and 
reassessment of the morbidity in rheumatoid arthritis has lead many 
rheumatologist to re-evaluate their str ategies of when such drugs should be used 
in the manipulating of the progressive disease (Hohnan 1993). As discussed 
below cytotoxic drugs such as cyclosporin A , rapamycin cyclophosphamide and 
Glucocorticoiods (including dexamethasone, prednisone and prdednisolone) 
interfere with specific phases of the mitotic cell cycle (Fig). There are 4 phases in 
mitosis ; G1 (pre-DNA synthetic phase), S (the DNA synthetic phase), G2 (the 
premitotic phase) and M (the actual mitosis). Cells in a prolonged mtermitotic 
period are consider to be in a GO phase (Albert et al, 1989). However any 
suppression effect on the cell RNA/DNA cell rephcation and proliferation leads 
to suppression of production and function of immune competent cells and other 
cells, in manner that dose not discriminate against those cells that may be of most 
pathologic significance.
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i. Cyciosponn A
Cyclosporin A (CsA) is a biologically active metabolite extracted from two 
species of fungi called a Cylindrocarpon Lucidum Booth and Trichoderma 
Polysporum Rifai (Borel et al., 1976). It is used widely as an powerful 
immunosuppressive drug (Borel, et al, 1977) in the treatment of several diseases 
including rheumatoid arthritis (Douglas et al, 1988). Structurally CsA is a cylcic 
polypeptide consisting of 11 amino acids (one of them unsatuiated C-9 that is 
unique to this molecule) (Hess & Tuschka 19980), 1976) and is insoluble in 
water but it can dissolve in ethanol. Several experimental animal studies have been 
reported that CsA inhibits antibody formation to T cell -dependent antigens, the 
prolongation of skin graft survival and suppression of delayed-type 
hypersensitivity reactions (Borel et al, 1988). CSA also exerts its 
immunosuppressive effects by selectively inhibiting the transcription of messenger 
RNA of IL-2 and IL-2 receptors by CD4+ T cells by at an eaiiy stage of growth 
(Gl) and other cytokines including lL-3, lL-4, lL-5, lL-6 (Grilly et al, 1995; 
Hedges 1993). CsA was also found to inhibit the mitogen activated but not 
phorbol ester-activated locomotion of human lymphocytes vitro (Wilkinson and 
Higgins 1987). In addition a recent study reported that CsA combined with 
methoftexate had a significant effect on the improvement of patients with sever 
RA (Tugwell et al, 1995). It has been observed that CsA mediates its 
immunosuppresive effect through an abimdant cytoplasmic protein termed 
cyclophilin of 17 kda. (Sigal & Dumont 1992).
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ü. Rapamycin
Rapamaycin was originally extracted from soil micro-organisms and became 
widely used as an antibiotic and as an immunosuppressive drug (Vezina et ai, 
1975; Martel et al., 1977). Like CsA it can affect a wide variety of cellular 
activities but its mechanism of action involves binding to DNA through 
inter calation with a consequent blockade of the synthesis of DNA and RNA (Sigal 
and Dumont 1992). Rapamycin has similar , but not identical actions to 
cyclosporin A, and may also prove a less toxic immunosupressant than the former 
(Fan and Rainsford 1994). Several studies have reported that rapamycin inliibits 
murine and human T cell proliferation. It interferes at a later time hr the activation 
processes than does CsA which act at an early stage of T cell signal transduction 
(Sigal and Dumont 1992). Further studies reported that rapamycin delays the 
growth of tumour cell lines transplanted in mice, suggesting that this compound is 
a general anti-proliferative agent (Sigal and Dumont 1992).
i ii  Cvclophosphaimde
Cyclophosphamide is one of the alkylating agents that have been widely used to 
tr eat rheumatic disease (Clement et al., 1974). Its mode of action is inhibition of a 
wide variety of cellular processes including T and B lymphocytes (Stockman el 
al., 1973). The alkylation of guanine in DNA can lead to miscoding, destruction of 
the purine ring and inhibition of DNA replication through cross-linking. Although 
the alkylating agents are not cell cycle specific, cells are most susceptible to
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alkylation in late Gl and S phase of the cell cycle and express blockage in G2 
(Kovaisky 1983).
1.2.5D. Glucocorticoids
Glucocorticoid hormones (GcH) are used widely in the therapy of inflammatory 
diseases including rheumatoid aithiitis (Morand et al, 1994). They mediate their 
action through cytosolic receptors. The glucocoiticoid-receptor complex then 
moves quickly into the nucleus. They bind to the to gluococoiticoid-responsive 
elements of genes, thereby influencing gene tiansciiption. In the immune system 
GcH acts primarily by inhibition of cytokine production and lymphocyte 
activation.
Several studies have reported the inhibitory effect of GcH upon lymphocytes and 
their response to mitogens (Dugherty, 1952). In addition it has been reported that 
GcH have an inhibitory effect on RNA, DNA and protein synthesis in 
lymphocytes (Makman et a l ., 1968). The number of chculating lymphocytes is 
reduced within 24h of GcH injection and more CD4+ T cells are affected than B 
cells. Also cells of the monocyte-macrophage lineage, NK cell (Paiillo and Fanci 
1979) and neutrophil functions are affected. It has been observed that lung 
inflammation is down regulated by dexamethasone therapy which affects the 
release of inflammatory mediators and the influx of neutrophils into the airways 
(Groneck et al, 1993). The activity of GcH on cytokine production has been 
extensively studied. For example it has been found that GcH acts primarily by
inhibition of cytokine production and T cell activation. GcH inhibits the 
production of IL-1 (see fig 1.3) , IL-6, IL-2, IL-4, TNF-a, and INF-y (Kavelaars et 
al., 1995; Rakasz el ai, 1993; Schlaghecke et ai, 1994). Taken together inhibition 
of lymphocyte activation by GcH may operate by the following mechanisms 
(Mendelsohn et al, 1977): (1) they suppress recruitment of cells fiom GO to Gl 
phase of the cell cycle. (2) the inhibit progression fiom Gl phase into S phase (3) 
they reduce the rate of DNA replication.
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Figure 1.3. Sites of action of glucocorticosteroids and cyclosporin A.(adapted 
fiom Basic and Clinical Immunology, Stites and Ten; 7th ed 1991).
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Section 2: OBJECTIVE OF PRESENT RESEARCH,
i. Introduction
Tissue lymphocyte infiltration occurs in response to different pathological stimuli. 
Lymphocyte locomotion across vascular endothelium venules (HEV) into 
inflamed sites plays a crucial part in initiating and modifying the disease process. 
Despite their importance, our knowledge of factors stimulating and controlling 
lymphocyte locomotion and chemotaxis into rheumatoid lesions is still unclear. 
A lthou^ it would be advisable to examine synovial tissue from each patient with 
RA to compare histological changes with those fiom previous specimens and 
assay for lymphocyte subset and chemotactic factors production by these cells or 
synovial cells, this is very difficult and impractical. Synovial fluid is a good 
source; by examination of its characteristics (Chemoattractant activity, cell count, 
chemotactic factors levels), one can gain a good appreciation and learn more about 
the extent of inflammation and events occurring in the synovium itself.
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ii. AIM of research.
To study the role of chemotaxis in the accumulation of T lymphocytes in 
rheumatoid and other inflammatoiy joint diseases.
I. Examine the chemotactic activity of synovial fluids from RA in comparison to 
OA and other inflammatoiy arthiitides where the lymphocytes infiltiate is much 
less. The Study involves the response of normal blood T cells to joint fluids.
II. To identify and quantify T lymphocyte chemotactic factors in joint fluid and to 
use specific monoclonal antibodies to inhibit their activity.
Ill To study the response of synovial tissue T cells to joint fluids and to cytokines 
in comparison with cells from blood.
IV. To study the role of activation of T cells in the locomotor response to joint 
fluid. Phenotyping of responsive cells for activation markers, e.g CD45RO.
V. Study of the inhibitory effects of anti-rheumatic drugs on the locomotion of T 
cells.
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CHAPTER 2.
PATIENTS, MATERIALS AND METHODS
2.1 Patients
The chnical categories of the patients used in this study are summarised in table 1 
and 2. Synovial fluid was obtained from joints of patients attending the 
Rheumatology day ward at Gartnavel General Hospital and Glasgow Royal 
Infiimaiy for aspiiation and corticosteroid injection into their painful joints.. The 
fluid was taken by rheumatologists from knee joints since synovial fluid is most 
easüy obtained. Synovial fluid was transferred to transport medium and was in 
the laboratory within about 1-2 hours. The fluid was aspirated using full aseptic 
precautions and before any steroid was injected. Fifty one patients with a 
confirmed chnical diagnosis of rheumatoid arthritis or other arthritides were 
studied. The patients were classified into two groups , RA and non RA. The RA 
patients (n= 35 median age 56; range 33-91 years) diagnosed according to the 
American College of Rheumatology criteria (Arnett, et al 1988) were classified 
according to disease duration (see Table la, lb, Ic). The non RA group were 
Osteoarthritis (n—7 median age;76; range 59-78), ankylosing spondyhtis (n=5
median age: range 30-70) psoriatic arthritis (n=3 age 48 and 70 years) intermittent 
hydroarthrosis (n=l age 32), polymyalgia rheumatica (n^l age 48) and 
pyrophosphate arthropathy (n=l, age 77). The drug regimen in the RA group
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consisted of non-steroidal anti-inflammatory drugs (NSAIDs) such as 
Ibuprofen, Voltaiol, Indocid, and disease modifying anti-rheumatic drugs 
(DMARDs) such as methotrexate, azathioprine, sulphasalazine,or gold. 
Corticosteroids such as prednisolone were also used. Cytotoxic drugs were 
occasionally used. The non RA group were either treated with NSAIDs or not 
treated. Only a few patients were treated with DMARDs. The Westergien 
erythrocyte sedimentation rate (ESR) , and C-reactive protein (Beckman), 
antinuclear antibodies (Immunofluorescence) and rheumatoid (Rose-Waaler 
or ELISA ) factor were routinely measmed in all patients.
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Table 2.1 A . Descriptive characteristics of the patients with RA
disease duration (1-10 years).
Code
Disease
duration
(years)
Age
(years)+Sex Overall severity+Erosion Drugs
W.C
M.G
G.H
C.W
ÏLM
M.MA
4
8
6
9
4
9
67(F) 
57(F) 
76 (M) 
63(F) 
82(F) 
66 (F)
SEV+Eros (++) 
MOD+Eros (++) 
SEV+Eros(++) 
MOD+none 
SEV+Eros(+++) 
SEV+Eros(++)
Feldene+SASP 
Ibtiprofen+SASP 
Oruvail 
Relifex+Mepti de 
Voltarol+Gold 
SASP+Feldene
M.MO 8 52 (F) MOD+Eros(++)+nodules Ibuprofen+Fenicillamine
D.G
B.M
R.E
7
9
9
35 (M) 
59 (M) 
50 (M)
MOD+none 
SEV+Eros(++)+anemia 
SEV+Eros(++)
Voltarol+Gold
Ibiiprofen+Gold
Indocid+peniciUamine
H.M 7 44 (M) SEV+Eros(+++) Methotrexate+Prednisolone
M.EZ
H.Y
JK
IS
L.M
4
6
9
9
6
70(F)
88(F)
60 (F)
39(F)
37(F)
SEV+Eros(++)
V.seve
NA
NA
NA
NA
Sulindac+acupan 
PeniciUamine+Naproxen+ 
Co-cadamol 
Indojnethacin+Inmran+ 
Co-cad ajtiol 
Gold
2.1B: RA. Disease duration (11-20 years I
Code
D isease
duration
(years)
Age
(years)+Sex Overall severity+Erosion Drugs
l.F 20 81(F) MOD+Eros (++) Voltarol+SASP
M.B 19 80 (F) SEV+Eros(++) NA
S.S 17 53(F) SEV+Eros(++)+Ray Hand's Siilindac+SASP
J.C 20 56 (M) SEV+Eros(++) Relifex+Penicillamine
R.L 16 51 (M) V.SEV+Eros(++)+NFA Feldene+cyclopliosphaniide
S.K 11 33 (M) M OD+none SASP+Naproxen
D.R 14 67(F) NA Feldeiie
B.L 19 77(F) NA NA
C.M 13 55(F) MOD+Eros(+++) Volta rol
E.P 16 56 (F) SEV+Eros(++) Aspiriii+Gold
G.j 18 41(F) NA NA
M.N 13 60(F) NA Copraxamol+Methotrexate+Analgesics
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2.1C : RA. Disease dnratiop(>20 years).
Code
Disease
duration
(years)
Age
(years)+Sex
Overall
severity+Erosion Drugs
A.M
W.M
M J
G.W
D M
J.A
M.S
25
23
51
40
23
31
40
60 (F)
80(F) 
50 (F) 
47 (M)
59(F)
53 (M) 
74(F)
MOD+Eros (++)
SEV+Eros (+++)
SEV+Eros (++)
SEV+Ero (++)
SEV+Eros (++) 
+Nodules
MILD+Eros (++)
Mild+Eros (++)
Indocid+SASP
SASP
Naproxen
Indocid+Penicillamine
Voltarol
Indocid+SASP
Indocid
Synovial fluid was collected from different patients with rheumatoid arthritis 
(n=35) 16 patients with disease duration of 1-10 years (Table la), 12 patients of 
10-20 years (Table lb) and 7 patients with >20 years disease duration (Table Ic) 
were in this study. RA patients were treated with NSAIDs: Ibuprofen, indocid, 
Voltaiol, and Disease modifying antirheumatic dings (DMARDs): gold, D- 
penicillamine, salphasalazine (SASP), methotrexate, naproxen and aziothioprine; 
or corticosteroids such as prednisolone or cytotoxic drugs such as 
cyclophosphamide A. Eros=erosion , NA=information not available, 
RA=rheumatoid arthritis, Sev=severe, Mod=moderate, M=Male, F=Female.
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Table 2.2. Clinical description of the patients with non RA*
Code Provisionaldiagnosis
D isease
dwiation Age {years)+Se>
Overall
severity Drugs
H.Me
D.SC
A.SO
EM c
D.Ba 
AjBa
E.Ch
D.SM
D .SH
W.G
R.Mc
C.Ca
M.T
W.S
B.T
S.T
B.P
G.M
OA
OA
OA
OA
OA
OA
OA
AS
AS
AS
AS
AS
PSA
PSA
PSA
IM .H .A
PMR
PARP
5
10
15
12
10
10
8
5
30
15
10
2
1
78(F)
76 (M) 
59 (F) 
72(F) 
78 (M) 
68 (M)
66 (F)
44 (M) 
30 (M) 
70 (M) 
NA
54 (F)
48(F) 
70 (M)
58 (M)
32(F) 
58 (M) 
77(F)
Mild+Eros
Mod
Mod
M ild
M ild
M ild
Mild
V.SEV+Eros
Mod
M ild
NA
Seve+Eros
NA
M ild
Seve+Eros
Mild
M ild
NA
NA
Voltarol
Voltarol
Paracetamol
Paracetamol
Co-Cadamol
NSAIDS+
Paracetamol
Gold+Ibitprofen
Voltarol
Ibuprofen+
Coproxamol
N A
Salazopyrn+
Voltiuol+
Paracetamol
Paracetamol
Ibuprofen
Lederfen+
Copraxamol
N A
Prednisolone
Paracetamol
SF sample from patients with non RA (n=18). Osteoarthritis (OA, n-7). ankylosing 
spondylitis (AS n=5). Psoriatic arthritis (PSA n=3), intermittent hydroarthritis (IMHA, 
n=l). Polymyalgia Rheumatica (PMR n-1) and pyrophosphate arthoropathy (PARP, 
n=l). Patients in this group were untreated or treated either with analgesics and NASIDs 
orDMARDS.
NA=information not available, M=Male. F=Female, SEV=Severe.
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2.2 Materials
2.2.1 Preparation of Media
Hanks’balanced salt solution (HBSS), and calcium and magnesium free salt solution 
(ICN Flow Ltd., High Wycombe, U.K) were obtained as lOx strength solutions. 
These were diluted to Ix strength with distilled water and were buffered to pH 7.4 
with (3-[N-morpholino] propane sulphonic acid (MOPS; Sigma Chemical Co, Ltd., 
Poole, UK) or HEPES (Gibco BRL, Life Technologies L td.. Paisley, U.K) . Hepes 
(N-2 “Piydoxyethyl] piperazine-N-[2-ethane sulphonic acid) was used at 20mM. The 
pH of HBSS was adjusted to 7.4 using 2M NaoH or HCL (BDH), if necessaiy. 
RPMT 1640 (Gibco BRL, Life Technologies Ltd., Paisley) was obtained as a Ix 
strength solution with sodium bicarbonate. This was supplemented with lOmM 
HEPES buffer ,2mM L-glutamine, lOOu/ml penicillin, and lOOpg/ml streptomycin
2.2.2. Foetal calf serum (ECS)
PCS (Flow , Rickmansworth, Herts, England) was heat inactivated at 56 ^C for 30 
minutes and then diluted in HBSS. For routine use FCS was diluted either in HBSS 
as 25% (v/y) or 5-10% in RPMI. A 25% FCS was used to culture the cells for long 
periods ( 24, 48, hrs).
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2.2.3. Human serum albumin (HSA)
HSA (Behringwerke, Maiburg,FRG) was used at 10 mg/ml in HBSS (HBSS/HSA).
2.2.4. N-formvl-L-methionvl-L-leucvl-L-pheiiylalanine (FMLP, Sigma) was 
prepared as a stock solution of 10'  ^M in dimethyl sulphoxide (DMSO , Grade I , 
Sigma) and stored at -20''C.
2..2.S. Preparation of biiffers 
2.2.5. A1 MOPS
One molar MOPS [ 3-(N-moipholmo) propanesulphonic acid] pH 7.4, was used as 
standard buffer in most media preparations. MOPS (Sigma ) was prepared by 
dissolving 20.93g in 90ml of distilled water . Final volume was adjusted to 1 0 0  ml 
by adding sterile distilled water. Then the pH was adjusted to 7.4 by adding an 
appropriate amount of sodium chloride (BDH) and stored at 4°C. This buffer was 
routinely used as lOmM.
2.2.5.A2. Phosphate Buffered Saline
PBS (pH7.4) was prepared at 25x strength in one htre of distilled water by 
dissolving 200 g of NaCL (BDH ); 5g of KCL BDH) ; 5g Of KH2PO4 (BDH) and 
28.75g of NA2HPO4 (BDH) . For routine use it was diluted to Ix strength in
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distilled water.
2.2.5.A3. Tris-bpffered saline (TBS, pH 7.6)
It was prepared as stock 0.5 M Tris-HCL in water and was diluted 1/10 in saline. 
This buffer was used throughout as diluent for APAAP substrate, diluting of 
antibodies and for washing slides between incubation steps.
2.2.5A4. lL-15 ELISA coating buffer
1.59g of NaCo3 (BDH), 2.9g of NaHC03 (BDH), were dissolved in , one litre of 
distilled water and pH was adjusted to pH 9.6, or 2.9 g of 0. IM Sodium bicarbonate 
was dissolved in 250 ml of distilled water and the pH was adjusted to pH 8.2. The 
coating buffer can be stored for 2 weeks at 4 ^C.
2.2.5A5. Substrate buffer for IL-15 ELISA
MgCl. 2.6 H2O (O.lOg, BDH), and 0.20g of sodium azide (NaN3, BDH) were 
dissolved in 800ml of water and then 97ml of diethanolamine was added and the pH 
was adjusted to pH 9.8.
2.2.5.A6. Washing buffer for IE-15 ELISA (PBS/Tween )
Tween 20 (0.5ml; Sigma) was mixed with 1 litre of PBS and stored at 4"C for 2 
weeks.
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Saline
This was prepared by dissolving NaCi (8.5g/l; BDH) in distilled water and the 
solution was sterilised at 121°C for 15 min or it can be prepared as 25X without 
sterilisation.
2.2.6. Preparation of fixative.
To ensure the best preservation of structur al detail of lymphocytes, different fixatives 
were used in this study as follows:
2.2.6A1. Glntaraldehvde
Grade U glutaraldehyde (25% aqueous solution, Sigma,Poole,Dorset) was used as a 
2.5% solution . A 2.5% stock was prepared fi-om 10 ml of 25% aqueous solution in 
90ml saline and stored at 4 . It was used as the routine fixative in polarisation and
collagen gel assays. Glutaraldehyde was not suitable for fluorescence studies because 
it gives strong background fluorescence (Nicholas, et al, 1992). Therefore, for these 
studies, paraformaldehyde was used.
2.2.6A2. Paraformaldehyde
Paraformaldehyde (BDH;) was prepared at 1% (w/v) by dissolving
paraformaldehyde powder in PBS at 60-70 for 45-60 min. A stock solution was 
stored at 4 ‘^ C. This fixative allows both a reasonable preservation of cell
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morphology and antigen detection (Nicholas, K., 1992).
2JZ.6.A3. Methanol /acetone (BDH).
This was prepared by adding one volume of methanol to one volume of acetone and 
stored at room temperature.
Preparation of sodimw azide (NaNA
Stock sodium azide (BDH) was prepared at 10% (w/v) in distilled water and was 
used at 0.1%.
2.2.7 Preparation of snhstrates
2.2.7.A1 APAAP substrate
Levamisole (Img/ml, Sigma) , 5.5 ml of water and 4 mg/ml fast red (sigma) were 
mixed with 0.5ml of naphthol AS-MX phosphate (0.25% alkaline solution; sigma). 
The whole solution was filtered using Whatman filter paper (Kent; UK).
2.2.7 A2. DA15 ELISA substrate
This was prepared by dissolving one tablet of paia-nitrophenyl in 5ml of subshate 
buffer.
Preparation of Mounting Media
This was prepared by diluting 4 volumes of glycerol (Hycor. Biomedical. INC. CA) 
in one volumes of PBS 7.4.
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2.2.8. Preparation of primary phenotypic antibodies
All primary antibodies used in APAAP and FACS (see below) were monoclonal and 
of murine origin and unconjugated. Anti CD3 (Reinherz and Schlossman, 1979) was 
from Oifhoklein (Rahway, NJ, USA ) or the Scottish antibody production unit, 
(Carluke, U.K.) Anti-CD4 (Reinherz et al., 1979), anti-CD8 (Reinherz et a/., 1980) 
and Anti“CD22, (Dorken et al., 1986 ) and antiCD56 (Griffin et al 1983; Hercend et 
al 1985 ) were from SAPU (Cariuke, U.K). Anti CD 14 (Dimitriu-Bona et al, 1983) 
was from Dako Ltd (High Wycombe, U.K). Anti-CD45RA (2H4; Morimoto et al 
1985a) was from Coulter Electronic (Luton, U.K.) and was used at a final dilution of 
1/10. Anti“CD45RO (UCHLl; Smith et al, 1986) was a gift from Prof. P.C.L 
Beverley, ( ICRF, London, U.K) and was used as final dilution of 1/2.
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Preparation of negative control antibodies.
Unconjugated mouse IgGi (Dako) or FITC-conjugated mouse IgG) anti-human 
tissue and serum protein (Coulter) were used.
2.2.9. Preparation of cvtoknies and cytokine specific antibodies. 
il Cytokines
Recombinant human (rh) IL-2 was provided as a gift to Dr D.I. Stott of this 
department by Glaxo, Geneva, Switzerland. This material gave a single band at MW 
1500 on reducing sodium dodecyl sulphate-polyaciylamide gel electrophoresis (SD- 
PAGE) indicating >99% purity (Wilkinson and Newman 1994). It was used at 
lOOng/ml. Recombinant human (rhu) IL-8 was from British Biotechnology (Oxford, 
U.K) and was used at lOOng/ml (Wilkinson and Newman 1988; Wilkinson and 
Watson 1990). Recombinant human M lP-la (LD78) was a gift from Dr. G.J. 
Graham (CRC Beatson Institute, Glasgow, U.K.) and originated from R&D 
(Minneapolis, MN). Recombinant human MCP-1 was from PeproTech EC LTD 
(London, U.K) and was used at Ing/ml (Wilkinson P.C. unpubHshed obseivations). 
Purified recombinant human (rh) IL-15 derived from a simian kidney epithelial cell 
line was provided by Immunex Corp., Seattle, WA and was used at lOOng/ml 
(Wilkinson and Liew 1995). This material gave a single band at 14-15 kd on SD- 
PAGE and induced proliferation of PHA-activated human T-cells at concentrations 
between 0.1 and lOng/ml (Grabstein, et al 1994 ).
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i) Cytokines specific antibodies
Anti-IL-2 (Tsudo et al 1989) was from R&D and was used at 1/500. Rabbit anti­
human anti-IL-8 (aIL-8), originally documented by Stricter et al 1989 was provided 
by Dr. S. Kellie (Yamanouchi Research Oxford, U.K) and was used at 1/500. This 
antibody was shown earlier not to react with cytokines of the P-thromboglobulin 
gene family (Huber et al, 1991). Anti-human MIP-1 or anti-LD78 was a gift from 
Dr. G.J. Graham (CRC Beatson Institute, Glasgow, U.K.) and was used at 1/500. 
Monoclonal mouse anti-human IL-15 (Mouse IgGl) was provided by Immunex Corp 
(Seattle, WA) and also was used as 1/500. Goat anti-human MCP-1 was provided by 
R&D and was used at 1/50.
2.2.10. Preparation of drugs
Aspirin; Indomethacin; Ibuprofen; Cyclophosphamide ( Kovarsky 1983), D- 
penicillamine, Gold (Karlsson-PaiT, Qt al, 198C, Vini, et ai, 1994), 8-aminoquiiioline 
(Mihaly et al, 1985) dexamethasone (Groneck et al 1993), prednisone and 
prednisolone were from Sigma. Cyclospoiin A (Borel, 1972., Yocum et al 1990; 
Wilkinson and Higgins 1987) was a gift from Dr A.W. Thomson University of 
Aberdeen and originally from Sandoz (Basel Switzerland). Rapamycin was also a 
gift from Dr A. W. Thomson. The drugs were dissolved in ethanol as stock 
solutions at 50-100mg per ml . Cyclosporin A and rapamycin were dissolved m 
ethanol and DMSO respectively as stock solutions at 10 and 3 mg per ml.
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2.2.11. Preparation of collagen.
The preparation of collagen gels was originally described by Elsdale and Bard (1972) 
and modified by Hatson and Wilkinson (1988). Tails from more than five adult 
rats were collected and fixed in 70% ethanol for 5min and stored at -20 or -70 ”C . 
Then the tails were thawed and the skin was removed. The longitudinal bundles of 
tendons were stripped and collected in 200 ml acetic acid (BDH) diluted to 3% (v/v) 
in water , and incubated for 24-48 hours to allow collagen to dissolve. After the 
incubation the tropocoUagen was allowed to settle down in solution (Gross et al ., 
1954). Then the whole solution was filtered through 100pm Nitex guaze (R. Cadish 
and Sons London UK) and centiifiiged at 800 xg for 30 min to deposit any debris. 
The collagen was mixed with 10-20% w/v sodium chloride and left to precipitate 
overnight. The precipitate was removed into a sterile flask and centrifuged for 30 
min at 600g and then the precipitated collagen was collected and redisolved in 3% 
acetic acid overnight and centrifuged 2x for 15 min at 800g . The collagen solution 
was dialysed against distilled water, and adjusted to pH 4.0 with HCL The optical 
density of the solution was estimated according to Schor, 1980; and Haston and 
Wilkinson 1988a by comparing the optical density value at 230nm (using matched 
cuvettes in a Pye Unicam spectrophotometer , SP 1800) to a freeze-dried sample of 
known concentration.
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2.3 Cells: preparation and culture.
2.3.1 Peripheral blood mononuclear cells (PMNC). 
Separation principle
Peripheral blood mononuclear cells were separated from red cells and 
granulocytes on the basis of their differing densities on a dense osmotically 
balanced solution, Ficoll-Hypaque (Boyum 1968), Following centrifugation, cells 
separate as in Fig 2.1.
Separation method
Human blood was collected from normal individuals by Venepuncture, 
anticoagulated with heparin (CP pharmaceuticals Ltd, Wrexham U.K) at 2 units 
per ml blood in sterile plastic universal tubes . Five ml of whole blood were 
carefiilly layered onto 2.5ml lymphocyte separation medium (Lymphoprep™ 
Nycomed pharma Oslo, Norway) Tubes were spun at 400g, for 30 minutes at 
room temperature. Using a fine plastic sterile pipette (Sterilin Ltd Staffordshire 
UK) the mononuclear cells were carefully separated from the interface between 
the platelets, plasma and the separation medium (Fig 2.1) into 10-12 ml tubes. 
The cells were then washed 2x in HBSS (i.e centrifuged for 10 minutes each 
wash at 1 lOOrpm) and resuspended in 10 ml of HBSS-HSA. For purification of
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FIGURE: 2.1 Principle of Mononuclear cells separation.
Whole heparinized bloods 
(5ml)
Separation medium 
(2.5ml)
for 30 minutes
Plasma and platelets
Mononuclear cells  >
Separation medium 
granulocytes+red cells
Before separation After separation
As shown in the diagram after centrifugation, mononuclear cells can be carefully 
separated fiom the layer between the separation medium and plasma. This 
method gave about 10-20x106 cells/20 ml of whole blood.
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lymphocytes, cells were mixed with 25% FCS+sodium bicarbonate and seeded 
into 24-well plates (ICN Flow) at 0.5-1x10^ per ml. Then cells were cultured at 
37 ^C +5% CO2 for 24 hours to allow adherence to the plastic plate. Non­
adherent cells were gently removed to 10-12ml tubes and washed 2x in HBSS- 
HSA. This method gave about 15-20x10^/ cells/20ml of whole blood, 95% of the 
cells were viable by trypan blue stain or morphology using phase contrast 
microscopy. The non-adherent cells (>90% T lymphocytes) were routinely used 
for locomotion studies. Monocytes were not removed from the cell preparation , 
because GO lymphocytes (resting cells) are poorly motile and the locomotor 
capacity is acqufred as the cells enter G l. T cells requires contact with 
appropriate accessory cells during G l to increase their locomotion activity in the 
culture (Wilkinson and Higgins 1987 and, Wilkinson and Newman 1992).
2.3.IB. Peripheral blood polvmorplioiiuclear cells.
AS mentioned above 5 volumes of human heparanized blood was layered directly 
over 2.5 volumes of lymphocyte separation medium . After 30 min 
centrifugation at 1100/ rpm, plasma, platelets, mononuclear cells and the rest of 
separation medium were removed. Two ml of dextran 110 (Mwt 110,000 Fison 
Ltd., Loughborough) was added to the pellet of heparinized blood (contains red 
cells and polymorph) then mixed with 6ml HBSS and incubated for 45-60 
minutes at room temperature. The neutrophil-rich supernatant was collected and
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washed 3x in HBSS to remove red cells and debris . One ml of distilled water 
was added for 30 seconds to lyse the remaining red cells. Then the pellet was 
resuspended in HBSS and washed Ix . The polymoiphonuclear cells were 
counted. This method gave about 2-3x10^ cells/ml of blood (>95% were round 
neutrophils as stained by Leishman and examined under light microscopy at 
x40). The cells were used at 0.25-0.5xloVml for locomotion studies within a 
short time after separation.
2.3.1C Synovial tissue cells
Rheumatoid synovial membranes were collected in RPMI 1640 medium from 
patients with rheumatoid arthritis receiving surgical treatment. Using forceps, 
scissors, scalpel and Disposable micro-touch latex medical gloves, fat, fibrous 
material and blood clots were carefully removed. Then the synovial membranes 
were dissected and finely minced with scissors in RPMI 1640 medium with 
heparin, 10% FCS, and lOpg/ml Penicillin-Streptomycm 10 ml/ml (Abrahamsen 
et al 1975) . The minced tissue was mixed with 20 volumes of RPMI 1640 
containing 5mg/ml collagenase (Worthington Biochemical Corporation, New 
Jersey, U.S.A). After constant stirring in a small flask for 90 minutes at 37‘’C, the 
cell suspensions were filtered through sterile nylon sieves and washed 3 times. 
The mononuclear cells were purified by separation medium for 30 min and were 
seeded on petri dishes at an approximate cell concentration of 0.5-1x10^ cells/ml.
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I l l
After incubation for l-3hr at 3TC, in 5% CO2, non adherent cells were removed i
by gently washing the plate three times with RPMI 1640 and were collected for 
use in locomotion studies.
i
2.3.ID Synovial fluid cells
As mentioned above synovial fluids were collected from patients with rheumatoid 
.and non rheumatoid aithiitis. Fluids were initially spun for 10 minutes at 400g to 
deposit cells and debris . The supernatant fluid was removed aliquoted and 
stored at -70 for locomotion studies. The cells in the pellet were washed 2x 
and resuspended in 10ml HSA/HBSS. Total WBCs were counted using an 
improved Neubauer haemocytometer (depth 0.1mm Weber England) and 
cytocentrifuge slides were prepared using cleaned plastic cytofunnels in contact 
with methanol-cleaned slides and filter cards (Southern Instinments, Swickely,
P.A., U.S.A). Trypan blue stain was used to check the cells’ viability. May - 
Grünwald-Giemsa- or Lieshman stain were used for differential counts 
Separation of neutrophil and mononuclear cells was performed as for blood cells.
I:
I
1
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;
2.3.2 Cells: Checking the viability
As it is important to know how many viable cells to work with ,various dyes 
are used to stain live or dead cells. Tiypan blue (see stain method) for example is 
excluded by viable cells . Cells which stain blue have become permeable and 
are considered dead.
i. Trypan blue (Stain method)
A cell suspension (50 pi ) was mixed with 450pl of trypan blue solution (BDH ) 
1% v/v in PBS). Without delay the suspension was mn into a haemocytometer. 
One minute was allowed for cells to settle. Within 3 minutes the number of 
stained versus unstained white cells were counted.
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2.33 Cells: Staining, differentiation and countiiig
As it is difficult to differentiate between unstained neutrophils and lymphocytes 
under phase contrast microscopy or after separation of these cells fiom inflamed 
materials such as synovial fluid or synovial tissue, May -Grünwald’s-Giemsa and 
Leishman stains were used in tins study.
i. May and GriinwaM-Giemsa
After the cytospin preparation the slides were fixed in methylated spirit for 5 min 
and stained in May-Grunwald’s stain (BDH) for 4 min. The sHdes were washed 2x 
in and covered with distilled water for 4min. 2 volume of Giemsa stain (BDH) were 
mixed with 3 volume of water and filtered using Whatman filter paper. Then the 
shdes were covered with Giemsa for 10 mins, washed 2x mounted and were read 
under hght microscopy. Using the xlOO objective 100 cells were counted and then 
the differential count was calculated.
it. Leishman stain
Fixed cytospin slides were covered with neat leishman stain for 2 min and then 
covered with distilled water for 5min, and mounted under a cover slip for counting.
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2.4 METHODS
2.4.1 Polarisation assays 
.i. Background
The measurement of the change fi om spherical to polar ised shape as the earliest 
event of locomotion of leukocytes including neutrophils and monocytes was 
reported by several groups (Smith et al. 1979; Keller et el. 1983; Shields and 
Haston 1985; Cianociolo and Synderman 1981; Islam and Wilkinson 1988). In 
1985 Haston and Shields reported a method to measure the polarising response 
of neutrophils to various factors using an assay that measures the proportion of 
polarised cells in a population in suspension and suggested that this method could 
be used both clinically and experimentally to give rapid and less equivocal results 
than those obtained by the Boyden filter technique (1962) . The shape change 
assay was also used to measure the response of lymphocytes to a range of 
stimulants in short-term assays and also to measure the change in numbers of 
locomotor cells in long term cultures with and without activating agents 
(Wilkinson 1986; Wilkinson and Higgins 1987a,b). In this study I used this assay 
to investigate the polarising response of lymphocytes and neutrophils (from 
normal human blood and from synovial fluid and synovial tissue) to synovial 
fluid and to other chemotactic factors.
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ii. Assay principle
Unstimulated lymphocytes or neutrophils remain rounded, but within a few 
minutes of adding chemotactic agents (such as synovial fluid or other 
chemotacic factors), cells changed to locomotor morphology (an elongation or 
ruffling at one edge or polarized morphology with constriction ring and/or 
mopod), which can easily scored and quantified to obtain an accurate dose 
response curve (Haston and Shields, 1985). These motile cells are scored using a 
40x objective and phase contr ast.
ÎÜ. Method of assay (short-term effects!
In all polarisation experiments using either lymphocytes or neutrophils the 
polarisation assay was performed as follows. 0.25-0.5 xlO 6 cells/ml were added 
to different dilutions of synovial fluid or different concentrations of cytokines 
and incubated for 30 minutes at 37 . Cells were then fixed in an equal volume
of 2.5% glutaraldehyde for 10 min at room temperature and washed 2x in saline 
at 2000rpm, 10 minute each wash. The supernatant was removed and the pellet 
was resuspended in the remaining droplet of fluid. Then 10 pi of fluid was added 
to the slide and 200-300 cells were counted using phase contrast microscopy 
(Olympus BH-2 microscope) at x40. As mentioned previously cells that were 
spherical were scored as immotile and cells that showed ruffling at one edge or 
polarized morphology were scored as motile (Fig 2.2 a ) . HBSS-HSA alone was
115
fîused as the negative control (i.e the percentage of cells polarized in response to
I 'HBSS-HSA is subtracted from the values obtained by SF or other 
chemoattractants; Fig 2.2 b). As FCS consistently stimulated locomotion in short
aterm assay, 25% FCS w^ as used routinely as a positive control.
iv. Method of assay (long-term effects)
To measure locomotor morphology in cultured lymphocytes, the cells were 
cultured with an appropriate amount of either synovial fluid or anti-CD3 for 24,
48 and 72 hours at 37 °C+5% COg. Cell were then fixed with an equal amoimt I
of 2.5% glutaraldehyde. After washing a small number of fixed cells were
examined rmder phase-contrast microscopy (Nicon, Japan) x 40 and cells were 
scored as mentioned above.
I
i-'ir
I
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FIG 2.2.(a) Phase-contrast photographs o f lymphocytes direct from blood in 
HBSS-HSA showing most cells are immotile.
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FIG 2.2 (b). Phase-contrast photographs o f lymphocytes after 30 min in 
rheumatoid synovial fluid (at dilution 1: 4) showing that a proportion o f cells 
change to a ty p ica l, polarized locomotor shape
1 1 8
2.4.2. Invasion of collagen gels
i. Background
Thr ee dimensional collagen gels have been shovm to be a useful substratum for 
the study of locomotion of leukocytes in vitro including neutrophils (Brown 
1982; Islam 1985), monocytes (Brown 1984) and lymphocytes (Haston., et al 
1982; Schor., et al 1983; and Wilkinson 1985a). Several factors have been shown 
to stimulate lymphocyte locomotion into collagen gels, including colchicine 
(Wilkinson, 1986); phorbol esters (Wilkinson et al 1988) IL-8 (Wilkinson and 
Newman), IL-2 (Newman and Wilkinson 1994), IL-15 (Wilkinson 1995) and 
synovial fluid from rheumatoid arthritis patients and other arthritides (Al- 
Mughales et al. submitted for publication).
ii. Assay principle
The principle of the collagen gel assay is similar to that of the micropore filter 
assay. The leukocytes (lymphocytes or neutrophils) are overlaid on the surface of 
collagen gels. Then the cells are allowed to invade the 3-dimensional fibrous 
matr ix of the gels in response to a diffusing gradient of attractant incorporated 
within the gel. After an appropriate time interval the gel can be fixed with 
glutaraldehyde. The number of cells which invaded and which remained on the 
upper surface of the collagen gel are counted (see below).
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iiî. Method of assay
As mentioned above type I collagen was prepared from rat tail tendons by the 
method of Elsdale and Bard, 1972; and stored in H2O at pH4. Stock collagen gels 
were prepaied by returning the gel to physiological pH and ionic strength as 
described by Haston and Wilkinson, 1988. Before gelation, the collagen was 
pipetted into 24-well dishes (0.5ml per well) and allowed to set. Before the gel 
set, synovial fluid at optimal dilution was added to the collagen to give a final 
concentration of collagen of 1.75 mg/ml. After setting, cells (0.25-0.5x10^ per 
gel) were carefully layered onto the upper surface of the gels which were then 
incubated for 4 hours or overnight at 3TC to allow the cells to invade. The tests 
were then fixed with 2.5% glutaraldehyde. After washing, the number of cells 
remaining on the upper smface of the gel and the number of cells which had 
invaded the gel was counted in 6 fields per gel. The percentage of invading cells 
was calculated. For phenotyping, cells on the upper smface of the gel were gently 
removed before fixation with glutaraldehyde into a 10 ml tube and washed 2x 
with HBSS-HSA. The gel was then digested with collagenase (Shields and 
Wilkinson 1984; Ratner et al, 1988) at 50pl/ml for 30min at 37°C (Lome 
Laboratories LTD, Reading, UK) to recover the cells which had invaded. 
Collagenase was shown not to affect expression of relevant surface markers 
(Newman and Wilkinson, 1990). Cells from both the invaded and the non 
invaded populations^ were phenotyped for CD45RA and CD45RO by
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immunofluorescence as described below.
2.4.3, Phenotvpîng of locomotor cells
2.4.3. A l, Modified alkaline phosphatase anti-alkaline phospliatase (APAAP) 
t. Background
The potential value of alkaline phosphatase as an antibody label was established 
in 1969 by Avrameas et al., Temynck and Avrameas 1976. Other experiments 
were done by Dmguet and Pepys in 1977 on human lymphocyte membrane 
immunoglubulin labelling. In 1978 Mason and Sammons inhoduced a simplified 
method for this assay by adding alkaline phosphatase anti-alkaline phosphatase 
in one step (rather than sequentially). APAAP assays have gained wide 
acceptance through the last decade, because of their clear appearance in term of 
staining details. In contrast with immunofluoresence the reaction can reviewed at 
a later date, 6 months (personal observation) without loss of staining intensity . 
Furtheimore , it has been established that a huge number of CD maikers of cell 
or viral antigens can be recognised by immunoperoxidase staining (Mason and 
Tylor 1977). In 1992 this assay was modified (Newman and Wilikinson 1992) to 
phenotype polarized and round lymphocytes by prefixing the cells with 2.5% 
glutaraldehyde to retain locomotor moxphology dming staining. This modified
121
assay was perfonïied for detection of CD3, CD22, CD56, CD45RA and CD45 
RO, but CD4, CDS, CD 14, CD 19 and CD25 were not stained by modified 
APAAP.
H. Assay principle
As shown in Fig 2.3 the complex (APAAP) of alkaline phosphatase (AP) and 
mouse anti*alkaline phosphatase is linked to the primary mouse anti-X antibody 
by the use of a bridging rabbit anti-mouse immunoglobulin. Developing the 
phosphatase label, with the substrate Naphto AS-MX and fast red TR produces a 
red precipitate at the site of the antigen X. Thus in cytospin preparations or 
blood smears, lymphocyte differentiation antigens can be identified by the 
presence of a red cellular staining deposit.
iii. Method of assay
After short term polarisation assays lymphocytes were fixed with an equal 
amount of 2.5% glutaraldehyde for 15 min at room temperature. Stock 0.05M 
glycine (Sigma) was diluted to 1/10 in saline and an appropriate amount was 
added and incubated with the fixed cells for 15 min to quench fiee aldehyde 
groups (Sullivan, et al., 1984; Haston, 1987) . Cells were then washed 2x in 
saline and cytocentrifuge slides were prepared (see above). Then 50pl of the
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FIG 2.3, Principle of alkaline pliosphatas anti-alkaline phosphatase 
(APAAP).
Red
precipitate
Naphtol-AS- 
MX+Fast red
APAAP complex (mouse 
anti-alkaline phosphatase)
Bridge antibody (rabbit 
, antimouse Igs)
Primary antibody (mouse anti-X)
X=Cell surface antigen
Schematic illustration of monoclonal APAAP procedure. Note that in order to 
enhance the intensity o f labelling, the anti-mouse Ig and APAAP stages may be 
repeated one or more times (adapted from Cordell et al 1984).
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diluted unlabelled primaiy antibodies were added to the slides and incubated for 
20-30 minutes at room temperature in a moist chamber . Using a glass Pasteur 
pipette, slides were briefly rinsed with TBS then washed in the same buffer for 
20 min. The excess buffer around the cells was wiped off and then anti-mouse 
immunoglobulin (AMIg) was added and incubated at room temperatuie in a 
moistchamber for 30 min. Slides were briefly rinsed as above and washed for 20 
min in the same buffer. APAAP complex was added and incubated for 30 min in 
a moist chamber. Slides were briefly rinsed as above, washed for 20 min and 
AMIg and APAAP complex steps were repeated 10 min incubation each. This 
idea behind repeating steps was to enhance staining intensity. Slides were 
covered with alkaline phosphate substrate and incubated for 15 min at room 
temperature and then rinsed with buffer and washed. Counterstain (0,5% w/v 
aqueous methyl green, BDH) was added to the slides and incubated for 20 min , 
then the slides were rinsed with distilled water. Slides were dried and mounted 
with glycerol mountant and examined under the Olympus BH2 microscope at x40 
magnification. The proportion of marker positive and marker negative polarised 
and round cells (Fig 2.4, a, b, c) was scored (500 cells were counted).
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FIG 2.4 Lymphocyte incubated with synovial fluid in a 30 min polarization 
assay and fixed in glutaraldehyde to retain morphology, then phenotyped by 
APAAP for:
a) CD45RO
S=spherical or round , Popularized.
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b) CD45 RA
RA»
c) Negative control (no surface marker).
#
2.4,3 A2 Immunofluorescence
i. Background
The development of flow cytometry systems capable of sensing electronic and 
optical signals illuminated by laser or mercury arc lights has made possible 
simultaneous multiparameter analysis of surface characteristics, cell volume and 
cell size (Park, and Lanier 1985). The essential goal of immunophenotyping 
analysis of human lymphocytes is to identify and enumerate those populations 
that may be associated with particular functional properties and which may be 
altered in disease states.
ÎÏ. Assay principle
When surface antigen present on peripheral blood lymphocytes is bound by 
specific mouse monoclonal antibody, the cells labelled with this antibody are 
detected with fluorescent dye directly conjugated to the monoclonal antibody or 
itself bound to a secondaiy antibody, The most common fluorescent dye for 
identifying surface lymphocytes antigens is fluorescein which when excited, 
emits green light with a wavelength near 490mn. Rhodamine, which emits an 
orange-red colour with a wavelength near 545nm has been recently replaced by 
phycoeiythrin dyes which emit light when excited as the same wavelength as 
fluorescein,, thus allowing two colour staining analysis with a single light source.
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Characteristics such as light scatter and cell volume are used to identify selected 
leukocytes populations by electronic analysis and then the fluorescent 
characteristics of each cell in the selected group are measured. The data are 
displayed as frequency histograms for the selected characteristics (for example 
number of cells versus fluorescing intensity) or as two dimensional dot plots.
ÜL Method of assay
Phenotyping of cells recovered from collagen gels (for which cell shape was 
irrelevant) was performed by flow cytomehy. Appropriate primaiy unlabelled 
antibodies were added to cell suspensions and incubated for 30 min on ice, then 
washed in PBS+0.1% sodium azide (BDH). After washing, the secondary 
antibody, fluorescein-conjugated F(ab')2 rabbit anti-mouse immunoglobulin 
(DAKO) at concentration of 1/100 was added. Then tlie cells were washed and 
fixed in an equal volume of 1% paraformaldehyde (BDH). Cell surface markers 
were then analysed on a Becton Dickinson FACS using the lysisll program. 
5,000-10,000 events were recorded.
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2.4.4. Enzyme Linked Immunosorbent Assay (ELISA).
i. Background
The use of en2yine-labelled antibodies in quantitative immunoassays was 
suggested in 1968 ( Miles and Hales 1968) and described in 1971 (Engvall and 
Perlmann 1971; Engvall and Johonson 1971). This was followed by rapid 
development of many enzyme immunoassays for a wide diversity of antigens and 
antibodies (Shurrs et al., 1977; Vollar et al., 1978) including assays related to 
the present study such as detection of antibodies to IL-2, IL-8, IL-15 and MIP-la 
in the synovial fluid. IL-15 was measured by multiple antibody sandwich 
ELISA which was developed in our laboratory (see below) and IL-2, IL-8 and 
MIP-1 alpha were assayed by single antibody sandwich ELISA using 
commercially available kits from R&D (see below).
ii. Principle of multiple antibody sandwich ELISA
In the multiple antibody sandwich ELISA assay a plastic micrometer plate is 
coated with purified first antibody and incubated with a test sample or antigen 
overnight. If the synovial fluid contains IL-15, the IL-15 will form a complex 
with aIL-15 on the coated plate. After washing unreacted reagent from the plate, 
the later is incubated with secondary antibody from different species then an 
antibody-enzyme conjugate was added . The conjugate will react with the Ab-SF- 
Ab complex. If the synovial fluid dose not contain IL-15 the conjugate will not
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bind to the well plate surface and will be removed by washing. The presence of 
the enzyme on the plate surface is determined by incubating the washed plate in 
an appropriate enzyme substiate which leads to the production of a yellow- 
orange colour which is measured in a spectr ophotometer adjusted to a wavelength 
of 630 test/450 reference.
iii. Method of imiltiple antibody sandwich ELISA.
Individual wells of a 96 plastic (PVC) plate (Dynatech, Billingshurt, UK) were 
coated with 50-100 gl of a predetemiined concentration of mouse anti-human 
monoclonal antibody to IL-15 (Ml 12, Immunex aIL-15 , 5-lOpg/ml) in coating 
buffer (O.IM Sodium Bicarbonate pH 8.2). The plate coated with aIL-15 was 
incubated overnight at 4®C . Then the plate was washed 4x with PBS-Tween 
(400pl/well) for 2 min each time. The prediluted synovial fluid in Hanks was 
added to all antibody coated wells and incubated for 3h at 37 . Plates were
then washed with PBS/Tween and 1% BSA 4x for 2 min each time. Next , a 
secondary antibody (lOOpl/well) namely rabbit anti-human polyclonal IL-15) was 
added to the complex and incubated for 1 h. A third antibody (lOOpl/well) 
biotin-conjugated goat anti-rabbit IgG (Sigma) diluted 1:1000 in PBS/Tween was 
added and incubated for Ih at 37*^ 0 . The plate was washed 4x in PBS/Tween 
20. Subsequently, Extravidin-labelled horseradish peroxidase reagent
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(lOOpl/well) was added and then wells incubated for Ih at 37 ^C. The plate was 
washed 4x and paranitrophenyl phosphate substrate (lOOjitl/well) was added and 
incubated 30 min at 37 . Then 50 pi of NaOH was added to all wells to stop
the reaction. Increased absorbance due to bound, immunoreactive cytokines was 
measured by the ELISA reader at a wavelength of 630/450nm (MR500,
Dynatech Laboratory Limited Billingshurst). All samples were assayed for IL-15 
in duplicate. Results were calculated by taking average of the duplicate readings 
and the zero standaid was subtracted. The concentration of IL-15 in each 
synovial fluid was calculated from the standard cuiwes (Fig 2.3). The limit 
detectable dose of IL-15 was between 0.1 and 0.5 ng/ml. This was calculated as 
the mean optical density of two zero standards (Fig 2.5).
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Fîg 2.5 IL-15 Standard curve.
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The concentration of IL-15 was calculated as follows: first the optical density 
(OD) value on Y-axis of each sample was determined. Then a horizontal line was 
extended to the standard curve and at the point of intersection a vertical line was 
extended to the X-axis and then the concentration of IL-15 in each fluid was 
calculated. The mean value of 2 OD zero standards (0.005±2SD) was considered 
as the limit of detection. Results of prediluted samples were multiplied by the 
dilution factor.
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iv. Single antibody sandwich ELISA
This method was used to measure IL-2 , IL-8, M IP-la and MCP-1 in the 
synovial fluid, Cytokines were assayed using commercially available kits horn 
R&D (Minneapolis, MN, USA), hi brief a microtiter plate (part D2051) was 
coated with a monoclonal antibody specific for the human lL-2, lL-8, M IP-la 
and MCP-1 and the plates were incubated with 100 pi of standard and synovial 
fluid for 2 h at room temperature. Unbound material on the plate was washed 4x 
for 2min each wash. Then 200 pi of the polyclonal antibody against cytokines 
conjugated to horseradish peroxidase was added to the wells and incubated for 2h 
at room temperature. Finally 200 pi o f the substi ate solution was added to each 
well and incubated for 30 min at room temperatuie. Increased absorbance due to 
bound, immunoreactive cytokines was measured by the ELISA reader at 530nM. 
The cytokine concentration was determined as mentioned above.
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2.5. Inhibition of activity of synovial fluid using anti-cytokines specific 
antibodies. 
i Polarization assay
Anti-IL-2, Anti-IL-8, anti-IL-lS, anti-MIP-la and anti-MCP-1 were used to 
inhibit the lymphocyte attractant activity of their respective cytokines. First the 
optimal dilution of antibody sufficient to inhibit the activity of its own cytokine 
at maximal effective concentration was deteimined. Since the effective dilution 
for all antibodies was 1/500, (except anti-MCP-1 which was used at 1/50) this 
dilution was used for all three. Synovial fluids showing strong activation of 
lymphocyte locomotion, i.e from the top of the range (see chapter 3., Fig 3.2) 
were chosen for study. The fluids were preincubated with antibody for 30 min 
before being tested in polarisation assays as described above. Percent incubation 
was calculated as:
%înhibition=100-(%polarîzed cells in antibody-treated fluid xlOO)
(%polarized cells in untreated fluid)
where the medium contr ol value has been subtracted from each reading.
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ii. Collagen gel assay
This was carried out as mentioned above. Briefly neutralising antibodies (at 
maximal effective concentration mentioned above) aIL-8, aIL-15, aMIP-la ,aIL- 
8+aIL-15 (combined), aIL-8+aMIP-l alpha (combined) , aIL-15+aMIP-la 
(combined) and IgG control were incubated with the synovial fluid for 30 min at 
3TC. Then the SF-antibody complex was incorporated in a collagen gel. 
Immediately after setting cells were overlaid on the top of the gel The gels were 
then incubated overnight at 37^C. Fixation and counting procedure was as 
previously described.
2.6 Inhibition of lymphocyte locomotion using anti-rheumatic drugs,
i. Polarization assay
The inhibitory effect of Analgesics, NSAIDs and DMARDs on lymphocyte 
polarization in response to different samples of synovial fluid was tested in this 
study. In preliminary experiments dose-response curves for drug-induced 
inhibition of polarization of human lymphocytes after 24hr of culture in 0KT3 
(lOng/ml) was determined. Then further dose response data for drug induced- 
inhibition of polarization were determined using precultm ed human lymphocytes 
in 25% FCS in response to different synovial fluids in a 30 min polarization 
assay. Drugs were incubated with the lymphocytes for 30 min at 37 and the
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cells were then exposed to the optimal dilution of different synovial fluids in a 
short term polarization assay as mentioned above.
ii. Collagen gel assay
Drugs that significantly inhibited lymphocyte polarization in response to synovial 
fluid in polarization assays were then tested in collagen gel assays. These drugs 
were cyclosporin A, Dexamethasone and prednisolone. The maximal effective 
concentration of drugs (1-lOOpg/ml) as determined in the polarization assay was 
chosen for study. The drug treated-lymphocytes (lymphocytes incubated with the 
drugs for 30 min at 37 ”C) were overlaid on the top of collagen gels incorporated 
with the optimal dilution of synovial fluid. Test tubes were incubated as 
mentioned above.
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2.2.7. Photomicroscopv
Photomicrographs were taken on an Olympus microscope equipped with phase 
contrast and differential interference contrast optics with xlO or x40 objectives, using 
an Olympus camera.
2.8. Statistical analysis
Statistical analysis was carried by using student t-test, Marm-whitney U test and 
Wilcoxon’s sum rank test as appropriate. P values < 0.05 were regarded as 
significant and p values <0.01 as highly significant. Numerical results in Tables 
and Figures are given as mean ±SEM unless otherwise stated.
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CHAPTER3
CHEMOATTRACTANT ACTIVITY OF RHEUMATOID SYNOVIAL 
FLUID FOR HUMAN LYMPHOCYTES AND NEUTROPHILS.
3.1 Chcmoattractant activity of synovial fluid for htmimi lymphocytes measured 
by polarisation and collagen-gel invasion assays
3.1.1 Background
Several studies on proportions of human T and B lymphocytes have reported that 
T cells are predominant in both synovial tissue (John et al, 1975) and synovial 
fluid (Sheldon 1974). Recently several investigators have also reported that T 
lymphocytes play a critical role in rheumatoid arthritis and are thought to 
contribute to the initiation and sustained activity of the disease (Cush and Lipsky 
1988; Cavallo et al., 1994; lannone, et al, 1994). T cells show a rapid 
circulatoiy pattern and although some memory T cells are thought to remain at 
the site of inflammation a majority of cells tiaffic through the rheumatoid joint 
(Kingsley ei at 1988; Lasky el al, 1988; Mackay 1991). The migration of such 
inflammatory cells from blood requires adhesion to vascular endothelium at the 
inflarmnatoiy site, accompanied by locomotor attraction mediated by chemotactic 
factors released in the lesion which activate the selective migration of defined 
leukocyte types (Wilkinson, 1987). Activation of locomotion is characterised by 
rapid morphological changes in the responding cells from a spherical to polarised
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shape with a formation of an extended ruffled, anterior veil or lamellipodium 
(Zigmond 1974). This morphological change is easily measured in vitro (Haston 
and Shields 1985; Wilkinson 1986). As mentioned above the majority of 
lymphocytes that infiltrate into the joint are T-cells. Many of these are of the 
memory cell type (Pitzalis et ai, 1987). These cells pass through the synovium, 
and become activated as shown by their expression of T cell activation markers 
such as adhesion molecules, HLA-DR, the IL-2 receptor a  chain (CD25) or 
CD69 (lannone, et al 1994). It has been also reported that neutrophils obtained 
from the peripheral blood of RA patients show reduced locomotion activity in vitro 
(Mowat &Baum 1971) although accumulation of neutrophils within the joint space is 
a feature of inflammation in rheumatoid arthritis (Ropes & Baurer 1953). There is 
httle information about the locomotor activity of neutrophils from the synovial fluid 
of rheumatoid artlmtis, although their phagocytic activity is reduced as compared to 
peripheral blood neutrophils (Bodel & Hollingsworth, 1966; Turner, et al, 1973). 
However it has not formally been demonstrated that synovial fluid attracts 
neutrophils using assays for polarisation and collagen gel invasion, though such 
attraction has been studied using the filter assay. The aim of the present study in 
this chapter was to examine the effect of synovial fluids on the locomotion and 
polarization of circulating peripheral blood lymphocytes, and to phenotype the 
responding cells in order to better understand the mechanism of local 
inflammation in RA. The assays used were the polarization assay (Haston and
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Shields 1985) which measures the morphological changes conelated with 
locomotion and the collagen gel invasion assay (Haston and Wilkinson 1988) 
which measures locomotor attraction directly. In this the chemoattiactant effect 
of SF for peripheral blood and synovial fluid neutrophil was also examined as 
well as the chcmoattractant effect of FMLP for synovial fluid neutrophils to 
compare the response of neutr ophils with those of T lymphocytes.
140
3.1.2 RESULTS
3.1.2A Response of normal blood lymphocytes to synovial fluid.
3.1.2A1. Comparison of responses of cultured and non cultured lymphocytes 
responses.
In order to prepare lymphocytes for locomotion studies and to check the 
chcmoattractant activity of synovial fluid, first lymphocytes direct from normal blood 
were tested against several synovial fluids from patients with active rheumatoid 
arthritis. Synovial fluids were first diluted in HBSS and then incubated with 
lymphocytes in dose response polarisation assays. The PBMC from normal blood 
was also tested after overnight culture in FCS. Fig 3.1 shows that lymphocytes 
cultured overnight in 25% FCS gave higher responses to a representative synovial 
fluid than lymphocytes direct from blood. As reported earlier overnight culture in 
FCS increases the locomotor capacity of lymphocytes (Berman 1966; O' Neill and 
Parrott 1977). FCS also has mitogenic activity (Woodhff and Onesti 1968). 
However activation of locomotion is seen long before mitosis and is evident with 24 
hours.
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FIGURE 3.1
Effect of FCS culture on Üie polaiisation response of normal blood lymphocytes to 
synovial fluid.
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Lymphocytes were incubated with the same synovial fluid after separation from 
blood or after culture for 24 hours in 25% FCS. Althougli the background was higlier 
after overnight culture, cells on the day of separation gave low responses (circles) 
compared with cells cultured overnight (squares). The graph shows means and 
standard en or of three experiments.
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3.1«2A2. Polarization dose response of Lymphocytes cultured overnight to 
synovial flnîds>
In these experiments lymphocytes were first cultured overnight in 25% FCS (0.5- 
1x10 6 cells/ml) then washed twice in HBSS and tested against different dilutions of 
synovial fluid from patients with RA, OA and other inflammatory arthritides. First 
the dose response curve for each fluid was obtained. In most cases, a bell-shaped 
dose-response curve was obtained with maximum activity at dilutions between 1:2 
and 1:16 (Figure 3.2). From these curves an optimal dilution of each fluid at which 
lymphocyte polarisation was maximal, which was used in subsequent experiments, 
was determined. There was no relation between the optimal dilution and the amount 
of activity obtained at that dilution. Some fluids gave veiy flat curves, others gave 
good peaks of activity (Figure 3.2). The fluids at optimal dilution were then retested 
several times in polarisation assays. Figure 3.3 shows that the majority (23/29) of RA 
joint fluids caused strong polarization of lymphocytes but 6 fluids were negative or 
shghtly higher than the medium control. The response of OA fluids was also tested, 
but 3 out of 5 showed low activity. Also fluid fi*om other inflammatoiy arthritides 
were tested but 3 out of 7 gave low responses.
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FIGURE 3.2
Lymphocyte polarisation dose-response to synovial fluid.
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Polarisation dose-response of normal blood lymphocytes to five synovial fluids, three 
with high activity and two vrith low activity, selected to show the diverse patterns of 
response obtained. Optimal concentrations deteimined fiom such data were used in 
subsequent experiments.
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FIGURE 3.3
Lymphocyte polaiisation in response to optimal dilutions of synovial fluid.
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Lymphocytes were tested after overnight culture against an optimal dilution of 
synovial fluid of 29 patients with rheumatoid aithiitis (RA), five patients with 
osteoarthiilis (OA) and seven patients with others inflammatory arthiitides (others). 
Each point represents the mean of six experiments. Bars represent the median for 
each gioup. The control value (HBSS-HSA) has been subtracted from the values 
shown. Results were statistically significant when compared RA to OA (p<0.05 
Mann Whitney).
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These were from patients with psoriatic arthritis (n=l) , inteimittent hydio-arthrosis 
(n=l) and spondylo-arthritis (n==l).
3.1.2A3. Time-course of lymphocyte response to synovial fluid
In these experiments synovial fluid at an optimal dilution of 1:4 was added to a cell 
suspension that had been cultured overnight and the polarisation response was 
measured at various times from 0 to 60 minutes. Fig 3.4 shows that the polarisation 
response was at maximum after 10-40 minutes when 45% of the cells were 
polarised. These results indicated that lymphocytes respond to synovial fluid vrithin 
a short time of exposure by showing rapid shape changes which were dose and time 
dependent.
3.1.2A4. Long term effect of synovial fluid on lymphocyte polarisation.
To assess the effect of synovial fluid on lymphocyte polarisation in a long teim assay, 
cells were cultured with synovial fluid at a dilution of 1:8. Fig 3.5 shows that 
prolonged incubation (24hr) caused a slight increase in lymphocyte polarisation 
compared with the short term assay. Cultuie of these cells for 48hr led to the same 
results. The percentage decreased upon further incubation up to 72hr. This may be 
due to internalisation of receptors during continuous culture in synovial fluid.
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FIGURE 3.4
Time course of lymphocyte shape change dming 60 min incubation with synovial 
fluid.
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Lymphocytes were incubated with synovial fluid at a dilution of 1:4. Cells were fixed 
in suspension with 2.5% glutmaldehyde and the propoition of polaiised cells was 
counted as described above. Squares represent the mean polarisation response to 
synovial fluid and circles represent the medium conti'ol (Mean+SEM for two 
experiments).
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FIGURE 3.5
Long tenn effect of synovial fluid on lymphocyte polarisation.
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Lymphocytes were cultured with an optimal dilution of a chosen synovial fluid at a 
dilution of 1:8 for 24, 48 and 72 hours (clear bars). Cells were fixed in 2.5% 
glutaraldehyde and polarisation was measured as mentioned before. Each column 
represents the m eant standard error of three experiments. The mean proportion of the 
medium control (black bars) was different at 24, 48 and 72 hour s of incubation.
Also at 72hr cell viability was 79% (as measur ed by trypan blue) compared with 
89%at48hr.
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3.1.2A5. Collagen gel assay
This assay supplements the polarisation assay and provides direct evidence for active 
locomotion of lymphocytes towards an attiactant (Wilkinson 1986). An optimal 
dilution of each fluid (found in polarisation assays) was incorporated into collagen 
gels and the proportion of lymphocytes which invaded the gel was measured. Fig 3.6 
shows that the majority (21/29) of rheumatoid joint fluids attracted lymphocytes 
strongly but that there was a small group of fluids which were negative or only 
slightly higher than tire medium control. Too few fluids from other forms of arthritis 
were tested to draw definitive conclusions, but 3 out of 5 osteoarthritis fluids and also 
3 of 5 of other inflammatory arthritides showed low locomotion activity .
3.1.2A6. Correlation between polarisation and collagen gel assays
Figure 3.7 is a scatter graph showing the responses of blood lymphocytes to the 
joint fluids, each at optimal dilution, using both the polarisation and the collagen gel 
invasion assay. In most cases the proportion of lymphocytes that invaded the 
collagen gels closely paralleled the proportion of polarised cells. Tliere was an 
excellent correlation between the two assays. This provides evidence that polarisation 
is therefore a reliable correlate of locomotion (r^O.85, P<0.01).
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FIGURE 3.6
Lymphocytes invading collagen gel in response to synovial fluid
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Lymphocytes were allowed to invade the collagen gels overnight. The collagen gels 
incorporated optimal dilutions of synovial fluids from 29 RA, five OA and seven 
patients with others inflammatory arthritides. Each point represents the mean of 
thr ee experiments. Bar s represent the m edian of lymphocytes invading collagen gel 
in each group. The negative control value (HBSS-HSA) has been subtracted fiom 
the values shown. Results were statistically significant when compared RA to OA 
(p<0.05; Mann Whitney)
II
■I
i
#■
I
Î!
I
150
, j
FIG 3.7. Correlation between polarization and collagen gel assays.
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Response of blood lymphocytes to 39 fluids each at its optimal concentration, in a 
polarization assay (x-axis) and a collagen gel invasion assay (y-axis); each point 
represents the mean of three experiments.
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3.1.3. Correlation between locomotion activity of RA SF and the clinical 
parameters of RA-disease activity.
C-reactive protein (CRP) and eiythiocyte sedimentation rate (ESR) were first 
measured in blood samples taken at the same time as fluid was removed. Although 
the CRP (Fig 3.8) and ESR (Fig 3.9) tend to be higher in the RA than non RA 
group, the correlation of these results with the locomotion activity of RA-SF was not 
statistically significant.
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FIGURE 3.8
Concentration of C-rcactîve protein (CRP) in the serum of RA and non RA
patients.
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The Concentration of CRP in seinm obtained from patients with RA (n~26), OA 
(n=4) and other inflammatory arthritides (n==6) was determined utilising an 
immunoturbidimetric assay (Each point represents die value (mg/ml) for an 
individual patient. Normal value is 10 mg/1. Bars represent the median in each group.
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FIGURE 3.9
Measurement of ESR in RA and non RA patients.
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ESR in patients with RA (n-31) OA (ii“ 5) and other inflammatoiy arthritides (n-5) 
was measured utihsing the Westergren technique. Each dot represents the percent 
value for each patient. Normal value is : M 0-20, F 0-30 mm/h (see reference ; ICSH 
, 1977). Bars represent median in each group.
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3.2. Lymphocytes from synovial tissue
3.2.1. Characteristics of synovial tissue cell suspensions after Ficoll-Hvpaque 
centrifugation.
In these experiments, first it was necessary to assess the chaiacteristic features of the 
cell suspension puiified Jfrom the synovial tissue (cell viability, differential count or 
phenotyping). Table 3,1 shows the differential counts of the cells after Ficoll- 
Hypaque centriftigation in three patients with active rheumatoid arthritis. The 
number of mononuclear cells was different from patient to patient varying with the 
amormt, size, and quahty of the tissue and varies with the severity of the 
inflammation. The average viability was 84% (range; 73-92). Differential counts 
showed lymphocytes to be the predominant cells (Table 3.1). The other cells were 
macrophage like cells, neutrophils, tmclassified cells and dead cells. T lymphocytes 
of the CD45RO+ type were found to be the predominant in all cell suspensions as 
phenotyped by FACS.
3.2.2. Effect of collagenase on the cell surface markers fcontrol experiments)
In order to phentoype cells it was necessary to investigate whether collagenase (used 
during synovial tissue digestion for lymphocytes separation) has any effect on the 
cell count and on cell surface markers.
155
STABLE 3.1
Differential count of synovial tissue cell suspension after Isopaque-Ficoll 
centrifugation in three patients with RA.
Cells
G.D
Patients
N.M P.E
Total count (xloVml) 9.6 5.1 7.3
Cell viability (%) 87% 92% 73%
Lymphocytes 89 88 80
Macr ophage-hke cells 10 9 10
Neutrophils 2 » 1
Unclassified cells 2 2 4
Dead cells 1 I 5
* Cells were separated ftom the synovial tissue of patients with classical RA (n=3) 
with joint involvement receiving surgical treatment. The tissue was obtained at 
synovectomy performed on knee joints (see chapter).
The percentage of viable cells was assessed by the trypan blue exclusion test.
For the differential counts cells were stained with May-Grünwald/Giemsa (200 cells 
were counted).
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Mononuclear cells obtained from normal blood were treated the same way as the 
synovial tissue. Table 3.2 shows that collagenase treatment caused slight reduction 
in the cell count but had no effect on cell surface marker expression as examined by 
FACS for CD3, CD45RA, CD45 RO and CD22.
3.2.3. Locomotion assay
Lymphocytes purified from different samples of synovial tissue were motile and 
responded by polarisation in response to synovial fluid. Fig 3.10 shows the 
proportion of polarised cells in response to HBSS and synovial fluid. In contrast to 
blood cells, which required a period of culture to allow them to acquire locomotor 
capacity, the synovial tissue cells were active directly after preparation, suggesting 
that the cells were aheady activated in vivo.
3.3. Lymphocytes from synovial fluids
Synovial fluid lymphocytes were separated from theft own synovial fluid, washed 
three times in HBSS and tested against that synovial fluid and FCS or against IL-8. 
In contrast to the blood lymphocytes and the synovial tissue lymphocytes, synovial 
fluid cells showed almost no response in polarisation assays compared with the 
medium control. (Figure 3.11).
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TABLE 3.2
Effect of incubation of mononuclear cells from normal blood with Collagenase on 
their expression of CD3 CD45RA CD45RO and CD22.
Cells treated with 
^collagenase
Cells without 
collagenase
Total cell count (10^/ml) 1.7 1.8
Marker
CD3 59.2 54.3
CD45RA+ 55.6 57.2
CD45RO+ 26.4 28.4
CD22+ 11.5 9.6
* Collagenase (Worthington Biochemical Corporation, New Jersey, U.S,A) used here 
was different from that used in the collagen gel invasion assay (BDH, Type 1 
collagenase). The type 2 preparations are extracellular enzyme produced by the 
bacterium Clostridium histolyticum and especially used for tissue dissociation.
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FIGURE 3,10
Effect of synovial fluid on the polarisation of synovial tissue lymphocytes
25-
"d 2 0 -
FCS Medium
Cells were separated from synovial tissue and then exposed directly (see separation 
method) to synovial fluid (1:8) in a dose response polarisation assay. Results were 
statistically significant (* p~0.0026; **p= 0.0091) when compared with the medium 
control The SF bar represents the mean±SD for 3 synovial fluids results in three 
different experiments.
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FlG UR E3.il
Polarisation response of rheumatoid synovial fluid lymphocytes in response to 
various stimuli.
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Synovial fluid lymphocytes were separated from RA synovial fluid (n=10) and 
washed three times with medium and then exposed to Synovial fluid (SF 1:4), IL-8 
(lOOng/rnl) and FCS (25%). Clear bars show that the polarisation response to stimuli 
was not statistically significant when compared with the negative contr ol (medium 
alone). Filled bars show response of normal blood lymphocytes (used as control 
cells) to SF and IL-8. Results expressed as mean+SEM (n~6 for synovial fluid cells 
and n=3 for blood cells).
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3.4. Cell Pheiiotvnîng using APAAP
3.4.1, Control experiments
The blood lymphocytes that polarised in response to different synovial fluids were 
phenotyped by APAAP staining to see if the response to these fluids was selective for 
any cell class. Before phenotyping some control experiments were performed to 
confhm APAAP previous observations using this assay (Newman and Wilkinson 
1992). First it was necessary to compare the proportion of polarised cells in 
suspension and the proportion of the same cells in APAAP-stained cytospin 
preparations. Table 3.3 shows that the proportion of polarised cells was similar in 
both assays. Second to check if the monoclonal APAAP procedure can be used to 
label a wide range of monoclonal antibodies (such as CD3, CD4, CDS, CD22, 
CD56, CD45RA and CD45RO) with a degree of clarity and fully comparable to that 
obtained with the FACS labelling technique. Table 3.4 shows CD3 , CDS, CD22, 
CD56, CD45RO and CD45 RA were stained positively with the same intensity as in 
FACS preparations. CD4 did not stain positively in the APAAP assay.
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STABLE3 3
Comparison of fixed polarised lymphocytes (in response to synovial fluid) in 
unstained wet and APAAP-stained cytospin preparations.
Stimulus EXPl EXP2 EXP3
%lymphocytes polarised (200 cells counted)
WP CP WP CP WP CP
HBSS-HSA 6.3 9 7.5 4.5 10.5 12
SFl 28 25 32 33 39 49
SF2 49 46 37 35 39 41
SF3 39 32 25 27 37 28
SF4 52 49 30 37 47 57
* Lymphocytes were separ ated fiom blood and cultured overnight in FCS.
Cells suspensions from wet preparations were fixed and examined under phase 
contrast microscopy x40. Cells fiom the same suspension were fixed cytocentrifuged 
and stained by APAAP and then examined under phase contrast X40. SF=^synovial 
fluid, WP=wet preparation (unstained cells)
CP-cytospin preparation (APAAP-stained cells)
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TABLE 3,4
Comparison of percent staining intensity using the APAAP and FACS procedures 
with monoclonal antibodies for CD3, CD4, CD8, CD22, CD56, CD45RA and 
CD45 RO lymphocytes.
%Marker
EXPl EXP2 EXP3
APAAP FACS APAAP FACS APAAP FACS
CD34- 49.2 48 76.8 64.58 76.67 78.67
CD4+ ND 40.63 ND 41.87 ND 39.6
CD8+ 25.58 27.9 20.7 22.36 29.3 26.87
CD22+ 7.8 3 6.9 8.36 7.3 9.84
CD56+ 6.1 5 10.2 7.55 15.3 14.2
CD45RA+ 56 51.60 61.3 69.3 49.2 56.7
CD45RO+ 27.2 31.64 24.3 22.1 19.2 25.3
* Note that the lymphocytes used for both assays in each experiment were from the 
same preparation. EXP==Experiment, ND=Not detectable.
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3.4.2, Phenotyping of polarised lymphocytes.
The normal blood lymphocytes polarised in response to synovial fluids were 
phenotyped using APAAP staining to see if the response to these fluids was selective 
for any class. Fig 3.12 shows there was no significant selection for or against CD3, 
and CD22. The polarisation response of CD22+ and CD3+ cells was not statistically 
significant. CD56+ cells were also studied, but the number of polarised cells in this 
minority population that it was possible to coimt was too low to give rehable results.
3.4.3. Phenotype of lymphocyte subsets
Fig 3.12 also shows no significant selection for or against CD45RA+ cells but a 
higher proportion of CD45RO+ cells was polarized than would be expected fiom the 
proportion of polarized cells in the whole lymphocyte population (*p <0.05). These 
CD45RO+ cells were mostly (>90%) T cells. This suggests that lymphocytes that 
have recently responded to antigen and which are characteristically CD45RO+ 
(Smith et al., 1986) are attracted more vigorously by factors in the fluid than antigen- 
unreactive (naive) cells.
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FIGURE 3.12 Phenotyping lymphocytes and lymphocyte subsets using APAAP.
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Proportion of CD3+ CD22+ , CD45RA+ and CD45RO+ lymphocytes which 
polarised after short term exposure to synovial fluid. Cells were incubated with an 
optimal dilution of different synovial fluids for 45 min and phenotyped by APAAP. 
Clear bars represent the proportion of polarized cells among all cells, both positive 
and negative for the marker only. Note that variation in the proportion of total cells 
polaiized between different groups (clear bars) is due to tests for different markers 
being done on different samples. Differences between the total and the marker 
positive populations were not significant except for CD45RO+ (*p<0.05). Each bar 
represents the mean+SEM of 12 RA synovial fluids (n~3).
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Condusions
SF attracts lymphocytes and activated cells respond better than imactivated cells. 
Synovial tissue cells respond immediately but blood cells respond best if activated by 
overnight culture. Synovial fluid cells are unresponsive cells . Cells of CD45RO 
phenotype respond better than those of CD45RA phenotype.
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3.5 Phenotyping of locomotor cells invading coHageii gels recovered after 
collagen digestion.
Since the polarization assay suggested that CD45RO+ locomotor cells were selected 
for, phenotyping for CD45 isotypes was canied out by FACS analysis on 
lymphocytes. Two populations were studied, (a) The non-motile cells that remained 
on top of the gel. (b) The non-motile cells that had migrated into the gel were 
recovered after collagenase digestion of the gel. Both were stained for CD45RA and 
CD45RO. The superior locomotor activity of CD45RO+ cells over CD45RA+ cells 
was more clear-cut than in the polarization assay and selection against CD45RA was 
also obvious (Table 3.5)
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TABLE 3.5
Distribution of CD45 isotypes in locomotor and non locomotor lymphocytes 
following invasion of collagen gels incoiporating rheumatoid synovial fluid
percent of lymphocytes in population 
(Mean+SEM, n=3)
Subset on upper 
surface of gel
released from 
collagenase-digested 
gel (locomotor cells)
CD45RA+
CD45RO+
73.4+4.3*
44.5+6.6*
33.8+3.8
59.2+1.9
*Note that the total % of CD45+ cells in the non motile population is >100%, 
suggesting the presence of double-positive cells. Results ar e statistically significant 
(P<0.05; for both CD45RA and CD45RO Student t test) when comparing invasive 
with non invasive cells.
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3.6. Chemoattractant activity of synovial fluîd for human neutrophils measured 
by shape change and coUagen gel-iiivasion
3.61A. Response of normal blood neutrophils to synovial fluid
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In this study neutrophils from normal blood (>90% pure) were tested with different 
synovial fluids (from different groups of inflammatory diseases such as RA, OA and 
other inflammatory arthritides), medium (used as negative control) and in a uniform 
concentration (10'^) of FMLP (used as a positive control). Neutrophils incubated in 
HBSS/HSA at 37 for 30 minutes remained spherical. Neutrophils tested in a short 
term polarisation assay in different synovial fluids changed shape from round to 
polarised. Fig 3.13 shows a bell shaped dose response vrith maximal activity 
between 1:4 and 1:8. Then from these curves an optimal dilution was tested many
times in a subsequent short term polarisation assays. Synovial fluid from different
"Irheumatoid arthritis patients showed high polarisation activity compared with fluid
...5Î
from osteoarthritis patients and other inflammatory arthritides (Fig 3.14).
FIGURE 3.13
Polaiisation dose response of normal blood neuP ophils in response to synovial fluid.
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Reciprocal of dilution of synovial fluid 
Cells were separated from noimal blood and flien exposed to five synovial fluids, in 
a dose response polarisation assay. Three fluids with high activity and two with low 
activity have been selected to show die diverse pattern of activity obtained.
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FIGURE 3.14
Neutrophil polarisation in response to vaiious synovial fluids at optimal dilutions.
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Cells were tested against an optimal dilution of synovial fluid from RA (n-20) OA 
(n=5) and other (n—5) mflammatoiy aithiitides (n=^ 5). Each point represents the mean 
of 3 expeiiments. Bars represents the median of polarization response in each group. 
Control value has been subtmcted from the values shown. Results statistically were 
not significant
a"
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3.6. IB. CoUagcn gel invasion
To investigate the locomotion activity of neuti'ophils in response to synovial fluids, 
20 RA and 10 non RA synovial fluids were incotporated into collagen gels and 
incubated for three hours at 37  ^C. Fig 3.15 shows that 11/20 RA and 3/10 non RA 
synovial fluids were capable of attracting neutrophils. These results also coirelated 
with the polarization response mentioned above (r=0.789, p<0.01).
3.6.2. Neutrophil from synovial fluid
Neutrophils separated from synovial fluid were washed three times in medium , and 
tested against their own synovial fluid and against other chemotactic factors in a 30 
min polarisation assay. Figure 3.16 shows a comparison between the response of 
normal blood neutrophils and synovial fluid neutrophils to synovial fluid, and 
FMLP (10'^). Synovial fluid neutrophils showed almost no response.
Conclusions.
Rheumatoid synovial fluid attracts significantly normal blood polymorphonuclear 
cells. Synovial fluid polymorphonuclear cells showed defective locomotion activity 
in response to rheumatoid synovial fluid and FMLP compared with the control.
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FIGURE 3.15
Neutrophil invasion collagen gels in response to synovial fluids.
%
&
ÎH
&
r-H
*0V
**0or
ns
§
(/)
2PNIc
70
60
50
40
30
20
10
0
# #
e #
#
RA OA Others
Synovial fluids were from RA (n=20) OA (n=5) and others patients (n=5) Each point 
represents the mean of two experiments. Bars represent the median of polarization 
response. Control value has been subtracted fiom the values shown. Results were 
statistically significant when compared RA to OA (p<0.05).
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FIGURE 3.16
Polarization of synovial fluid neutrophils in response to dilfereiit stînmli.
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Polarization activity for polymorphonoeuclear neutrophils of synovial fluids (clem' 
columns) from patients with rheumatoid arthritis (n=lO) in response to synovial 
fluids (n=10) and FMLP as compared with normal human neutrophils (Filled 
column). Results are expressed as mean± SEM (n~3).
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3.7 CONCLUSIONS
Rheumatoid Synovial fluid has strong chemotactic activity for human peripheral 
blood lymphocytes as measmed by polarization and collagen gel assays. It has been 
found that the locomotion activity of these fluids is time dependent and uncorrelated 
with the inflammatory indicators including ESR and GRP. The data from polarization 
assays ar e correlated with collagen gel assays.
It has been also shown that the synovial fluid attracted significantly CD45RO+ cells 
(90% T cells) compared with insignificant selection against CD45RA, CD3, CD22 
and CD56 (as phentyped by APAAP and FACS). In addition it has been obseived 
that the synovial tissue lymphocytes had strong chemotactic activity in response to 
synovial fluid compared with cells from synovial fluid which were found to be 
immotile cells.
Regarding the neutrophils it was concluded that the synovial fluid has strong 
chemotactic activity for peripheral blood neutrophils, whereas neutrophils from 
synovial fluids were immotile cells.
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3.8. DISCUSSION
3.8.1 Locomotion activity of normal blood lymphocytes in response to synovial 
fluids.
3.8.1 A l. Comparison of the polarization activities of cells direct from blood and 
cells cultured overnight.
In the present study normal human lymphocytes directed from blood and cultured 
overnight (in FCS) were tested against rheumatoid synovial fluid in a short term 
polarization assay in order to compare the maximal polarization activity of these 
cells. Lymphocytes cultmed overnight in FCS (Berman 1966), gave h i^ e r  
polarization responses (30-49% to rheumatoid synovial fluid (at a dilution of 1:4 and 
1:16) than lymphocytes direct from blood (15-19% at dilution also of 1:4 and 1:16) 
This results are consistent with the suggestion by Parrott and Wilkinson 1981; 
Wilkinson, 1986 and Wilkinson 1987, that lymphocyte contact during culture with 
activators including FCS, or anti-CD3, PPD, PHA and allo-MLR (O' eill and 
Parrott 1977; Wilkinson 1986, Wilkinson and Higgins 1987) or Con A (Wilkinson et 
al y 1976), is essential for lymphocytes to acquire locomotor capacity. In other 
words the locomotion activity of lymphocytes taken from blood is very low, 
because these cells are not in cell cycle (GO). When they ar e cultured overnight with 
activators such as FCS, they acquire locomotor capacity and increase in size and
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RA and protein synthesis. These metabolic changes occurs during the G1 phase of 
cell cycle. Although FCS is reported to be a mitogenic factor, its mitogenic activity 
is not a critical step for stimulation of locomotion duiing overnight culture, because 
locomotion is activated long before the cell begin to synthesis DA . Increase in the 
locomotor response is dependent on activation and is enhanced as resting cells move 
into early G1 (Wilkinson 1986; Wilkinson 1992)
In conclusion to get the maximal locomotor immune response, resting or immotile 
cells should be cultmed with a suitable activator to acquire locomotor capacity and 
then tested against chemoattractant stimuh.
3.8.1 A2. Short term lymphocyte polarization in response to synovial fluids.
As the previous section determined that the propoition of polarized lymphocytes 
direct from blood was veiy low, cells were routinely cultured overnight and then 
exposed to a wide range of rheumatoid and non rheumatoid synovial fluids. There 
were differences of both optimal dilution and the level of polarization activity found 
in these fluids. The majority of the rheumatoid synovial fluids gave a bell-shaped 
dose response curve with a maximal activity at dilutions of between 1:2 and 1:16. 
The maximal proportion of polarized lymphocytes was 50-60%. In contr ast synovial 
fluids from OA gave negative or slightly higher responses than the normal control. 
This is not surprising since as will be discussed in chapter four, OA synovial fluid 
contains veiy low concentrations of cytokine chemoattractants. In addition several
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synovial fluids from other inflammatory arthritides such as polymyalgia rheumatica 
and psoriatic aithritis gave higher responses with 49-51% of polarized lymphocytes. 
These fluids had got sufficient levels of chemoattractants (>40ng/ml) to produce this 
maximal polarization activity. There was no relation between the optimal dilution 
and the amount of activity obtained at that dilution. However as will be discussed in 
the next chapter the polarization activity of these fluids is most likely to be due to a 
combination of chemoattractants. The maximal polarization activity was time 
dependent. The maximal percentage of lymphocytes was 35-45% after 10-30 min 
incubation. Further incubation of these cells at 40, 50 and 60 minutes did not result 
in any further increase.
3.8*1 A3. Lymphocytes invading collagen gels in response to synovial fluids.
In rheumatoid synovial tissues in vivo migrating lymphocytes must interact with 
extracellular matrix, and collagen is the major component of extiacellulai’ matrix of 
vertebrates (Linsenmayer 1981; Kuhn and Glanville 1980). To simulate migration or 
locomotion of lymphocytes as it occurs in vivo at synovial compaitments. Type 1 
collagen gel is a suitable matrix in vitro (Elsdale and Bard 1972). This method has 
got several advantages including allowing cells to be visuahsed m situ in the gels, 
and digestion of collagen gel matrix (Shields, et ai, 1984; Schor 1980) allows the 
invading cells to be recovered and phenotyped. In this section lymphocytes were 
allowed to invade tire collagen gel incorporated with the optimal dilution of synovial
178
fluids. It was found that the results of this assay correlated with the polarization assay 
mentioned above. This data are consistent with the observations of Wilkinson (1986) 
who reported that collagen gel assay supplements the polarization assay and provides 
direct evidence for active locomotion of lymphocytes towards chemoattr actants.
3,8,2. Locomotion activity of synovial tissue lymphocytes
During short term polarisation assays it was observed that lymphocytes separated 
directly from synovial tissue respond successfully without any pre-activation with 
any stimulators, compared with normal blood cells mentioned above (which need 
overnight culture to increase their locomotion capacity). This is interesting as these 
cells (synovial tissue lymphocytes) may acquire their locomotion capacity during 
ongoing local inflammatory processes (i.e recognition of unknown antigen 
somewhere in the synovial tissue, or may be these cells are activated in the 
circulation and then migrate to the joint tissue via specific homing receptors. Whether 
these cells ar e acti vated in a joint by a yet unidentified antigen or are in fact selected 
to migrate from lymphoid tissue to the site in the inflamed joint needs further 
investigations.
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3.8.3. Locomotion activity of rheumatoid synovial fluid lymphocytes
During separation of these cells from the synovial fluid it was noticed that cell 
viability in the majority of rheumatoid aithritis synovial fluids was not affected, and 
several other studies from different laboratories reported that these cells can 
proliferate in response to various stimuli (Hemler, ei al, 1986; Gaston et al, 1990), 
During short term polarization assays (in responses to active rheumatoid synovial 
fluid or other chemotactic factors such as IL-8), the polarization activity of 
rheumatoid synovial fluid lymphocytes was impahed ( i.e the synovial fluid 
lymphocytes are not locomotor or non motile), compared with the control. This is 
interesting but it is difficult to explain tins unresponsiveness. The following 
suggestions are possible (a) These cells might have completed their locomotor 
function in vivo and ceased their movement because they have internalised their 
chemotactic receptors but can continue other activities including cytokine production 
(b) As rheumatoid artliritis is considered as an autoimmune phenomenon 
autoantibodies or immune complexes produced in vivo (including autoantibodies 
against cytoplasmic proteins) might affect the frmctional activity of the chemotactic 
receptors of these cells, (c) chemotactic inhibitors (in synovial fluid) may selectively 
block the activity of particulai* chemotactic factor receptors. Agents that raise cyclic 
AMP levels in cells, e.g ÎL-1, prostaglandin, are able to do this and may be present 
in tlie fluids.
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It has been reported that dming binding of chemotactic receptors to leukocytes the 
intracellulai’ concentration of calcium and cAMP rises ( Bouceck and Synderman 
1976; Simchowitz et al., 1980). The former is reported to be necessary for many 
cellular functions, whereas the latter seems to inhibits leukocyte activities (Pike and 
Synderman 1984). There may be inhibitors (in the synovial fluid) to cAMP- 
phosphodiesterase which in turn raises cAMP, which might contribute to the 
termination of the cells response to any chemotactic receptors (i.e render these cells 
immotile). These chemotactic inhibitors may be considered as immunoregulatory 
molecules for the inflammatory immune response in rheumatoid arthritis.
t
3,8.4. Phenotvping of polarized lymphocytes and lymphocytes subsets
The proportion of CD3+, CD22+, CD45RA+ and CD56+ polarized cells that were
polarized reflected the proportion of these phenotypes in the whole population.
However the proportion of polarized CD45RO+ (95% are T cells) was higher.
than would be expected suggesting that this phenotype is associated with locomotion.
The significant selection of CD45RO+ cells suggests cells tliat have recently
responded to antigen are more likely to respond to chemotactic factors in synovial 
.fluid than naive cells. In collagen gel assays it was also observed that CD45RO+ 
cells were more motile than CD45RA+cells. In addition the acquisition of 
locomotor capacity is associated with cell growth (Wilkinson 1986) and CD45RO+
: |
cells are larger in area and volume than CD45RA cells after activation (ewman 
and Wilkinson 1994).
It has been reported that cytokines such as RATES are selectively chemotactic 
factors for CD45RO+ lymphocytes using polycarbonate filters (Schall et al, 1990) . 
We did not include RATES in our assays, though this cytokine may be present in 
the synovial fluid. We have not obtained good chemotactic activity for T cells using 
RAS. As will be discussed in the next section , our results do not support a 
simple correlation between levels of single cytokines and migration of lymphocytes 
into the inflammatory sites.
3.8.5 Locomotion activity of neutrophils
It has been reported that neutrophil migration into an inflammatory site is a self- 
amplifying phenomenon. Specific granules contain a protease that cleaves 
complement component C5 to release the strong chemotactic fragment C5a 
(Matzner et al., 1983). Chemotactic factors are released by the first few neutrophils 
which arrive at a site of inflammation, attracting more neutrophils. It has been also 
suggested that the locomotion response causes tissue damage in the inflammatory 
site including the rheumatoid synovium. If this response uncontrolled it could lead to 
a serious consequences.
eutrophil chemotaxis in rheumatoid arthritis had been studied using the leading 
fiont technique or raft technique (Hanlon et al, 1980; Goddard, et al, 1984). These
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studies concluded that neutrophils from RA patients (cells isolated from RA blood) 
showed reduced chemotaxis, and this defect in locomotion was reported to be due to 
several factors including neutrophil chemotactic inhibitors (i.e anti-complement 
fr agments or unidentified factors) either in RA blood or rheumatoid synovial fluid.
In this study polarization and collagen gel assays were used to do frnther neutrophil 
locomotion studies. It has been observed that cells from normal blood have shown 
strong chemotactic activity in response to a wide range of rheumatoid and non 
rheumatoid synovial fluid . This is not surprising as 1 will discuss later that synovial 
fluid contains a high concentration of neutrophil chemotactic factors including lL-8, 
but as will be discussed in the next chapter , IL-8 is not correlated with the neutrophil 
accumulation in the fluid. This data suggest that the chemoattraction activity of 
synovial fluids for neutrophils is due to combined chemotactic factors including IL- 
8 and C5a or other as yet unidentified factors.
On the other hand synovial fluid neutrophils incubated with their own synovial 
fluid or FMLP in a short term polarization assays showed a significantly reduced 
locomotion activity compared with controls. This indicated that these cells may be in 
the same situation as lymphocytes separated from synovial fluid (see above). In 
addition it has been observed here that the cell viability of neutrophils in some fluids 
was very low compared with the cell viability of synovial fluid lymphocytes from 
the same fluids.This indicates that synovial fluid can be considered as a grave for 
some inflammatoiy cells.
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CHAPTER 4 :
CYTOKINES IN SYNOVIAL FLUID:
THE PRESENCE OF LYMPHOCYTE CHEMOATTRACTANTS
4.1 INTRODUCTION
As the previous chapter showed that synovial fluid has a chemotactic activity for 
human leukocytes, cytokines present in SF may be relevant to its chemoattraction 
activity and to the accumulation of lymphocytes and other inflammatory cells in 
the synovia. The activity of lL-2 (Komfeld, et al., 1985; Wilkinson and ewman 
1994), IL-8 (Wilkinson and ewman 1992), M IP-la (Taub et al., 1993; 
Wilkinson and ewman 1994) and MCP-1 in stimulating of lymphocyte 
locomotion and chemotaxis has been reported. Recently lL-15 was shown to be a 
lymphocyte chemoattractant (Wilkinson and Liew 1995) and also, may play an 
important role in T cell migiation and activation in rheumatoid synovial tissue 
(Mclnnes et al, 1996).
In order to quantify the cytokine levels in SF, various commercially available 
immunoassays based on monoclonal antibodies were used. To measure the IL-15
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levels, a sensitive and specific double sandwich ELISA assay had to be 
developed in our laboratory.
By measuring chemoattractant cytokine levels in SF from patients with RA, OA 
and other inflammatoiy arthritides, it was possible to compare differences in 
chemoattractant cytokine distribution in different joint diseases. It was also possible 
to assess the correlation between the leukocyte count and the chemoattractant levels 
in SF. Finally it was important to investigate the role of these chemoattractants as 
mediators of SF locomotor activity by study of the inhibitory effect of anti- 
cytokine- specific antibodies (anti-IL-8, anti-IL-15, anti-MlP-la and anti-MCP-1) 
on SF-induced lymphocyte polarization and collagen gel invasion.
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4.2 RESULTS
4.2.1 Preliminary Experiments (leukocyte counts in inflamroatory synovial 
fluids
As mentioned in chapter 2, synovial fluids collected from different inflammatory 
arthritides were initially spun and the cells in the pellets were washed. The total 
WBCs, were counted and preparations were stained for differential counts. As 
shown in figure 4.1 the synovial fluid total white blood cell (TWBCs) count was 
significantly higher in rheumatoid arthritis patients than in osteoarthritis (p <0.02) 
and also significantly higher than in other inflammatoiy athritides (p <0.05). In 
addition synovial fluid from patients with rheumatoid arthritis contained more 
lymphocytes (fig 4.2) than OA fluids ( P <0.04) or fluid fiom other inflammatoiy 
diseases (P <0.05). eutrophil counts were also obtained (fig 4.3). RA-SF contained 
a significantly Ihgher numbers of neutrophils when compared to OA (P =0.0446) and 
other inflammatory arthr itides (p <0.05).
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FIGURE: 4.1
Total Leukocyte count m Synovial fluids
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Total WBC count in SF of patients with RA (n=34) OA (n=6) and other 
inflammatory arthritides (n=l 1). Ail results are expressed as individual data. Medians 
are indicated by horizontal bars. For more details see tables 4.1, 4.2 and 4.3.
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FIGURE: 4.2
Lymphocyte Count in Synovial fluids
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Lymphocyte count in SF of patients with RA (n—34) OA (n—6) and other 
inflammatory arthritides (n=l 1). Ail results are expressed as individual data. Medians 
are indicated by horizontal bars. For more details see tables 4.1,4.2 and 4.3.
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FIGURE: 4 3
Neutrophil count in synovial fluids.
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eutrophils count in SF of patients with RA (n=35) OA (n=6) and other 
inflammatory arthritides (n=l 1). All results are expressed as individual data. Medians 
are indicated by horizontal bars. For details see table 4.1,4.2 and 4.3.
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Table: 4.1 leukocyte counts in RA SF*
«éîf
M.B 0.1 05M.S 6.7 0.8 4.9W.M 0.4 .03 0.1
S.S 12.3 - 1.8 I il' 4.1
J.C 0.1 0.2 0.2
O.R 0.7 : - 0.5 ■
R.L 2.7 0.6 1.9
G.W 4.7 4.1
J.G 65.5 . 56.9
" CM 21.7 ' 6.8 -,C.W 15.7 i', Jj;
10.2
MJVfA 4.3 # # # # # # # 3.9w .c 24.0 10.8È'; 0.7 01
R.M 0.2 ^ 0.1-'M.M 1.2 0.6 : -I:; 0.5 ■
HJVI -n - '9 '"Jjb.ju_ 1.33;4 -30.0 20.4
1.2 04 ,
ILG 2.6 . 09" 4.8;^.;Vr: kj:,:., ..%3 2.9,
H.Y 1.5 1.3I#:!-: - 7 CJ .J “'IV K ‘ ““ 6.1
f  JA I t  '6.4 ' 4.7 lîht" - *• t} 1.21:2
J.K 3.2 1.3S7""' 2.5i||||||ÿ‘-' | |i ||||||V  .; 0.9 {y'l-Y'i"'-''
L.M i" -
2.0
3.0 4i;jij||Ai±i:SK& J..-/
RJVl 9.2 4.9 2.9
MJEJL 10.2' 5:2-, 3.2 ' 1G.H 23.8 11.5 6.8
B.L 0.1 , : ■ - i - 0.5 ■IJ ,, : 0.3I.F ............ L2........ . 0.7 „  ,$!„V-
* Total cell count in RA-SF (n=35) was determined (for details see method in chapter 2) as 
described above and is expressed as cells/ml SF (total leukocyte number). The proportion of 
those cells that are lymphocytes and neutrophils is gven.
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Table ; 4.2. leukocyte counts in OA SF*
i: .,^ T o ta im s a  '
'  (ceX l$ xl(f/m !)r^
 ^ L ym p ko cytes\^.
xiw’- y
^N eutroph ils r < ^
f t
H.Mc 0.1 0.1 0 1
D SC 0.2 0.1 ■ 0.1 <:K -
11 (.t —E.Mc 0.1 0.1 0.1
.A # . ; .  , 3.3 0.3 ~  —' 2,5
DJSA 2.4 05 1.7
i i i i i l 1.2
- # # # « : - ■
E.CÀ 1.9 0.5 1.2
Table; 4 3 . Leukocyte counts in other inflammatory arthritides*.
D.SM SPA 2 2 0.3 1.6
CCA k ... SPA ' :: M 1“ ! 1:!^ H n 1 -rif -i •. W-J: 6.9 X ^ g
R.MC SPA 3.2 0.5 2.7
F . # ; / PMR 1.3 ■ii|||ï||Wîip4 0.2 :M C R PART 3.7 lemrnk: i . W 1.9
AS 0.3 . -I 0.21
S.T IMHA 0.8 0.2 0.6
PSA 0.2. 0.1
B.T PSA 7 9 1 9 5.7
W.SP PSA #m. 2.3%&.:i!S
M.TH 0.2
Total cell count in OA-SF ( n=7 ,table 4.5) and other inflammatory arthritides (n=l 1,table 4.6) was 
determined (for details see method in chapter 2) as described above and is expressed as cells/ml SF 
(total leukocyte number). The proporticm of those cells that are lymphocytes and neutrophils is shown 
OA=osteoarthritis, SPA=sercmegative spondyloarthritis, PMR= polymyalgia iheumatica, 
AS=ankylosing spondylitis, IMHA^intermittent hydroarthrosis , PSA=psoriatic arthritis, 
PART=pyrc^hosphate arthropathy.
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4.2.2A. Detection of chemoattractant cytokines m SF 
4.2.2A1. Interleukin-2 (lL-2)
The levels of IL-2 in the synovial fluid of patients with RA, OA and other 
inflammatoiy arthritides were measured. As shown in figuie 4.4, low amounts of IL- 
2 were detected in patients with RA, (n=29) OA (n= 5) and patients witii othei 
inflammatory arthritides (n=7). IL-2 levels were below 250 pg/ml in all fluids. 
Although the IL-2 levels was significantly higher m RA compared with OA and other 
mflammatoiy aithiitides the concentrations shown m Fig 4.4 are well below the level 
(lO-lOOng/ml) at which pure IL-2 acts as a T lymphocyte attractant (Wilkinson and 
ewman 1994).
4.2.2A2. Interleukin 8 (IL-8).
To confirm whether IL-8 is present in the synovial fluids of patients with RA, 
synovial fluids firom RA (n=28) were tested as well as fluid from OA (n=5) and 
other ai thiitides (n=9). IL-8 was detected m the j o v i a l  fluids of most patients with 
rheumatoid arthiitis (Fig 4.5), The concentration of IL-8 in the synovial fluids from 
patients with seropositive rheumatoid arthritis
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FIGURE: 4.4
Levels of IL-2 in synovial fluids.
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Concentration of IL-2 in synovial fluids obtained from patients with RA (n=29) OA 
(n=5) and other inflammatory arthritides (n=7) was determined 
using ELISA. All results are expressed as individual data, Medians are indicated by 
horizontal bais. Broken line represents the limit of detection. For details see tables
4.4, 4.5 and 4.6.
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FIGURE: 4.5
Levels of IL-8 in synovial fluids.
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Concentration of IL-8 in synovial fluids obtained from patients with RA (n=29) OA 
(n=5) and other inflammatoiy arthritides (n=7) was determined using ELISA, All 
results are expressed as individual data. Medians are indicated by horizontal bais. 
Broken line represents the limit of detection. For more details see tables 4.4, 4.5 and
4.6.
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was higher than in the two groups of OA and other arthritides. There was a veiy wide 
variation in IL-8 levels between different fluids. Most contained substantial 
quantities of IL-8 (for details see table 4.4) though, in two patients with RA , one 
patient witli OA and two patients with other inflammatoiy arthritides, IL-8 was not 
detectable. T lymphocytes from noimal peripheral blood (Wilkinson and 	ewman 
1992) respond optimally to IL-8 at 100 ng/ml (and many rheumatoid joint fluids 
contained IL-8 at levels close to this). Although the clinical parameters of disease 
activity (ESR and CRP) tended to be higher in RA patients than in OA or non 
RA/OA there was no correlation between these paiameters and the concentiation of 
IL-8 in the synovial fluids. The concentiation of IL-8 in the synovial fluids from 
seropositive RA patients was comparable to concentrations previously shown 
(Wilkinson and 	ewman 1992) to induce chemoattractant activity for lymphocytes 
or neutrophils.
4.2.2. A3. Levels of interleukin-15 (IL-15)
The IL-15 concentration in synovial fluid fr om patients with different rheumatic 
disease was determined . As shown in fig 4.6 (for details see tables 4.4, 4.5 and 
4.6) IL-15 was detected at nanogram level in most cases of rheumatoid arthritis 
tested. On the other hand very low levels of IL-15 were found in OA synovial
1 95
fluids. IL-15 was also detected at high levels in some cases of other inflammatory 
arthritides.
4.2.2A4. Levels of macrophage inflammatory protein-alpha (MIP-la).
MlP-1 alpha levels was detected in synovial fluid using ELISA (Fig 4.7). The 
patients with RA (n=30) had M IP-la in most fluids, 7/30 at a level above the level at 
which pure M IP-la acts as a T lymphocyte attractant (Wilkinson and 
ewman 
1994). M IP-la alpha was also detected in small quantities in OA (n=6) and other 
inflammatory arthritides (n=8).
4.2.2.A5. Levels of macrophage chemotactic protein-1 (MCF-1)
MCP-1 levels were determined in synovial fluid of patients with RA (n=18) OA 
(n=5) and other inflammatoiy arthritides (Fig 4.8). Almost all RA fluids had 
MCP-1, (17/18) above the level at which pure MCP-1 level acts as T lymphocyte 
attractant (1-lOng/ml) (Wilkinson.P.C. unpublished obseivations). MCP-1 was 
also detected in 3/5 OA and in five patients with other inflammatory arthritides.
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FÏG 4,6. Level of lL-15 in synovial fluid.
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Concentration of IL-15 from patients with RA (n-23) OA (n=5) and other 
inflammatory aithritides (n=8) were determined using ELISA. All results are 
expressed as individual data, medians are indicated by horizontal bais. Broken line 
represents the limit of detection. For details see tables 4.4, 4.5 and 4.6.
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FIGURE: 4.7
Levels of MIP-1 alpha in synovial flaids.
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Concentration of MIP-1 alpha in synovial fluids obtained from patients with RA 
(n-30) OA (n-5) and other inflammatoiy aithritides (n-7) were determined using 
ELISA. All results are expressed as individual data, medians are indicated by 
horizontal bars. Broken line indicates the limit of detection. For more details see 
tables 4.4, 4.5 and 4.6.
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FIGURE. 4.8
Level of MCP-1 in synovial fluids 
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Concentration of MCP-l in synovial fluids obtained from patients with RA 
(n=18), OA (n=5) and other inflammatory aithritides (n=6) was determined using 
ELISA. All results are expressed as individual data. Medians are indicated by 
horizontal bars. Broken line represents the limit of detection. For details see table
4.4, 4.5 and 4.6.
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Table: 4.4. Levels of chemoattractants in SF of patients with RA.
MCP^ J X
M.B 90 0.0 NA 0.2: = NA
M S - 120 47.8 , 17 Bf'""T0.9::xgL NA
DM 95 2872 78 ' 0 . 1 ' ' # 107
-W.M " 145 26.5 no / 12
SJS 120 0.0 58 g y  . '' 6.1 _ 22
J .C 150 84.4 NA : o . 2 # # NA
D.R 189 417.8 8 32.3::.g@,, 0.67
» x 102 \ _ 181.2 74 . M '" ' . ' K â # L 55
G.W 185 200.3 17 NA
XG 135 . 161J . : 41 5.7 _
CM 169 46.0^ 27 NA
CW 100  ^ GSfV 36  ^0.2 , J . ' A .
MJEZ 135 432.0 31 A
W.C : . 0.0 876.0 i 16 •T' 10.2
M J 100 84.4 86 0.2 18.3
75 \ :  287.2 120.0 8.2
" m x m j 80 # # # # - 3.5 3.8 6.6
BM 95 110 # # # # 21.9
S.K 137  0.8 0.0
120 . 2.5 , 1 116 ,
29 434 36 0 34.6 34
».G 140 . 167 \   ^ 65.0 8,6 0.0MO.E 160 219 65.0 487 11.9
H.Y L 100: 110 -,  ^253.0 , 11.6
216 299 510 19.6 11 7
80 , 82.0 ^ -, 230 , 33.2
BX 2.9 NA  A A
85 ■ NA 11.0 L9 , 1 A
M.MO A NA 890 A 6.0
IVCM . A 36.7 i  , 2,8 11.8
J.K A 25.0 A A 8.2
US A' ■ . ; ^ A 5.8 A
I.M A A A 1.9 A
Levels of chemoattractants (IL-2, IL-8, IL-15, MIP-1 alpha and MCP-1) in synovial fluid of 
patient with rheumatoid arthritis. A= not available. ote that the concentration of IL-2 was 
in pg/ml.
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'Table: 4.5. Levels of chemoattractants in synovial fluid of patients with OA.
Codé - JJ^ 2 QfgM)
. .. . . ....... j* .. .... ... (ngMd) MIP-1 a(nsMh : MCP-1 - :
H.Me 0.2 11 NA 1.6 2.8
D isc g.. NA 2:0 2.0 NA
E.Mc ' ' 132 11 3.0 2.7 2.4
À.SO 100 11 3.0 1.7 0.1
DBA 80 11 1.0 0.9 1.3
AJLA NA 3.0 NA - 2l7 , NA
E.CA NA 0.0 2.0 NA 2.4
=^ Table. 4.6, Levels of chemoattractants in SF of patients with other inflammatory 
arthritides.
CodeH1.V ' iDÜgttosis^" ^ .3 JL-8 f JI^ IS Mmi a MCP-l,
D.SM SPA 100 65 19 0.1 5.2
F.BW m&i^80ü# 110 '  ^ 4 . 0 , # 1.0
M.GR PART : :: NA'"" 11 2.0 5.0 2.6
D.SH AS 120 „ 0.0 ; 24 0. : 0.7
S.T IMHA #::: 95 0.0 1.0 0.0 1.8
W.G PSA 100 110 1 hO ' 0.1" NA
B.T PSA NA 26.4 NA :: 2.0 4.8
W.SP PSA 130 48.5 , 13.0 î;b::.œ«;' 12 iifi, 6.6
M.TH PSA 85 44.9 5.0 2.0 NA
Levels of chemoattractants (IL-2, IL-8, IL15 and MIP-1 alpha) in patients with OA and other 
inflammatory arthritides. OA=osteoarthritis, SPA= seronegative spondyloarthritis, 
PMR=polymyalgia rheumatica, PART= pyrophosphate arthropathy, AS=ankylosing 
spondylitis , IMHA- intermittent hydroarthrosis, and PSA= psoriatic arthritis,. ote that the 
level of IL-2 was in pg/ml.
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4.3. Correlation between Chemoattractaut levels and accumulation of 
inflammatory cells in synovial fluids.
To compare levels of IL-2, IL-8, IL-15 and MIP-1 a  with accumulation of 
inflammatoiy cells in synovial fluid, I calculated the coiTelation coefficient between 
levels of the chemoattractants and counts of inflammatory cells and also compared 
levels of each cytokines with those of the other cytokines. As shown in table (4.7a 
and 4.7b), levels of cytokines in SF did not coirelate with each other except IL-8 and 
M IP-la (p <0.01), IL-15 and MCP-1 (p<0.01), MCP-1 and TWBC (p<0.05). There 
was no correlation between levels of any synovial fluid chemoattractants (table 4.7) 
and accumulation of inflammatory cells in any of the three patient groups (RA, OA 
and others).
4.4. Correlation between SF IL-8 and scrum RF
It was reported that mononuclear ceUs Jfrom RA patients spontaneously release IL-8 
and that production is markedly enhanced by RF-containing immune complexes 
(Sietz, et al 1991). In the present study rheumatoid factor was measured in 17 
patients with seropositive RA (Figure 4.9). There was no correlation between the 
titer of seinm-RF and the concentration of IL-8 in the synovial fluid.
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FIGURE. 4.9
Level of rheumatoid factors In senim of patients with RA.
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i
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100 :
D.D(1-10yrs) D.D (11-20 yrs) D.D(>20yrs)
Level of rhemnatoid factors in the seinm of rheumatoid arthritis patients with disease 
duration (D.D) 1-10 years (n=l 1), 11-20 (n=4) and >20 years (n=4) were determined 
utilizing Immunoturbidometry. All results were expressed as individual data, medians 
are indicated by horizontal bars.
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Table; 4.7 Summary of correlation coefficient of chemoattractants levels with
inflammatory cell accumulation in synovial fluids.
X X -0.181 NS
X X NS
X X 0.060 NS
X X 0.164 NS
X X 0.127 NS
r' X X ‘ I ‘ p<IJ72% 0.01
X X "''6.267'''''' NS
'' , x ^ [{ll- ‘ ' X ; 0.220 NS
X 0.189 NS
m SK a X ' ";_L ,, 0.050 NS
X X -0.031 NS
.y ■ * X y - ,..,., ......... : ; , , ,* # % NSX X 0.044 NS
# : X .: 3 -y! ■ ft. rj.it: 7 rjJ h NS
X X 0.027 NS
X - ' ; ^ 0:089 NSA X : 1 X ! -0.029 NS
JV. X ; 0.505 0.011 X X 1 0.034 NS' -t?. ■ ..■X yjHill 0.443 0.05X J X -0.095 NS
'■U.X-/.Î -0.014 NS
* Calculated by Spearman rank correlation test. 
NS=not significant.
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Table: 4.7b. Summary of correlation cocfiBcient of chemoattractants levels with
inflammatory cell accumulation In synovial fluids.
iL~2
w w
IL-8 IL-tS
A eW
MIP-Ia MCP-I TWBCs 149^aw/ha Neutro r P*
X X -0.181 NSX X 0.163 NSX X 0.060 NSX X 0.164 NSX X 0.127 NS
X X 0372 0.01X X 0.267 NSX X 0.220 NSX X 0.189 NS
. X # X 0.050 NSX X -0.031 NSX X 0.136 NS
X X 0.044 NS
X X 0.161 NSX X 0.027 NSX X 0.089 NSX X -0.029 NSX X 0.505 0.01X X 0.034 NS
X X 0.443 0.05
X X -0.095 NS
X X -0.014 NS
* Calculated by Spearman rank correlation test The P values above indicate the attained confidence 
level for individual pairs o f variables or correlates. However, if  we apply the 95% confidence criteria 
to the table taken as a )^ole, using Bonferwii’s inequality, we find that only cxie o f the correlation’s 
may be regarded as statistically significant namely that between IL-15 and MCP-1 (P=0.0085)
N S ^ o t significant.
4.5. Chemoattractant activity of cytokines for rhemnatoid human lymphocytes
As discussed earlier the synovial fluid has several chemoattractants with a 
concentration above the level at which they can act as T lymphocyte attractants. A 
further study was earned out to investigate the locomotion activity of pure 
cytokines using lymphocytes fiom RA synovial tissue and RA peripheral blood. As 
there were difficulties in collecting enough materials (RA Synovial tissue and RA 
peripheral blood) the locomotor response of RA synovial tissue T lymphocytes and 
peripheral blood T lymphocytes to IL-8 and IL-15 only was investigated. As 
shown in Figure 4.10 T lymphocytes fiom synovial tissue responded significantly to 
IL-8 (lOOng/ml) compared with the medium control (HBSS). A dose response assay 
was also done to test polarization of RA lymphocytes to IL-15. T lymphocytes fi om 
active RA peripheral blood show (Fig 4.11) a similar polarization dose response to 
IL-15 as blood fi-om noimal subjects (Wilkinson and Liew 1995). RA Lymphocytes 
also were allowed to invade collagen gels in response to EL-15 (lOOng/ml) and to 
optimal dilutions of synovial fluid (1:8). Figure 4.12 shows the locomotion activity of 
these cells compared with the cells from normal peripheral blood (used as a positive 
control).
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FIG 4.10. Effect of IL-8 on the polarization of synovial tissue lymphocytes
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Dose response of synovial tissue lymphocytes to IL-8 in a polarisation assay. Cells 
were tested directly after separation against IL-8 at difterent concentrations.
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FIGURE: 4.11
Polarisation of T cells from RA and normal blood in response to IU-15.
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•S 15-I^
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Concentration o f IL-15 (iig/m l)
Lymphocytes were separated from peripheral blood and incubated with IL-15 in a 
dose response polarisation assay. Squares represent the polarisation response of cells 
fr om active RA patients and cfrcles represent the polarisation response of cells 
from normal blood.
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FIGURE 4.12
Invasion bv RA and normal blood lymphocytes in response to IL 15 and synovial
fluid.
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Lymphocytes were allowed to invade collagen overnight in response to IL-15 
(lOOng/ml) and SF (1:8). The percentage of invaded lymphocytes was measured as 
mentioned above. The Clear bars represent the results widi RA cells and filled bars 
represent the results with normal blood cells (used as contr ol)
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4.6. Inhibition of activity of synovial fluids with cvtokine-specific antibodies
4.6.1 Preliminary experiments
To examine the inhibitory activity of anti-cytokine antibodies, seven rheumatoid RA 
synovial fluids (Table 4.8 A and 4.8 B) were chosen for study. Four specific 
cytokine-antibodies (anti-IL-8, anti-IL-15, anti-MIP-la, and anti-MCP-1) were used 
for study of their inhibitory effect. The effective dilution of all antibodies was 
determined as 1/500 or higher (P.C. Wilkinson, personal communication) except 
anti-MCP-1 which was used at 1/40 or 1/50 (Fig 4.13).
4.6.2 Inhibitory effect of antibodies to individual cytokines
Studies using aIL-8, aIL-15, anti-MIP-la and anti-MCP-1 showed that no antibody 
against any individual cytokine (see below), used alone, had significant inhibitory 
activity on the polarization response o f lymphocytes to synovial fluid even though 
the antibody was used at a concentration which had previously been shown to block 
the activity of pure cytokine at levels present in the synovial fluid.
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Table 4.8 A: Levels of chemoattractants in SF of RA patients 
(used for anti-cytokine antibodies inhibitory study).
. V • f' ‘
A' /L-/5L W P -i a(ng/mi) . ^
. A '..LlL/.ÿ.
MCP^ l (ng/ml)^
a^... *A i'... ,
D.G 167 65 8.6 0.0
3 3 8 " # * 82 230:$:..###:' 33.2"
 ^ ... 181 417 74 ' 55
219 48.7  ^ , 119
H.Y 110 NA 253 11.6
DJM 287 78 0.1 107
48.7 0.9 ..Y . < , UL- 44".NA ’'"-'’-i-
Table 4.8 B: Clinical descriptions of RA patients (used for anti cytokine
''pjtji/vîf'iL'gc:S'yeaAt+SéS^ eSs:-..;-Drags:! r ,®
D.G 7 35 (F) Modtnone Voltarol+Gold
AJ 23 53(M) Mild+Eros (-H -) Indocid+SASP >
R.L 16 V.sfeve+Eros (++j Feldçne+Cyclo-
#  /  : ; , phosphamide
H.Y Viï 88 (F p ïi Sulindac+acupan
;l|i FJVI .Ï : 5 S | ( F | | | Ibuprofen+Gold
DM 23 '  5 Ï | ( f | | | Seve+Eros (-Ff) Voltarol
,  M.S #40' -, Mild+Eros (++) :: g indocid # ÿ :
These tables show the chemoattractants levels and the chnical descriptions of fluids 
from RA patients used in the inhibition of lymphocyte attractant activity of synovial 
fluid using anticytokine specific antibodies (see above). For study of inhibitory effect 
of combined anti-IL8+anti-IL-15 6 RA fluids were used (D.G, A.J, R.L H. Y, E.M 
and M.S), H, Y, A.J , and E.M were used for anti-IL-8+anti-MIP-l a or combined 
anti-IL-15 and anti MIP 1 a). D M, A.J, and E.M were used for anti-MCP-1 
combined with other anti-cytokine antibodies. D.D=disease duration, Eros=erosion, 
V.seve=wery severe
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FIG 4.13; Inhibitory effect of anti-MCP-1 against MCP-1 (Ing/ml)
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This figure represents the inhibition of the response of blood lymphocytes to MCP-1 
(used at Ing/ml, Wilkinson, P.C unpublished observations) in the presence of anti- 
MCP-1 at valions dilutions . ote that at a dilution of 1/40, anti-MCP-1 inhibited 
>97% of MCP-1 polarization activity. This dilution (1/40) was deteirmned as the 
effective dilution of anti-MCP-1. Actual values for proportion of polarized cells in 
MCP-1 (Ing/ml) and Hanks-HSA were 27% and 14% respectively.
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4,6.3 Inhibitory effect of combinations of antibodies to cvtokmes
As shown in Fig 4.14 preincubation of fluids from 5 RA patients (Table 4.8) with a 
combination of anti-IL"8+anti-IL-15 substantially inhibited the attractant effect of 
synovial fluid (p<0.05-p<0.01) for lymphocytes as judged by polarization. Anti-IL-8 
or anti-IL-15 alone had no inhibitory effect on SF chemoattraction activity. These 
results indicated that the IL-8 and IL-15 present in the fluids (see Table 4.8A) may 
play a major role in lymphocytes chemoattraction into the synovial compartments of 
rheumatoid arthritis. The nrhibitoiy effect of a combination of anti-IL-8 and anti- 
M IP-la was also studied, hr these experiments preincubation of fluid from 3 RA 
patients with the combination of aIL-8 and a MIP-1 a  also showed significant 
inhibitory activity of polarization of lymphocytes in response to synovial fluid (Fig 
4.15). These results shows that IL-8 and MIP-1 alpha (Table 4.8) may contribute to 
the lymphocyte attractant effect of synovial fluid. In addition the inhibitory effect of 
combinations of anti-IL-15 and anti-MIP-la was studied. When combinations of 
these antibodies were used, consistent inhibitory effects were not seen (Fig 4.16). 
The inhibitory effect of anti-MCP-1 together with other cytokines was investigated.
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Fig 4.14 : Inhibition of the response of polarized lymphocytes to SF in the
presence of combination of anti-IL-8 and anti-IL-15 antibodies.
■O—  aIL-8 + alL-15 combined 
aIL-8 (1/500)
100 -  0- aIL-15 (1/500)
IgG Control
75 -
gcd
50 -
I P<0.01
P < 0 .02
25 -
32 2416 8
Reciprocal of dilution of synovial fluid
Inhibition of lymphocyte polarization to RA synovial fluids (n=5) in the presence of 
anti-IL-8, anti-IL-15 or a combination of the two antibodies. Each curve represents 
the Mean±SEM (n=3). P values were compared with the IgG conti’ol.
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FIGURE 4.15 Inhibition of the response of polarized lymphocytes to SF in the
presence of a combination of anti-IL-8 and anti-MIP-la.
aIL-8-+aMIP“l a  combined 
aMIP-1 alpha (1/500)
100
IgG control
s
50-
32 16 4 28
Reciprocal of dilution of synovial fluid
Inhibition of lymphocyte polarization to RA synovial fluids (n=4) in the presence of 
anti-IL-8, anti-MIP-la or a combination of the two antibodies. Results represents the 
Mean±SEM (n^3). Inhibition by the combined antibodies aIL-8+aMIP-l a  was 
statistically significant when compared with IgG control (P<0.01 for fluid at dilution 
of 1:8 or higher: not significant for fluid at 1:2 or 1:4).
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FIG 4M:  Inliibitioii of the response of polarized lymphocytes to SF in
the presence of a combination of anti-IL-15 and anti-MIP-la.
"D—— aIL-15+aMIP-la combined 
^ -----  aMIP-1 alpha (1/500)
aIL-15 (1/500)
IgG control§ 75»
50-
i
0 -
28 41632
Reciprocal of dilution of synovial fluid
Inhibition of lymphocyte polaiization to RA synovial fluids (n=3) in the presence of 
anti-IL-15 and anti-MIP-la or a combination of the two antibodies. Results 
represents the Mean+SEM (n=3). Inhibition by the combined antibodies aIL-15 and 
aMIP-1 a  was not statistically significant when compared with IgG control.
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As with the combinations of antibodies described above, the combination of anti- 
MCP-1 with anti-IL-15, or anti-IL-8 also caused significant inhibition of 
lymphocyte polarization to synovial fluid compared with the IgG control (Fig 4.17). 
This result indicated that MCP-1 present in the fluid (Table 4.8 A) may play a role in 
lymphocyte locomotion in rheumatoid arthritis.
Inhibition with combinations of three antibodies (aIL-8, aIL-15 and anti-MIP-la) or 
with four antibodies mentioned above togetirer was still stronger but was still below 
100% (Fig 4.18). This indicates that other cytokines (or non cytokines attractants) 
may contribute to the chemoattractant activity of these fluids for lymphocyts.
4.6.4 Inhibition of lymphocytes invasion of coliagen gels containing 
synovial fluid bv anti-cvtokine antibodies.
As shown in table 4.9 a combination of aIL-8 and aIL-15 significantly inhibits 
lymphocyte migration in collagen gels induced by RA fluids (p<0.001). A 
combination of aIL-8 and aMIP-1 alpha antibodies also significantly 
prevented the locomotion of lymphocytes into collagen gel induced by the 
same fluids (p<0.05, Table 4.10).
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FIG 4.17 Inhibition of the response of polarized lymphocytes to SF in
the presence of a combination of anti MCP 1+IL 15, and anti-MCP-1 and
anti-lL-8 or anti-MCP-1+anti-MlP-l alpha.
aMCP-l+aIL-15 
aMCP-l+aIL-8 
aMCP- ] +aMIP-1 alpha 
aIL-8
aMIP-1 alpha
aMCP-1
IgG
100-
i 75-1a
8 5 0 -
I
2 5 -
32  16 4 28
Reciprocal of dilution of synovial fluid
Inhibition of lymphocyte polarization to RA synovial fluids (n=3) in the presence of 
anti-MCP-1 +anti-lL-15, and anti-MCP-1+aIL-8 or anti-MCP-l+anti-MlP-la. 
Results represents the mean±SEM (n=3). Inhibition by the anti-MCP-1 together with 
aIL-15 or aIL-8 was statistically significant (P<0.05 for fluid at dilution of 1:8 or 
higher) when compared with the IgG control.
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FIG 4,18 Inhibition of the response of polarized lymphocytes to SF in 
the presence of four or three antibodies together.
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alL-8+aIL-15-+ 
aMïP-1 alplia+aMCP“ 1
aJL-8+aIL-15+aMIP-1 alphi 
aIL~8
aMlP-1 alpha 
aMCP-1
aIL-15
IgG
Reciprocal o f  dilution o f  synovial fluid
Inhibition of lymphocyte polaiization to RA synovial fluids (n=3) in the
presence of combined fom antibodies (alL-S+alL-lS+anti-MCP-l+anti-MIP-la) or
in the presence of three antibodies together (anti“MIP-l+aIL“15+aIL-
8). Results represents the mean±SEM (n-3). The inhibition by four or three
antibodies was stronger and highly significant when compared with the IgG control
(p<0.05-0.001 for fluid at dilution of 1:2 or higher) but still under 100%.
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Table 4.9 Inhibition of lymphocyte invasion of collagen gels bv alL-8 and
al5  antibodies.
Treatment of 
synovial fluid
% cells invading 
collagen gel 
meaniSEM
% inhibition 
mean±SEM
No tieatment 29.5±L2
IgG (1/500) 26.6±L0 9.7±1.0
anti-IL-8 (1/500) 28.0+0.7 5.0+2.4
anti-IL-15 (1/500) 27.1+2.3 8.4±6.3
anti-IL-8+anti-lL-15 IL4+2.2 60.6+8.8
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Table 4.10 Inhibition of lymphocyte invasion of coilagen gel bv anti-IL-8
and antî-MIP-1 a  antibodies.
Treatment of 
synovial fluid
% ceils invading 
collagen gel 
mean±SEM
% inhibition 
mean+SEM
No ti eatment 34.1+1.8
IgG (1/500) 33+1.4 3.2L0.85
anti-IL-8 (1/500) 32.5+1.5 4.7L0.50
anti-MIP-la (1/500) 33+2.0 3.2L0.90
anti-IL-8+anti- M IP-la 21.50+2.7 36.5±1.8
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4.7 CONCLUSIONS
Chemotactic cytokines are present in the synovial fluid in RA.The concentiations 
of IL-15, lL-8, M IP-la and MCP-1 are high enough to attract lymphocytes into 
the joint. The concentration of IL-2 is too low to do so. The chemoattractant 
activity of the joint fluid cannot be accounted for by any single cytokine, because 
no single anti-cytokine monoclonal antibody produces significant inhibition of 
the activity of the joint fluid. However combination of antibodies do produce 
significant inhibition activity for lymphocytes.
In comparison to RA, the level of chemotactic cytokines in OA fluid are low and 
these fluid are less potent in attracting lymphocytes.
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4.8. DISCUSSION
4.8.1. Lymphocyte chemoattractants and lymphocyte accumulation
ÎL-8 is reported to be a lymphocyte chemotactic factor for lymphocytes 
(Wilkinson and Newman 1992), but the proportion of responding locomotor 
lymphocytes is low compared with the very high proportion of blood 
neutr ophils obseiwed to be responding to IL-8. In the present study, it was found 
that there was no correlation between IL-8 level and lymphocyte accumulation in 
the synovial fluid. This is expected since as will be discussed later; lymphocyte 
accumulation in synovial fluid probably results from the action of several 
chemoattractants.
The infiltr ation or the accumulation of lymphocytes or lymphocyte subsets within 
the synovial compartments has been well investigated. The locomotion or 
migration of these cells into the joints or into the joint fluid is beheved to be due 
to the activity of chemotactic factors. Although this study demonstrated that 
there are several chemoattractants in the synovial fluid, it has been found some of 
these factors were present at concentrations too low to induce the locomotion 
activity of lymphocytes. For example the level of IL-2 was found to be less than 
Ing/ml in all patients tested either from active or non active RA. This dose is 
not enough to induce lymphocyte locomotion activity compared with that found
by Wilkinson and ewman 1994 (lO-lOOng/ml). This data is consistent with
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other studies showing that the lL-2 production in rheumatoid arthritis was 
deficient (Comb et ai, 1985; Kitas et al., 1988).
The explanation for the IL-2 defect production in RA still as yet not clear, but IL~ 
2 may consumed in the RA inflamed joints or there might be other potential 
mechanisms including inhibition of production by suppressor cells, or intrinsic 
abnonnalities of the IL-2 producing T lymphocyte population (Combe et al., 
1985). In addition other scientists suggested that the defect in IL-2 production 
may be due to factors produced by activated monocytes/ macrophages such as 
prostaglandin and hydrogen peroxide which may inhibit lymphocyte functions 
which in turn lead to the defect in IL-2 production (Kitas et ai, 1988).
In this study IL-15 was found (in fluids mostly from patients with RA in a dose 
level (>20ng/ml) that can induce locomotion activity of lymphocytes. These data 
are consistent with those observed by Wilkinson and Liew (1995) that > 20 
ng/ml of pure IL-15 can attract peripheral blood lymphocytes in vitro. The 
presence of IL-15 in the synovial fluid, and synovial tissue (Mcltmes et ai, 
1996) may provide an important alternative mechanism for chemoattiaction and 
activation of T cells in the synovial compartments in the absence of IL-2. IL-15 
has a similar action to IL-2 as an activator of T lymphocytes. Activation of T cell 
by IL-15 is blocked by treating cells with antibody to the p chain of the IL-2 
receptor (Grabstein et al., 1994) and the p chain of the IL-2 receptor is required
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for activation of locomotion by both IL-2 (Wilkinson and ewman 1994) and 
IL-15 (Wilkinson and Liew 1995). The discovery of IL-15 may provide an 
explanation for the IL-2 knockout mice make nearly-noimal immune response 
(Kundig et al., 1993) since it can substitute for IL-2 and may do so in the 
rheumatoid joint.
This study also demonstrated that other lymphocyte chemoattractants including 
M IP-la and MCP-1 were present in the majority of RA patients and several 
patients with other inflammatory arthritides in a dose high enough to induce 
lymphocyte locomotion. These data aie consistent with other studies showing 
that M IP-la and MCP-1 are produced at the site of the inflammatoiy joints (see 
chapter 1). M IP-la and MCP-1 are inflammatory chemokines which contiibute 
to lymphocyte accumulation in the joint as suggested by inhibition by their 
specific antibodies
The finding that adding antibody singly (including aIL-8, aIL-15, anti-MIP-la 
and anti-MCP-1) to the synovial fluids has no effect on the locomotion activity 
of these fluids, but combined antibodies can eliminate between 55-89% of the 
synovial fluid chemoattiaction activity (both polarization and collagen gel 
migration), indicates that the locomotion activity of lymphocytes in rheumatoid 
synovial compaitments cannot be attributed to any single cytokine. Moreover the 
accumulation of lymphocyte within the synovial fluid was not correlated with the
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level of any chemotactic factor in the fluids. It is probable that there are as yet 
unidentified lymphocytes chemotactic factors to be investigated.
It can be concluded that rheumatoid synovial fluids contain several of 
lymphocyte chemoattiactants at sufficient concentration to induce lymphocyte
■
locomotion. In contrast synovial fluids from OA contain small amounts of such 
factors and the accumulation of both neutrophils and lymphocytes was low.
Investigation of the other hand the locomotion activity of synovial tissue
4.8.2. Chemoattractants and lymphocytes (RA peripheral blood and synovial
' Itissues!
It has been suggested that lymphocytes from RA patients (peripheral blood) 
have a functional defect in response to several stimulators including P.H.A and 
Con A (Silverman et al., 1976). This study shows that the locomotion activity of
' :W-
RA lymphocytes (peripheral blood) is not impaired as judged by their noimal 
locomotion response to IL-15 and synovial fluids compared with cells from 
noimal blood. In order to draw a definitive conclusion regarding the normal 
locomotion of these cells a large study is required and , other chemotactic factors 
need to be tested.
lymphocytes in response to the above mentioned chemoattractants was an
important one of the important aim of the present study, but unfortunately there
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was only limited material for such investigations. Lymphocytes separated from 
the few synovial tissues available from patients with active RA showed 
locomotor responses to IL-8. This suggested that these cells have been already 
activated in vivo, and they can responded to chemoattiacatnts without needing 
further activation.
4.8.3 lL-8 level and accumulation of neutrophils.
As stated earlier the accumulation of inflammatory cells in the rheumatoid joint 
or rheumatoid synovial fluid is a histological feature of acute and chronic 
inflammation. For example in case of neutrophils it has been found (present 
study) that in most patients with active rheumatoid arthritis, neutrophil 
accumulation was veiy high in the synovial fluids. This data confirms the 
previous observations reported by other laboratories (Endo et al, 1991; Brennan 
et al, 1990). The neutrophil accumulation in the fluids was suggested to results 
from attraction by chemotactic factors such as IL-8, C5a, platelet activating 
factor or leukotriene B4 (Sietz et al, 1992). In the present study, IL-8 was found 
to be abundant in the synovial fluid of most patients with active RA and in 
several patients with other inflammatory diseases (see Table.4.6). The 
concentration of IL-8 was not correlated with neutrophil accumulation. These 
data suggested that IL-8 acts as contiibutoiy factor for such accumulation, but
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several molecules structurally related to IL-B (gro gene products) were shown to 
have neutrophil chemotactic activity equivalent to IL-8 (Brennan et ai, 1990). 
These factors are reported to be produced by fibroblasts and endothelial cells 
following stimulation with IL-1 or TF-a and such factors may be expressed 
during the inflammatory immune response in RA and may contribute to the 
chemotactic activity of the synovial fluid (Brennan et al., 1990).
Other investigators (Seitz et al, 1992; Rampart, et al, 1992) reported that the 
high-potency of rheumatoid factor-containing immune complexes triggers IL-8 
generation by peripheral blood and synovial fluid mononuclear cells. The 
presence of such immune complexes in the rheumatoid joints generates IL-8 
locally (Rampart et al, 1992). However the correlation between RF and IL-8 
was not significant (present study) and the production of IL-8 in the synovial 
environment may predominately be due to other stimuli including, IL-1 and 
TF-a which have been observed to be stronger inducers of IL-8 in vitro and 
reported to be in abundance in the synovial fluids (Seitz et al, 1992).
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CHAPTER 5:
EFFECTS OF ANTI-RHEUMATIC DRUGS ON LOCOMOTOR 
ACTIVITY OF LYMPHOCYTES IN RESPONSE TO SYNOVIAL
FLUID
5.1 Background
The rapid development in understanding of mechanisms of leukocyte locomotion 
has led to interest in the possibility of inhibiting white cell migration in vivo. 
Although not necessarily as part o f their mode of therapeutic action, various 
anti-inflammatory dmgs are widely used to inhibit the circulation, migration, 
activation and locomotion of leukocytes. The corticosteroids cause circulating 
lymphopenia in the blood (Fauci and Dale 1974; Yu, et al., 1974; Clark et al., 
1977; Cooper, et al., 1977), which appears to be due to the retention and 
selective redistribution of recirculating T lymphocytes (Yu, ei ai, 1977) and 
increased migration into the bone marrow (Cox and Ford 1982). Corticosteroids 
also downregulate cytokine production (see chapter 1) by mononuclear cells 
with a consequent inhibition of lymphocyte migration (Pitzalis 1995) and 
proliferation. In addition it has been observed that corticosteroids inhibit 
lymphocyte-endothelial cell (EC) binding through die inhibition of LFA-1 and
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CD2 expression following lymphocyte activation (Pitzalis et al., 1995; Pitzalis 
and Panayi 1993).
Cyclosporin A appears to have some therapeutic efficacy in RA (Tugwell et al., 
1995). Cyclosporin A was reported to interfere with the eaily stage of T cell 
activation (see chapter 1) and consequently reduces lymphocyte migration and 
locomotion. It inhibits cytokine production including production of IL-2 and IL- 
6, cytokines which play a major role in acute inflammatory immune responses 
(Crilly etal, 1995).
Taken together this suggests that drugs that interfere with lymphocyte 
inflammatory activity may be effective clinically (Carlos and Harlan 1990). In 
this chapter study of the effect of drugs on inhibition of lymphocyte locomotion 
in vitro is described. Since during the C l phase of cell cycle, lymphocytes 
acquire locomotor capacity, activated lymphocytes with locomotor capacity may 
therefore be recruited from the blood into the inflammatoiy lesion, e.g into the 
synovial tissue of rheumatoid joints. Such locomotor activation can be inhibited 
in vitro by culture of lymphocytes in the presence of cyclosporin A or FK506 
(Wilkinson and Higgins 1987 b, Wilkinson and Watson 1990), both of which are 
drugs which inhibit entry of lymphocytes into Gl. In this section, experiments
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are described in which the inhibitory effect of antirheumatic drugs such as 
NSAIDs, DMARDS and corticosteroids on the locomotor activity of lymphocytes 
in response to SF was investigated.
2 3 0
5.2 RESULTS
5.2.1 A. Preiiminarv experiments
5.2.1A1. Effect of preincubation with anti-rheumatic drugs on lymphocyte 
viability.
To determine the effect of preincubation with different anti-rheumatic drugs on 
lymphocytes viability, 1x10^ cells/ml were cultmed (in HBSS-HSA for 24 h at 
37 ^C) with graded doses (lOOOpg/ml-lpg/ml ) of different drugs used in the 
present study. After the incubation period, cell viability (as defined by trypan dye 
exclusion and confirmed by examining cell morphology under phase-contrast 
microscopy) for the dose of lOOpg/ml was above 79% (range 79-83%) for CSA, 
Rapamycin; Primaquine, cyclophosphamide and corticosteroids and above 82% 
(82-87%) for (DMARDs including Gold, D-penicillamine) and above 85% for 
NSAIDs (range 85-89% ) including aspirin, Ibuprofen and indomethacin. On the 
other hand there was no loss of cell viability at a dose of 10 pg/ml or less of all 
drugs tested in the present study. Table 5.1 shows the results using a dose of 
lOpg/ml of various dmgs as an example. The cell viability was above 87% (range 
87-96%). However there was cell damage (as determined by phase-contrast
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microscopy) and a significant loss of cell viability for the graded doses of 
500pg/ml or higher. In the cour se of this study graded doses of lOOpg/ml or less 
were chosen as in vitro physiological doses and used to investigate the 
inhibitory effect of these drugs on lymphocyte polarization and locomotion.
5.2.1A2. Effect of preincnbation with anti-rheumatic drugs on the 
lymphocyte response to chemoattractants.
In these experiments lymphocytes were cultured in 25% FCS for 24 hr at 37 in 
the presence of 10 pg/ml of Aspirin, Gold sodium thiomalate , Cyclosporin A, 
rapamycin, dexamethasone, prednisone and prednisolone. After the incubation 
period cells were separated and washed 3 times in HBSS-HSA and tested for 
their ability to respond to synovial fluid. Table 5.2 shows that the doses 
mentioned above are not toxic since the lymphocytes can respond strongly to 
synovial fluid (after washing out the dmgs) compared with the control.
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Table 5.1 Effect of drug preincubation on lymphocyte viability
Treatment cell viability (%)
Aspirin 96%
Ibuprofen 93%
Imdomethacin 89%
D-penicillamine 87%
Gold (sodium thiomalate) 89%
Primaquine (8-aminoquinoline) 87%
Cyclophosphamide 89%
Rapamycin 87%
Cyclosporin A 87%
Dexamethasone 89%
Prednisone 92%
Prednisolone 91%
* Lymphocytes were in cultured HBSS-HSA in the presence of drugs at a dose of 
10 pg/ml . The percentage of viable cells was assessed by the tiypan blue 
exclusion test. Percent of lymphocytes viability cultured without drugs which 
werer viable was 96%.
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Table 5.2 Effect of preincubation with drugs on the lymphocyte polarizatioa 
response.
Treatment 
(Cells preincubated in 
drngs+FCS25%)
% Polarized cells 
SFl (1:4)
%polarized cells
Aspirin 46 31
Gold sodium thiomalate 39 31
Cyclosporin A 43 30
Rapamycin 38 28
Cyclophosphamide 42 31
Dexamethasone 45 33
Prednisone 39 32
Prednisolone 38 28
** Lymphocytes preincubated in 
25% FCS alone
43 34
* Cells were cultured in 25% FCS in the presence of drugs (10 jug/ml) and 
subjected to washing 3-4 times in HBSS-HSA and then exposed to different 
synovial fluids (at dilutions of 1:4 and 1:8) in a short term polarization assay.
** lymphocytes were cultmed in 25% FCS without drugs washed three times in 
medium, and exposed to the synovial fluid. The Percent of lymphocyte polarized 
in HBSS-HSA (as a negative control for all experiments) was 11%.
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5.3. Inhibitory effect of drugs on the lymphocyte response to synovial fluid.
The inhibitory effect of several anti-rheiunatic drugs on the ability o f blood 
lymphocytes to respond to synovial fluids (Table 5.3) in polarization and 
locomotion assay were studied as follows.
5.3.1. Inhibition of SF-indpced lymphocyte polarization in the presence of 
NSAIDs and DMARDs (short term effect).
Lymphocytes were cultured for 24his in FCS washed and preincubated for Ih 
with the drugs (lOOng to lOOpg/ml), and then incubated with an optimal dilution 
(1:8) of RA-SF in a dose response polarization assay. As shown in fig 5.1 there 
was little inhibitory effect on lymphocyte polarization in the presence of 
indomethacin, aspirin or Ibuprofen. Preincubation of the same cells with tlie 
DMARDs (gold, D-penicillamine and gold+D-penicillamine combined fig 5.2) 
or 8-aminoquinoline and cyclophosphamide (Fig 5.3) also had an insignificant 
effect.
2 3 5
Table 5.3. Clinical descriptions of RA patients used for anti-rheumatic drugs 
inhibitory study.
Code D,D Ageyears+Sex Overall severity+Erosion best dilution
R.M 4 82 (F) seve+Eros (+++) 1:16
M.EZ 4 70(F) Seve+Eros (++) 1:8
C.J 16 51 (M) V. seve+Eros (++) 1:8
D.M 23 59 (F) Seve+Eros (++) 1:2
M.S 40 74 (F) Mild+Eros (++) 1:4
M.G 8 57(F) Mod+Eros (++) 1:8
H.Y 6 88(F) V.Seve 1:4
This table shows clinical descriptions of RA patients whose synovial fluids were 
studied for inhibition of lymphocyte polarization using anti-rheumatic drugs (see 
above).
For study of inhibitory effect of AIDS 3 RA fluid were used (R.M. M.EZ and 
M.S). For DMARDS and immunosuppressive drugs all other RA fluids mentioned 
above were used m different experiments. D.D=disease duration in years, 
Eros=erosion, V.seve=very severe.
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Fig 5.1. Inhibition of the response of lymphocytes to SF in the presence of
analgesics and NSAIDs.
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Dose response cuises for indomethacin (IM),Aspirin (ASP) and Ibuprofen (IBP) 
as inhibitors of polarization of lymphocytes in response to SF. Each curve 
represents the mean±SEM (n=2). The y axis shows percentage inhibition : actual 
values for proportion of polarized cells in SF and Hanks-HSA without drugs were 
38% and 18.6%. Results were not statistically significant.
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FIG 5.2, Inhibition of the response of lymphocytes to SF in the presence of
disease modifying antirlieumatic drugs.
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Dose response curves for Gold alone, Gold+D-penicillamine (DP) combined and 
D-penicillamine alone as inhibitors of polarization of lymphocytes in response to 
SF. Each curve represents the mean±SEM (n=3). The y axis shows percentage 
inhibition : actual values for propoition of polarized cells in SF and Hanks-FISA 
without drugs were 35% and 15.2% respectively. Results were not statistically 
significant.
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FIG 5.3. Inhibition of the response of lymphocytes to SF in the presence of 8-:
aminoguinoline and cyclophosphamide.
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Dose response curves for 8-aminoquinoline (8-AMQ) and cyclophosphamide 
(CPM) as inhibitors of polarization o f lymphocytes in response to SF. Each curve 
represents the mean±SEM (n=2). The y axis shows percentage inhibition : actual 
values for proportion of polarized cells in SF and Hanks-HSA without drugs 
were 42.3% and 11.6% respectively. Results were insignificant.
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5.3.2. Inhibition of SF-induced lymphocyte locomotion in the presence of 
corticosteroids (short term effect).
There was a significant inhibition of polarization in the presence of 
coiticosteroids (Fig 5.4) such as dexamethasone (10 fig/inl P<0.025) , 
prednisolone (Ipg/ml P<0.01)) and prednisone ( Ipg/ml P < 0.05). As shown 
in table 5.4 dexamethasone, prednisolone and prednisone significantly inhibit 
lymphocyte migration in collagen gels induced by RA fluids (p<0.01 for 
lOpg/ml DXM, Ipg/ml prednisolone and prednisone Table 5.4).
5.3.3. Inhibition of lymphocyte locomotion in the presence of cyclosporin 
A and rapamycin.
Cyclosporin A and rapamycin were defined as immunosuppressive natmal 
products with a common ability to inhibit T lymphocyte activation by interfering 
with intiacellular signalling mechanisms (Sigal and Dumont 1992). There was a 
significant inhibition of lymphocyte polarization in the presence of cyclosporin A 
(Ipg/nd p<0.01) but no inhibitory effect was see in the presence of rapamycin 
(Fig 5.5).
240
FIG 5.4. Inhibition of the response of lymphocytes to SF in the presence of 
corticosteroids.
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Dose response curves for dexamethsone (DXM), prednisolone (PRL) and 
prednisone (PR) induced inhibition of polarization of lymphocytes in response 
to SF. Each curve represents the mean±SEM (n=3). The y axis shows percentage 
inhibition : actual values for proportion of polarized cells in SF and Hanks-HSA 
without drugs were 49.3% and 9.6% respectively. Results were statistically 
significant. DXM (10 pg/ml p=0.025), PR ( Ipg/ml p<0.05) and PRL (Ipg/ml
p<0.01).
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FIG 5.5. Inhibition of the response of lymphocytes to SF iii the presence of
CSA and rapamycin.
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Dose response curves for cyclospoiin A (CSA) and Rapamycin (RAP) induced 
inhibition of polarization of lymphocytes in response to SF. Each curve 
represents the mean±SEM (n-3). The y axis shows percentage inhibition ; actual 
values for proportion of polarized cells in SF and Hahks-HSA without drugs were 
38.5% and 9% respectively. Results were statistically significant for CSA 
(Ipg/ml, p^O.012).
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Cyclosporin A also significantly inhibited locomotion of lymphocytes in 
collagen gels induced by the same fluid (p<0.05, Ipg/ml Table 5.4).
5.4. Long term inhibitory effect of SF-indwced lymphocytes polarization 
by anti-rheumatic drugs.
Table 5.5 a shows that dmgs including, dexamethasone, prednisone 
prednisolone and CSA at graded doses between 10 jag/ml-O.lpg/ml) have a 
significant inhibitory effect on the lymphocyte polarization activity during 
overnight culture with the synovial fluid at a dilution of 1:8. On the other 
hand rapamycin has little inhibitory effect. However Table (5.5 b) and Table 
(5.5 c) show that the DMARDs and SAIDs have insignificant effects on the 
lymphocyte polarization activity in response to SF during overnight cultuie 
compared with the control.
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Table 5.4. Effects of corticosteroids and cyclosporin A on invasion by of 
lymphocytes of collagen gels containing synovial fluid.
Cells treated in % cells invading 
collagen gel ±SEM
inhibition of invasion 
+SEM
Hanks-HSA 6.0±2.3
*SF alone 33.5+5.0 “
SF+ DXM (100 ng/ml) 9.5±2.7 71.612.6
SF+ DXM (lOpg/ml) 19.5+3.9 41.811.9
SF+PRL (Ipg/ml) 21.2+1.5 36.713.00
SF+ PR (1 ng/ml) 20.512.7 38.811.2
SF+ CSA (1 ng/ml) 23.7+3.8 29.315.9
DXM+dexamethasone 
PRL=prednisoIone 
CSA“cycIosporin A 
3 RA synovial fluids (SF)were tested at 1:8 dilution.
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TABLE 5.5 a . Effect of Corticosteroids, CSA and rapamycin on the 
polarization activity of lymphocytes during overnight culture.
% mean polarized cells 
for two experiments+SEM
DXM PRN PRL CSA RAP
SF(1:8)+  lOng/ml* 11+1.0 13.311.3 14.810.75 18.810.75 2911.0
SF(1:8)+  Ing/ml** 18+1.0 23.810.75 23.810.75 2011.0 29.712.6
SF (1:8)+ 0.1 ng/ml 3011.0 29.511.5 32.511.3 34.811.8 31.611.4
SF alone (no drugs) 
Hankks-HSA alone (no drugs)
3510.5
5.611.2
DXM=dexamethasone,PR=prediiisone,PRL=prednisolone, CSA^cyclosporin 
A and RAF=rapaniycin. Results were statistically significant for DXM , PRL, 
PR and CSA at a dose of 10 ng/ml (*p <0.01) and 1 ng/ml (**p <0.05).
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Table 5.5 b. Effect of DMARDs on the polarization activity of
lymphocytes during overnight culture.
%polarized cells in a 
single experiment
GLD D-PLM 8-AMQL
SF (1:8) + 10|Lig/ml 26 35 27
SF(1:8)+  Ipg/ml 35 33 29
SF (1:8)+ 0.1 pg/ml 30 35 31
SF alone (1:8) 31%
Hanks-FISA alone 6%
GLD=Goid (sodium thiomalate), D-PLM~D-penecillmaine and 
8-AMQL~8-aminoquinoline.
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Table 5.5 c. Effect of NSAIDS on the polarization activity of lymphocytes 
during overnight culture.
%polarized cells in a 
single experiment
ASP IBP IDM
SF(1:8)+  lOpg/ml 30 32 27
SF(1:8)+  Ipg/ml 35 36 31
SF (1:8)+ 0.1 pg/ml 39 39 35
*SF alone 38%
Hanks-HSA alone 6%
ASP=^Aspirin, IBP^Ibuprofen and IDM==indomethacin
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5.6 Conclusions
NSAIDs, (including Aspirin, îbuprofen and Indomethacin) DMARDs (Gold 
sodium thiomalate and D penicillamine and anti-malarial drugs or primaquine 
(8 -aminoquinoline) and cyclophosphamide had no inhibitory effect on 
lymphocyte locomotion. On the other hand CsA and Glucocorticosteroids had a 
significant inhibitory activity on the lymphocyte locomotion in response to 
synovial fluids.
Therefore lymphocyte locomotion in vitro cannot be controlled by SAIDs and 
DMARDs, but it can be contiolled by CsA and Glucocorticosteroids.
As synovial fluid-activated locomotion in vitro provides a model for 
chemoattractant-activated locomotion and since the locomotion is inhibited by 
gluocorticosteroids and CsA, and the significant inhibitory doses used in vitro 
were comparable to the whole blood concentration (0,5-lpg/ml) (Van et al, 
1989) it may be reasonable to suggest that part of the action of these drugs is to 
inhibit the recmitment or locomotion activity of lymphocytes into inflammatory 
lesions including those in rheumatoid joints.
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5.6. DISCUSSION
5.5.1 Anti-rhemiiatic drugs and lymphocyte locomotion
The data presented here investigated the locomotor inhibitory effect of NSAIDs, 
DMARDs, cytotoxic and corticosteroids drugs. ﬀSAIDs including Aspirin, 
Ibuprofen and indomethacin had no effect (either at high or low doses) on 
lymphocyte locomotion. This suggests that such dmgs have no effect on 
induction of the G1 phase of the cell growth necessaiy for non motile 
lymphocytes to acquire locomotor capacity and also had no effect on the 
locomotor mechanism itself in aheady motile cells. ﬀSAIDs including aspirin 
may suppress P.H.A-induced lymphocyte transformation (Opelz and TerasaJd 
1973). However this activity is related to late stages of the growth cycle ( DﬀA 
synthesis) after locomotor activation has occuned (Opelz and Terasaki 1973). 
Other studies reported that Aspirin influenced the migration of neutrophils and 
monocytes by directly affecting the surface of granulocytes and decreasing their 
ability to enter the extravascular space. It has been also demonstrated that 
ﬀSAIDS including indomethacin, increase the number of lymphocytes in the 
synovium (Bahremand & Ralph 1991). This might not be due to a direct effect 
of Indomethacin on the metabolic function of these cells but to reduction of 
prostaglandin synthesis induced by these drugs (prostaglandin as stated earlier is
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one of the important inhibitors of lymphocyte locomotion and also lymphocyte 
proliferation). Other drugs such as Ibuprofen have been reported to inhibit the 
migration and aggregation of inflammatoiy cells, mainly neutrophils, as well as 
the release of lysosomal enzymes (Konstan et ah, 1995).
DMARDs (including Gold sodium thiomalate (GST), D-penicillamine, 
combined gold+ D penicillamine, 8 -aminoquinoline) and other cytotoxic drugs 
(including cyclophosphamide) had little inhibitory effect on lymphocytes 
locomotion, suggested that these dings cannot suppress the progression of cell 
growth from GO into G1 or arrest the metabolic activity of G1 itself (ie. these 
drugs do not affect the G 1 phase of the cell growth and exert their action on the 
late stage of DﬁA synthesis). These data are also consistent with the suggestion 
that DMARDs including Gold compounds suppress rheumatoid synovitis by 
reducing the number of high endothelial small blood vessels available for 
emigration of lymphocytes (Bahremand and Ralph 1991).
The finding that CSA (present work) had an inhibitory effect on lymphocyte 
locomotion in response to chemoattractant synovial fluid at a dose range 
between 1-lOpg/ml confirmed previous work by Wilkinson and Higgins (1987) 
who reported that CSA inhibits lymphocyte locomotion in response to anti-CD3 
antibody. Anti-CD3 activation raises the intiacellular free Ca^" (intiacellular
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calcium mediates lymphocyte activation) and stimulates Ca^  ^ flux-dependent 
NaVH' exchange. Unpublished studies by Matthews and colleagues 
(Yamanouchi Research Institute Oxford) suggest that ﬂa+/H+ exchange may be 
an important event in lymphocyte polarization.
CSA has been reported to block the activation of lymphocytes early in the G1 
phase of giowth (Sigal and Dumant 1992). Its major activity appears to be an 
inhibition of IL-2 gene expression. This can be explained as follows: The 
induction of IL-2 gene transcription is mediated by a regulatory region which 
contains a number of nuclear proteins common to other promoters including ﬂF- 
AT (nuclear factor of activated T cells) OCT-1 and AP-Î (Paliogianni et aL,
1993). ﬂF-AT is reported to be absent in resting or unstimulated T lymphocytes 
and appears after 1 0 -2 0  min of T cell activation and continues to increase until it 
reaches a peak of less than 36h (Granelli-Pipemo & ﬂolan 1991).
It has been suggested that when CsA binds to intracellular proteins called 
cyclophilins, it become activated and then blocks the T cell activation mediated 
by ﬂF-AT, (the binding site for this protein is to sensitive to CSA) either through 
interference with its synthesis or transport into the nucleus or due to inhibition of 
its functional activity (Paliogianni et al.^  1993; Borel 1994; Fan and Rainsford
1994). Regarding the OCT-1 it has been observed that this molecule cannot be 
inhibited by CsA or glucocorticosteroids (Paliogianni et ah, 1993). On the other
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the other hand as will be discussed below it has been obseived that AP-1 activity 
cannot be inhibited by CsA but by glucocorticosteroids. In addition the CsA- 
cyclophilin complex is reported to inhibit the calcium protein phosphatase, 
calcineurin and protein kinase-mediated ti ansactivation of the IL-2 promotor (Fan 
and Rainsford 1994 Paliogianni et al,, 1993).
In contrast rapamycin had no inhibitoiy effect on lymphocyte locomotion. This 
not surprising as this drug is considered as an anti-proliferative agent (i.e it 
exerts its activity during DﬃA synthesis at a late stage of cell division) and not 
an anti-locomotive agent (i.e inhibiting RﬃA and protein synthesis) (Sigal and 
Dumant 1992).
The finding that Gluccoiticosteroids (including dexamethasone, prednisone and 
prednisolone) significantly inhibit lymphocyte locomotion at low dose (figure 
5.4 and Table 5.4 and Table 5.5) indicates that these drugs block the 
progression of cells either from GO into G1 or block the progression of cell 
during G1 its self during cell growth. However this significant inhibition may be 
consistent with principle of the mechanism of action of these drugs which is 
reported to inhibit IL-2 gene expression (mentioned earlier to be the critical early 
event during T lymphocyte activation).This obseivation is confirmed by the 
addition of IL-2 to cultures of T cells stimulated in the presence of
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inhibit IL-1 (synthesis and release) and cyclosporin suppresses IL-2 production.
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glucocorticosteroids which overcomes the inhibition of T cell activation (Jeffrey
et al, 1992). The inhibitoiy effect of these drugs is reported to be through
glucocoiticosteroid receptors (GRs) which interact with specific DA response 
.elements in the T cells (Jeffery et al, 1992). These receptors exist in the 
nucleous as high molecular weight molecules and there are about 3000-100000 
receptors per cell and they have high affinity for the gluocorticosteroids (Flower 
and Dale 1994; Evans 1988). It has been reported that glucocorticosteroids 
(through their GR) including dexamethasone inhibit or interfere with activity of
.the transcription factor AP-1 by direct protein-protein interaction (Jeffrey et al.
1992; Paliogianni et al, 1993). Although It can be suggested that CsA and :
glocucorticosteroids act synergistically (i.e CsA is a potent inhibitor for F-AT
and gluococorticosteroids are a potent inhibitors for AP-1) the inhibitory effect
of CsA does not require the presence of other sites of the IL-2 promotor. A
synergy is supported by other observations (Winkelstein 1991) that antigen
stimulation in vivo induces monocyte to release IL-1 (which induces T cells to 
.synthesis IL-2) and also induces responsive T cells to express the receptor for
IL-2. Glucocorticosteroids are reported (Winkelstein 1991) to act primarily to
CHAPTER 6. GENERAL DISCUSSION AND FUTURE
RESEARCH
The inflammatoiy infiltrate in rheumatoid lesions is heterogeneous but 
macrophages and T lymphocytes are usually prominent. The precise role of 
these cells is controversial and will probably remain so until the nature of the 
antigen (s) responsible for the lesions is deteimmed. The present study found 
that chemoattractants including IL-8,11-15, M lP-la and MCP-1 are present in 
substantial quantities in rheumatoid synovial fluid, their levels being higher in 
RA than in OA. In addition IL-8 , IL-15 and MCP-1 were found in abundance 
in a few patients with other inflammatory arthritides including polymyalgia 
rheumatica, psoriatic arthritis and ankylosing spondylitis. As stated earlier all 
four cytokines are produced by macrophages in large amounts. The fifth 
cytokine, IL-2, has lymphocyte attractant activity similar to IL-15 (Wilkinson 
and ewman 1994), but is present in quantities much too low to be playing a 
major role in chemoathaction. Thus it seems possible that macrophages are 
the important cells for releasing T lymphocyte attractants and that these cells 
may play a major role in T lymphocyte recruitment into the joint 
Synoviocytes may also be able to synthesis IL-15 (Mclrmes el al., 1996), 
Macrophages in rheumatoid lesions have been reported to make IL-8  (Koch et 
al., 1991) and other work from this laboratoiy (Mclnnes, et al., 1996) shows 
that they also make IL-15.  ! single cytokine is dominant as an attractant and 
mixtures of anti-cytokine antibodies are needed to inhibit the attractant effect 
of synovial fluid. IL-8 , IL-15, MCP-1 and M lP-la are all present in many of
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present in many of the fluids in concentrations sufficient for any one alone to 
attract lymphocytes. It is therefore not surprising that blocking with antibody 
to single cytokines is insufficient to block the activity of the fluid. This is in 
contrast to the previous observation that in PBMC cultured with aCD3 or I
PPD for 48h, the activation of lymphocyte locomotion was almost entirely due 
to IL-8  produced by monocytes in monocyte-lymphocyte clusters (Wilkinson 
and "ewman 1992). Almost no IL-15 was produced under those conditions 
(Wlikinson unpublished observations). However, that was a short-term in 
vitro study and it is possible that maturation of monocytes to macrophages is 
required for IL-15 production.
On the other hand the T lymphocytes found in rheumatoid lesions are I
activated as judged by expression of CD69, CD25 and MHC Class II (lannone 
et al., 1994). The capacity of T lymphocytes to respond by locomotion to 
soluble attractants is dependent on activation and is expressed as resting cells
move into early Gi (Wilkinson 1986). This is why blood T cells are cultured ;;
/"overnight to obtain optimal locomotor responses. Synovial tissue 
lymphocytes, which are already activated, do not require such culture. In 
normal human blood and lymphoid tissues, a variable, but usually a minority, 
population of T cells is CD45RO+ and these are probably cells that have 
become activated by recent contact with antigen (Bell et al, 1992). The 
proportion of CD45RO+ T cells in rheumatoid lesions is high (Pitzalis et al,
1987), and CD45RO+ cells adhere preferentially to peripheral (non-lymphoid) 
vascular endothelium (Pitzalis et al, 1988). CD45RO+ cells, as would be
a
I
Æ :
expected, are more motile than CD45RA (Newman and Wilkinson 1993), and 
these cells, when tested from blood, showed preferential locomotor responses 
to rheumatoid synovial fluids, particularly in the collagen gel assay, which has 
the advantage over most locomotion assays that the locomotor cells can be 
rescued and phenotyped. The better selection for CD45RO+ and against 
CD45RA+ cells in the collagen gel invasion assay than in the polarization 
assay may be because CD45RO+ cells are both more adherent and more 
motile. The collagen gel assay requires both locomotion and adhesion, but 
polarization measures locomotion independently of adhesion. The hypothesis 
relating the above findings to the ingress of lymphocytes into inflammatory 
lesions is as follows. Unprimed, recirculating lymphocytes (CD45RO 
negative) make contact with, and respond to, the as-yet undefined antigens 
responsible for rheumatoid lesions. This takes place on the surfaces of 
accessory cells either in lymphoid tissue or, since rheumatoid lesions contain 
liigh endothelium which recirculating cells are able to cross, within the joint 
itself. These cells become activated and therefore capable of making 
locomotor responses to inflammatory chemoattractants. When they detach 
from the lymphocyte-accessory cell cluster and re-enter the bloodstream, 
those which have acquired an activated phenotype (CD45RO+, 
CD25/CD122+) no longer recirculate but can attach to, and migrate across, 
inflammatory endotbelia (Mackay, 1991). These cells accumulate selectively 
in the joint attracted by cytokines produced by macrophages and other cells 
such as synoviocytes in the lesions..
256
1'+
Lymphocytes from synovial fluid were unresponsive to all stimuli in 
locomotion assays despite the fact that these cells are viable and capable of 
proliferation. Possibly prolonged exposure to locomotor inhibitory factors in 
the fluid, for example factors that elevate intracellular cyclic AMP, may have
render these cells immotile.
In addition in this study 1 have used the polarization and collagen gel assay to
.measure polymorphonuclear cell (PM#) locomotion and have demonstrated a 
significant locomotor response of PM# (isolated from normal blood) to 
rheumatoid synovial fluid and several fluids fiom other inflammatory 
arthritides. This finding may suggest that lL-8  abundance in these fluids may 
cause the attraction of these cells, but the insignificant con elation between the
Ï
accumulation of cells and IL-8  in the fluids indicates that such accumulation 
may be due to combined chemotactic factors. This results is in agreement with 
the finding of Brennan et al., 1990. In contrast PM# isolated fiom the 
synovial fluids showed significant reduction in chemotaxis. These results 
suggest that these cells internalized their receptors or may be prior ingestion of 
immune complexes (in case of PM#; either in RA peripheral blood or RA
.synovial fluid and RA synovial tissue) causes inhrbition of their locomotion
activity. In addition several PM# inhibitory factors reported in the synovial
fluids may selectively render these cells immotile or these may be a PM#
locomotion defect due to autoantibodies against their cytoplasmic proteins.
.Since anti-mflammatory drugs (including CsA) which are used for the 
treatment of RA are reported to inhibit lymphocyte chemotaxis (Wilkinson
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and Higgins 1987).It was important to consider the role of anti-rheumatic 
drugs in the locomotion activity of inflammatory cells including lymphocytes. 
Two observations are reported. First treatment of these cells in vitro with 
$%AIDs (including aspirin, Ibuprofen and indomethacin) and DMARDs 
(including gold, D-penicillamine, and primaquine) or other cytotoxic drugs 
(including cyclophospamide and rapamycin) showed no inhibitoiy effect on 
the locomotion activity of these cells. This suggested that the mechanisms of 
action of these drugs may be anti-proliferative (i.e they exert their inhibitory 
effect at a late stage of cell growth) or selectively suppress the release or the 
activity of inflammatory mediators (produced by the inflammatoiy cells) 
rather than suppression of cell motiUty. For example it has been observed that 
some of these drugs including cyclophosphamide cross-link DNA strands 
which results in decreasing the lymphocyte proliferative response in vitro 
(Winkelstein 1991). Second treatment the lymphocytes with CsA and 
Glucocoiticosteroids (including dexamethasone, prednisone and prednisolone) 
showed a significant inhibitoiy effect. These drugs exert their inhibitory 
action at an early stage of cell growth at a time when the locomotor 
phenotype in T cells begins to be expressed.
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Future Research
Despite a considerable amount of work using a variety of assay systems, 
the following questions remain about the role of lymphocyte locomotion 
in RA and the manipulation of locomotion of these cells. First, the 
locomotor activity of cells isolated from various RA synovial tissues and 
other inflammatory arthritides needs fiuther investigation and phenotyping 
of the responsive cells to well known chemoattractants and rheumatoid 
synovial fluid. A full comparison of lymphocytes from RA and other 
inflammatory arthritides with noimal controls would be useful. Second, 
inhibitory factors in the synovial fluid are as yet unidentified and their role 
is not clear. In addition the site of action of these inhibitors is also unclear 
(i.e whether they act on the lymphocytes or neutrophil themselves or on 
the chemotactic factors). Third despite the measurements of above 
mentioned cytokines, other chemoattractants in the synovial fluid need 
frirther investigation including RA&TES, MIP-(3 (our assays showed 
inconsistent results with these cytokines) and other as yet unidentified 
chemotacic factors.
Finally as long as the antigen which cause the activation of inflammation 
in rheumatoid arthritis is not identified it will be difficult to understand 
and contiol the locomotion of lymphocytes and other cells in rheumatoid 
arthiitis and other inflammatoiy arthritides.
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